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ABSTRACT 
Novel Molecular Engineering Approaches for Genotyping and DNA 
Sequencing 
Chunmei Qiu 
The completion of the Human Genome Project has increased the need for investigation 
of genetic sequences and their biological functions, which will significantly contribute to 
the advances in biomedical sciences, human genetics and personalized medicine.  
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry 
(MALDI-TOF MS) offers an attractive option for DNA analysis due to its high accuracy, 
sensitivity and speed. In the first part of the thesis, we report the design, synthesis and 
evaluation of a novel set of mass tagged, cleavable biotinylated dideoxynucleotides 
(ddNTP-N3-biotins) for DNA polymerase extension reaction and its application in DNA 
sequencing and single nucleotide polymorphism (SNP) genotyping by mass spectrometry. 
These nucleotide analogs have a biotin moiety attached to the 5 position of the 
pyrimidines (C and U) or the 7 position of the purines (A and G) via a chemically 
cleavable azido-based linker, with different length linker arms serving as mass tags that 
contribute large mass differences among the nucleotides to increase resolution in MS 
analysis. It has been demonstrated that these modified nucleotides can be efficiently 
incorporated by DNA polymerase, and the DNA strand bearing biotinylated nucleotides 
  
can be captured by streptavidin coated beads and efficiently released using 
tris(2-carboxyethyl) phosphine in aqueous solution which is compatible with DNA and 
downstream procedures. Reversible solid phase capture (SPC) mass spectrometry 
sequencing using ddNTP-N3-biotins was performed, and various DNA templates, 
including biological samples, were accurately sequenced achieving a read-length of 37 
bases. In mass spectrometric SNP genotyping, we have successfully exploited our 
reversible solid phase capture (SPC)-single base extension (SBE) assay and been able to 
detect as low as 2.5% heteroplasmy in mitochondrial DNA samples, with interrogation of 
human mitochondrial genome position 8344 which is associated with an important 
mitochondrial disease (myoclonic epilepsy with ragged red fibers, MERRF); we have 
also quantified the heteroplasmy level of a real MERRF patient and determined several 
mitochondrial MERRF mutations in a multiplex approach. These results demonstrated 
that our improved mass spectrometry genotyping technologies have great potential in 
DNA analysis, with particular applications in sequencing short-length targets or detecting 
SNPs with high accuracy and sensitivity requirements, such as DNA fragments with 
small indels, or SNPs in pooled samples. To truly implement this mass 
spectrometry-based genotyping method, we further explored the use of a lab-on-a-chip 
microfluidic device with the potential for high throughput, miniaturization, and 
automation. The microdevice primarily consists of a micro-reaction chamber for single 
base extension and cleavage reactions with an integrated micro heater and temperature 
sensor for on-chip temperature control, a microchannel loaded with streptavidin magnetic 
  
beads for solid phase capture, and a microchannel packed with C18-modified 
reversed-phase silica particles as a stationary phase for desalting before MALDI-TOF 
analysis. By performing each functional step, we have demonstrated 100% on-chip single 
base incorporation, sufficient capture and release of the biotin-ddNTP terminated single 
base extension products, and high sample recovery from the C18 reverse-phase 
microchannel with as little as 0.5 pmol DNA molecules. The feasibility of the 
microdevice has shown its promise to improve mass spectrometric DNA sequencing and 
SNP genotyping to a new paradigm.  
DNA sequencing by synthesis (SBS) appears to be a very promising molecular tool for 
genome analysis with the potential to achieve the $1000 Genome goal. However, the 
current short read-length is still a challenge. Therefore, the second part of the thesis 
focuses on strategies to overcome the short read-length of SBS. We developed a novel 
primer walking strategy to increase the read-length of SBS with cleavable fluorescent 
nucleotide reversible terminators (CF-NRTs) and nucleotide reversible terminators (NRTs) 
or hybrid-SBS with cleavable fluorescent nucleotide permanent terminators and NRTs. 
The idea of the walking strategy is to recover the initial template after one round of 
sequencing and re-initiate a second round of sequencing at a downstream base to cover 
more bases overall. The combination of three natural nucleotides and one NRT 
effectively regulated the primer walking: the primer extension temporarily paused when 
the NRT was incorporated, and resumed after removing the 3’ capping group to restore 
  
the 3’-OH group. We have successfully demonstrated the integration of this primer 
walking strategy into the sequencing by synthesis approach, and were able to obtain a 
total read-length of 53 bases, nearly doubling the read-length of the previous sequencing.  
On the other hand, we explored the sequencing bead-on-chip approach to increase the 
throughput of SBS and hence the total genome coverage per run. The various prerequisite 
conditions have been optimized, allowing the accurate sequencing of several bases on the 
bead surface, which demonstrated the feasibility of this approach. Both of these 
approaches could be integrated into current SBS platforms, allowing increased overall 
coverage and lowering overall costs. 
As a step beyond genotyping, the in vivo visualization of biomolecules, like DNA and its 
encoded RNA and proteins, provides further information about their biological functions 
and mechanisms. The third part of the thesis focuses on the development of a novel 
quantum dot (QD)-based binary molecular probe, which takes advantage of fluorescent 
resonance energy transfer (FRET), for detection of nucleic acids, aiming at their eventual 
use for detection of mRNAs involved in long term memory studies in the model 
organism Aplysia californica. We reported the design, synthesis, and characterization of a 
binary probe (BP) that consists of carboxylic quantum dot (CdSe/ZnS core shell)-DNA 
(QD-DNA) conjugated donor and a cyanine-5 (Cy5)-DNA acceptor for the detection of a 
sensorin mRNA-based synthetic DNA molecule. We have demonstrated that in the 
absence of target DNA, the QD fluorescence is the main signal observed (605 nm); in the 
  
presence of the complementary target DNA sequence, a decrease of QD emission and an 
increase of Cy5 emission at 667 nm was observed. We have demonstrated the distance 
dependence of FRET, with the finding that the target with 16 base separation between the 
QD and Cy5 after probe hybridization gave the most efficient FRET. Further studies are 
in progress to evaluate the effectiveness of this QD-based probe inside a cell extract and 
in living cells. 
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Chapter 1 Introduction to Genomic Analysis Technologies -- 
DNA sequencing, Genotyping, Nucleic Acid Detection 
For thousands of years, people have been seeking the answers to the mystery of life, 
what defines us inherently, what makes us different from others, and what causes 
malfunctions of our body, etc. Thousands of years of accumulated efforts by generations 
of pioneers and followers have revealed many of wonders of living organisms. From the 
discovery of DNA as the hereditary material to the central dogma, from the recognition 
of nucleotides as DNA building blocks to DNA’s double helical structure, from the 
deciphering of the sequential information to the tracking of the molecular events inside 
the cells, advances in genomic studies have continued to revise and deepen our 
understanding of life through abundant new discoveries, and are leading us to an epoch 
of synthetic genomics and personalized medicine with the promise of extending life 
expectancy. Nevertheless, the advances in genomic studies are more and more relying on 
sophisticated tools, wherein DNA sequencing, genotyping, and detection of nucleic acid 
in vivo have played some of the most revolutionary roles. DNA sequencing, as the means 
to determine the sequential order of nucleotides of a genetic information carrying DNA 
strand, together with genotyping, the fine interrogation of genetic variations in the DNA 
leading to phenotypic differences and disease, have shed light on novel biomarker and 
drug discoveries as well as gene therapy. The probing of nucleic acids inside cells to 
track the transmission and transcription of genetic information, is leading to deeper 
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understanding of biological phenomena and functions. Progress in any of these genomic 
technologies will eventually bring us incredible advances in our knowledge of cells and 
tissues in health and disease.  
1.1 Introduction to DNA sequencing technology 
1.1.1 Background and significance 
Deoxyribonucleic acid, or DNA, is a double helical polymer composed of 
deoxyribonucleotide monomers, each containing a base, a sugar and phosphate group1. 
These building blocks of the DNA molecule, normally called deoxyribonucleoside 
5’-trisphosphates (dNTPs) are shown in Fig. 1.1, where N refers to the base. Specifically, 
the 3’-hydroxyl group of the sugar of one nucleotide is joined to the 5’-phosphate group 
of the sugar in the adjacent nucleotide by a phosphodiester bond, generating the polymer 
strand (DNA) with a phosphate group on the 5’-terminal sugar unit (5’-end) and a free 
hydroxyl group at the 3’-terminal sugar unit (3’end). Sugar and phosphate groups of 
DNA molecules perform structural supporting roles, whereas it is the bases of DNA 
molecules that carry genetic information. There are four different bases, adenine (A), 
guanine (G), thymine (T) and cytosine (C), with thymine replaced by uridine in 
ribonucleic acid (RNA). Adenine and guanine are purine derivatives, while thymine and 
cytosine are pyrimidine derivatives. In the DNA double helix structure, adenine is always 
paired with thymine, and guanine with cytosine, which is often referred to “Watson and 
Crick base-paring” or “complementary base-paring”. The order of these bases (A, G, C 
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and T) determines specific genetic information.  
The DNA molecule undergoes two biological reactions: replication for transmission 
of the genetic information to daughter cells during cell division, and transcription for 
guiding the synthesis of RNA that is then translated into amino acid sequence to 
complete the flow of genetic information. Both of these processes play tremendous roles 
in cell biology. The deciphering of the complete sequence of the genomic DNA is of 
great significance for our inherent understanding of living species.    
 
Fig. 1.1 Chemical structures of 2’-deoxyribonucleotides (dNTPs). Each nucleotide is composed of 
a base (adenine, guanine, cytosine or thymine), a sugar and a phosphate group.  
Inspired by the DNA replication process, a template-directed event in which DNA 
polymerase accurately catalyzes the addition of complementary nucleotides to the 3’ end 
of a growing DNA strand via the formation of a phosphodiester bond between the 
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terminal 3’-OH group and the 5’-phosphate group of the incoming nucleotide, Sanger 
first developed chain-termination sequencing methods.2, 3 Since the first genome, 
bacteriophage phi x 174 DNA, was completely sequenced by Sanger,4 DNA sequencing 
technologies have made a significant impact in the biomedical sciences, with its 
applications across such fields as comparative genomics and evolution, forensics, 
epidemiology and applied medicine for diagnostics and therapeutics.  
With the completion of the Human Genome Project, the National Human Genome 
Research Institute (NHGRI) has called for new sequencing technologies to reduce the 
cost of the current Sanger based method by 100-fold in the near term ($100K Genome) 
and by a further 100-fold in the near future ($1,000 Genome).5 This invigorated the 
whole sequencing industry, resulting in a variety of new technologies and an astonishing 
number of scientific advances in the field of genomics and beyond.  
1.1.2 DNA sequencing technologies overview 
As a well established DNA sequencing method, Sanger sequencing has its strength 
in long read-length for de novo sequencing but limitations in its throughput as well as 
accuracy. The growing demand for sequencing has driven the development of alternative 
sequencing technologies towards rapid and inexpensive DNA sequencing, aiming at the 
vision of the $1000 genome. Various current and developing sequencing technologies as 
well as current underdeveloped sequencing technologies will be reviewed here.  
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1.1.2.1 Conventional Sanger Sequencing 
Since it was first presented in 1977, Sanger sequencing has been one of the most 
influential innovations in biological research.3 The principle of Sanger sequencing, also 
known as the chain-termination sequencing method, is to stochastically terminate the 
primer extension with labeled, distinguishable dideoxynucleotide (ddNTP) terminators to 
generate different fragment lengths that can aid in interrogating the terminating base. As 
shown in Fig. 1.2, in current Sanger sequencing reactions, uniquely fluorescently labeled 
ddNTPs (ddNTP-fluorophores) are mixed with non-labeled, natural deoxynucleotides 
(dNTPs) to generate elongation fragments ending at all positions along the template. The 
sequencing biochemistry is actually a cycle sequencing reaction with template 
denaturation, primer annealing and primer extension, resulting in a linearly amplified 
mixture of end-labeled extension products, which can be separated by gel electrophoresis. 
The sequence is then obtained by reading the fluorescent signal from the terminating 
nucleotides in length order.  
For decades, with the introduction of new improvements, such as capillary 
electrophoresis,6 laser induced fluorescent excitation of energy transfer dyes,7 a fully 
automated system8 and others, Sanger sequencing has evolved into a well-established 
sequencing method with an average sequencing read-length of 800 bases9 and has 
become the choice for numerous sequencing projects, including the first human genome 
project.  
However, electrophoresis based Sanger sequencing has inherent limitations due to 
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the resolution of the product separation matrix, and it is also too expensive and 
time-consuming for current and envisioned projects. Though people have been trying to 
further improve the Sanger sequencing method by pursuing multiplexing and 
miniaturization, there appears to be a few remaining approaches for achieving significant 
reductions in the cost and massively parallel performance. The limitations of the Sanger 
sequencing technique and the increasing demand of genome sequencing projects have 
propelled the new generations of sequencing technologies.  
 
Fig. 1.2. Principle of Sanger sequencing. 
1.1.2.2 Mass Spectrometry based sequencing 
Since the first application of matrix-assisted laser desorption/ionization 
time-of-flight mass spectrometry (MALDI-TOF MS) to oligonucleotide analysis in 
199010, MALDI-TOF MS has become one of the most powerful tools for DNA analysis 
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due to its high speed, high accuracy and high resolution. It has been widely explored as 
an alternative method to electrophoresis based Sanger sequencing. The most 
straightforward approach is to replace the polyacrylamide gel separation of the Sanger 
sequencing products with mass analysis,11 as shown in Fig. 1.3 A. The sequence is 
determined by the mass differences between the fragments produced by Sanger 
sequencing reactions. This approach was further improved by Ju et al. by introducing 
solid phase capturable and mass-tagged dideoxynucleotides,12, 13 which will be described 
in detail in Chapter 3.  
The other commonly used strategy is mass ladder sequencing by enzyme digestion, 
which was first described by Pieles et al.14 Generally, as shown in Fig. 1.3 B, the 
oligonucleotides are cleaved using an enzyme that sequentially removes nucleotides from 
either the 5’ or the 3’ end, like the 5’-exonuclease calf spleen phosphodiesterase (CSP) or 
the 3’-exonuclease snake venom phosphodiesterase (SVP). The sequence is determined 
by the mass change after each cleavage. Bentzley et al. further extended this method to 
achieve a read-length of 24 bases.15 It is also possible to identify bases with methyl 
modifications and sugar-modified nucleosides with different digestion strageties.16 This 
exonuclease digestion method has proven to be helpful for the sequence determination of 




Fig. 1.3. Schematic process of mass spectrometry assisted sequencing. (A) Sanger sequencing 
reaction based MS sequencing; (B) Enzymatic digestion based MS sequencing. 
As MALDI-TOF MS is well-suited to analyzing RNA, RNase digestion-based 
protocols have also been developed to investigate RNA sequences.17 As an alternative 
strategy to sequence ladder generation, Hahner et al. developed an approach to analyze 
the sequence by converting DNA to RNA and generating fragments using 
sequence-specific RNase.18 Gut et al. further modified it to a DNA/RNA chimera 
approach by replacing one of the four dNTPs with nucleoside triphosphate (NTP), 
allowing fragmentation by alkali backbone cleavage for the analysis.19 Both of these 
methods require a comparison between the unknown sample and a reference sequence, 
limiting their application in sequencing.  
Several other strategies for DNA sequencing with mass spectrometry were also 
reported, including gas-phase fragmentation that made use of fragmentation during mass 
spectrometric analysis to determine the sequence across the numerous fragments, and 
sequence determination based on mass ladders of the failure products generated in 
solid-phase oligonucleotide synthesis. However, technically, it is hard to control the 
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gas-phase fragmentation, and the sequencing of failure products is not applicable for 
natural oligonucleotides.20  
Though different mass spectrometry based sequencing approaches have been 
developed, mass analysis of Sanger sequencing products remains the most 
straightforward and simplest, and has the potential for unambiguous high speed 
sequencing. However, the main challenges of mass spectrometry lie in limitation of the 
range of masses one can obtain on a given instrument, the stringent requirement for 
purity, and difficulties in achieving massively parallel detection.  
1.1.2.3 Sequencing by hybridization 
With the availability of oligonucleotide synthesis and more and more understanding 
of DNA strand hybridization and denaturation,21 sequencing by hybridization (SBH) was 
first proposed by Drmanac and Crkvenjakov in 1987 as an alternative to conventional 
Sanger sequencing.22, 23 Originally, there were two formats for SBH. In one approach, the 
unknown target DNA was immobilized to a solid substrate and hybridized with a set of 
labeled oligonucleotide probes. The sequence was determined by assembling information 
from the overlapped probes. Drmanac has reported the sequencing of p53 exons 5-8 
using this approach with 10,000 7-mer probes.24 The other approach is to determine the 
sequence through the hybridization of labeled unknown DNA targets to substrate bound 
probes, which has been widely utilized by most current SBH technology, like Affymetrix 
(Santa Clara, CA, USA), Perlegen (Moutain View, CA, USA) and Roche NimbleGen 
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(Madison, WI, USA).25 Here, a DNA microarray/microchip with thousands of 
oligonucleotide probes is constructed, each probe representing a piece of reference 
sequence in the genome of interest. Though the SBH based microarray technology is 
useful in DNA resequencing and large scale genome analysis,26 it is more and more used 
in nucleotide variation detection rather than sequencing, which will be discussed in detail 
in the section on SNP genotyping. Besides, there are some limitations to this approach. 
Accuracy is always an issue due to the complexity of DNA hybridization which depends 
on many factors, including GC content, length, concentration and secondary structure of 
the target and probe sequences. False positives often occur between exact matches and 
those with a single base difference, and a region with repetitive sequence stretches also 
poses challenges in unambiguous determination. The use of longer probes offers the 
possibility of deciphering longer sequence stretches, but at prohibitive cost due to the 
exponentially increasing number of probe combinations. With these limitations, the 
prospects for de novo genome sequencing remain unclear.  
1.1.2.4 Sequencing by synthesis  
The heart of sequencing by synthesis (SBS) is to iteratively identify the 
incorporation of each nucleotide during the extension reaction by DNA polymerase. It 
has emerged as the core technology of second generation sequencing, and is also being 
widely explored for single molecule based third generation sequencing. Sequencing by 
synthesis was first revealed by Heyman in his description of pyrosequencing,27 and 
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quickly developed into a variety of approaches, such as pyrosequencing,28 sequencing by 
synthesis with cleavable fluorescent nucleotide reversible terminators,29 single molecule 
sequencing with virtual nucleotide terminators30 and SMART sequencing,31 each of 




Fig. 1.4. Schematic view of pyrosequencing.25 
The principle behind pyrosequencing is the detection of the pyrophosphate that is 
released during enzymatic DNA synthesis for nucleotide determination. It involves a 
cascade of enzymatic reactions.27, 33 Briefly, it starts with a nucleotide polymerization 
reaction in which pyrophosphate (PPi) is released, one pyrophosphate per nucleotide. 
The PPi is subsequently converted to ATP by ATP sulfurylase, which drives the luciferin 
oxidization reaction by luciferase and emits a photon of light (luminescence). By 
continuous stepwise addition of four deoxynucleotide triphosphates and observing the 
light signal, the nucleotide that is complementary to the DNA template can be identified. 
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This pyrosequencing method was first employed by Hayman and further developed by 
Pål Nyrén and Mostafa Ronaghi. A series of strategies have been utilized to optimize 
pyrosequencing,28 including the replacement of natural deoxyadenosine triphosphate 
(dATP) by deoxyadenosine α-thiotriphosphate (dATPαS) in the polymerase reaction to 
avoid a false positive signal from the added ATP analog,34 the introduction of apyrase to 
degrade the excess nucleotides,35 and the addition of single stranded DNA 
(ssDNA)-binding protein for longer template sequencing.36 Pyrosequencing evolved 
rapidly and became the first commercialized next generation sequencing technology, 
launched by 454 Life Sciences.37 In the Roche/454 pyrosequencing system, unlike 
conventional Sanger sequencing, the sample preparation avoids cloning and is instead 
achieved by emulsion PCR amplification of single DNA molecule on beads. As shown in 
Fig. 1.4, the larger amplicon carrying beads surrounded by smaller beads with luciferase 
and ATP sulfurylase are deposited onto a microfabricated array of picoliter-scale wells 
(picoTiterPlate). Other reagents are flowed in at each cycle. Only one of the four dNTPs 
is added in each cycle, generating light captured by a CCD camera if incorporation 
occurs. Apryase is flowed in to degrade excess nucleotides after each round. The current 
Roche/454 Titanium Platform has been used in whole-genome sequencing of different 
species with significantly improved throughput. However, there are some limitations. 
The major challenge is sequencing homopolymer regions, since the approach lacks 
accuracy in determining the number of nucleotides if continuous incorporation occurs. As 
the cycles accumulate, the efficiency of the immobilized enzyme drops. Synchronization 
  
13
is a problem since the data is generated from a cluster of DNA molecules.   
1.1.2.4.2 Sequencing by ligation 
 
 
Fig. 1.5. Principle of sequencing by ligation. (A) DNA template molecule with two mate-pair tags 
of unique sequence which are flanked and separated by universal sequences complementary to 
amplification or sequencing primers. (B) Steps of sequencing by ligation. 
Strategies for sequencing by ligation (SBL) were first developed in polony 
sequencing of the Escherichia coli genome by Church et al.32 Generally, the sample 
preparation before SBL involves library construction of DNA molecules with two 
mate-pair (sequencing reads derived from opposite ends of each fragment) tags of unique 
sequence which are flanked and separated by universal sequences complementary to 
amplification or sequencing primers (Fig. 1.5 a), emulsion PCR for generating multiple 
copies of a single DNA template (colony) on 1 μm magnetic beads, and the 
immobilization of colony carrying beads on a solid support for performing the 
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sequencing cycles. As shown in Fig. 1.5 B, sequencing by ligation is divided into four 
steps. An anchor primer is first hybridized to a priming site (immediately 5’ or 3’ to one 
of the two tags, A1 to A 4, in Fig. 1.5 A, indicating the priming site for each anchor 
primer) within the single-stranded template. A ligation reaction is then performed with a 
pool of fully degenerate, fluorescently labeled nonanucleotides with one encoding base 
that requires perfect matching for hybridization and ligation. Therefore, the nucleotide at 
the query position can be identified according to the fluorophore signal from the nonamer 
that is exactly complementary to this position. The cycle is repeated after stripping away 
the anchor-primer/fluorescent-nonamer complex. Church demonstrated that a total of 26 
bp was obtained through SBL, with 6 bases from the ligation junction in the 5’ to 3’ 
position and 7 bases from the ligation junction in the 3’ to 5’ direction for both 
mate-paired tags. The development of sequencing by ligation contributed to the 
commercial release of the Polonator and the ABI SOLiD, the latter of which introduced a 
slight modification to the original SBL method, the use of labeled degenerate octamers 
with two base encoding, 5 base extensions in each cycle with primer resetting (shift by 
one nucleotide) after multiple cycles.38, 39 However, limitations exist, including 
difficulties in localization of beads due to random dispersion, a higher error rate of raw 
sequence data than in the Sanger method, incomplete dye removal, false read out due to 
proximity of beads as well as a mixture of templates on beads, and errors and difficulties 
during in vitro amplification steps.40, 41 
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1.1.2.4.3 Sequencing by synthesis with cleavable fluorescent nucleotide reversible 
terminators 
An alternative sequencing by synthesis approach, SBS with cleavable fluorescent 
nucleotide reversible terminators (CF-NRTs), also known as array cyclic sequencing, was 
shown to have advantages over pyrosequencing in sequencing homopolymer regions and 
allowing addition of all four nucleotides at once, and possess advantages over the 
sequencing by ligation approach in terms of sequencing read-length and lower 
fluorescent background. It soon became one of the most widely explored sequencing 
technologies and has been commercially available for several years.  
 Generally, SBS with CF-NRT is composed of three steps: incorporation, detection 
(imaging), and deprotection (cleavage). The key is the reversible nucleotide terminators, 
which ideally should exhibit efficient incorporation by DNA polymerases, efficient 
deprotection under mild conditions and labels with desired characteristics.42 Nevertheless, 
it remained unsuccessful until Ju’s publication on the design of CF-NRTs by tethering a 
unique fluorescent dye to the 5-position of the pyrimidines (T and C) and the 7-position 
of the purines (G and A) via a cleavable linker, and attaching a small cleavable chemical 
moiety to cap the 3’-OH group.43 The rationale is that, though polymerase is sensitive to 
modification of the 3’ position due to its proximity to the amino acid residues in the 
active site of the polymerase, some modified DNA polymerases are highly tolerant to 
nucleotides with extensive modifications with bulky groups at the 5-position of the 
pyrimidines (T and C) and the 7-position of the purines (G and A). Different sets of 
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cleavable nucleotide reversible terminators have been developed, some of which have 
been employed in current next-generation sequencing.29, 44, 45 The whole process of SBS 
with CF-NRTs is illustrated in Fig. 1.6. Two sets of nucleotide reversible terminators are 
used, one for the incorporation step and one for capping. The first set consists of the four 
nucleotides, each linked to a different fluorescent dye, with their 3’ position blocked with 
chemical group R (CF-NRTs), while the second set consists of non-fluorescently labeled 
nucleotide reversible terminators (NRTs), but with their 3’ position blocked with the same 
R group. After the incorporation step, a template-dependent primer extension occurs with 
a CF-NRT, so the nucleotide can be identified according to the fluorescent signal. For 
synchronization, a “capping” step with NRTs is performed to extend un-reacted templates. 
Then the fluorescent dye and the blocking group are cleaved away, so the 3’ hydroxyl 
group is regenerated, in readiness for the next sequencing cycle. As the cycles progress, 
the sequence of the template can be identified base by base continuously. Hundreds of 
millions of amplified templates immobilized on slides can be decoded simultaneously 
using CCD cameras or other imaging approaches. 
Similar to other SBS approaches, the current limitation of this approach is the 
relatively short read-length, due to the DNA template cluster synchronization, the surface 
chemistry, and the efficiency of each step. These somewhat limit its application for de 




Fig. 1.6. Principle of sequencing by synthesis with cleavable fluorescent nucleotide reversible 
terminators. 
1.1.2.4.4 Single molecule sequencing-by-synthesis  
The previously described sequencing-by-synthesis methods rely on PCR to grow 
clusters of a given DNA template on a solid surface (beads or directly on flow cells) that 
are then imaged in a phased approach. This not only requires tedious labor and a large 
amount of genomic DNA, but also brings in biases via PCR amplification and 
synchronization problems during sequencing.41 Therefore, sequencing-by-synthesis 
without a prior amplification step, also known as single molecule sequencing, is 
currently being pursued. The introduction of single molecule sequencing (SMS), free of 
PCR amplification, will simplify sample preparation, avoid biases or errors from the 
library preparation or amplification step, allow asynchronous extension of single 
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molecules and flexibility in the kinetics of sequencing chemistry, enable extremely high 
densities of templates, make it possible to identify DNA modifications that are lost in the 
in vitro amplification process, and enable direct RNA sequencing.  
Since the first demonstration of the feasibility of single-molecule sequencing in 
2003,46 it took five years to launch the first sequencer that was able to sequence 
individual molecules instead of molecular ensembles created by an amplification process, 
the HeliScope single-molecule sequencer by Helicos Biosciences.30 The input genomic 
DNA is first fragmented, denatured, and a poly-A-tail added by polyadenylate 
polymerase, with the last adenine labeled with Cy3. The labeled poly-A-tail helps in 
localization of the DNA strand after it hybridizes to the poly-T oligonucleotides 
immobilized on the flow cell and also serve as primers during the incorporation process. 
The fluorescent label of adenine is released before the sequencing reactions start. The 
core of the Helicos single molecule sequencing method is their so called asynchronous 
virtual terminator chemistry. A virtual terminator is a type of nucleotide that is attached 
to a fluorescent dye via a disulfide bond linker (Cy5-12ss-dNTP analogs), while its 3’ 
position is unblocked.47 Virtual terminators can be incorporated by polymerase at a 
slower rate than natural nucleotides and are able to temporarily block incorporation of a 
second nucleotide on a homopolymer template if polymerase and excess nucleotides can 
be washed away instantly (termed virtual termination). Therefore, in each cycle, as 
shown Fig. 1.7, Cy5-labeled nucleotides are incorporated, asynchronous growth of 
individual DNA molecules is monitored by fluorescence imaging, and the fluorescent 
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dye is cleaved off for the next cycle of sequencing. Using this single-molecule method, 
Quake et al. have reported the sequencing of an individual human genome, with an 
average read length of 32 bp.48 
 
Fig. 1.7 Schematic of the single molecule sequencing-by-synthesis approach with virtual 
terminators.49  
The introduction of Zero Mode Wavelength (ZMW) technology50 has spawned a 
different approach, Single-Molecule Real Time Sequencing-by-synthesis (SMRT), 
developed by Pacific Biosciences.31, 51, 52 As shown in Fig. 1.8, ZWM is a nanophotonic 
structure, with nanoscale wells of 70 nm in diameter and the light projects inward at the 
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opening, allowing an illumination detection volume of 20 zl (10-21 l) where a single DNA 
polymerase is immobilized. This enables detection of an individual fluorophore on an 
incorporating nucleotide against a dense background of labeled nucleotides, hence 
guaranteeing fast and processive enzyme synthesis as well as a significantly reduced 
signal-to-noise ratio.53 Distinguishable fluorophores are tethered to the phosphate chain 
of the nucleotide through a phospholinker so that the natural strand of DNA will be 
regenerated after cleaving away the linker-dye, enabling continuous incorporation 
without steric hindrance. As shown in Fig. 1.8 B, the DNA sequence is determined by 
detecting the fluorescent pulse from the correctly base paired (cognate) nucleotide 
binding in the active site of the polymerase. The lifetime of the fluorescence is controlled 
by the rate of catalysis, and ends after the cleavage, the period of which is much longer 
than diffusion and non-cognate sampling, allowing correct identification of incorporation 
reactions. The period between each pulse reflects the DNA molecule’s translocation and 
subsequent nucleotide binding. Based on the direct observation of a processive DNA 
incorporation reaction, SMRT has the potential for continuous observation of DNA 
synthesis over thousands of bases with a maximum read length in excess of 10,000 bp. 
Chin et al. have successfully employed this technology to sequence the whole genome of 
the pathogen responsible for the recent cholera epidemic in Haiti, the Haitian Vibrio 
cholera outbreak strain.54 In addition, since modifications of the nucleotides could be 
identified by different polymerase kinetics, appearing as different arrival times and 
durations of the resulting fluorescence pulses through the incorporation, Flusberg et al. 
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were able to directly identify nucleotide methylation and hydroxymethylation, including 
mA, mC and hmC sites, without bisulfite conversion.55 However, due to the very short 
intervals, dissociation of the complementary nucleotide before incorporation, and 
spectral misalignment of fluorescent dyes, the accuracy of SMRT is still very low. 
Furthermore, the throughput is limited by the number of ZMWs that can be read 
simultaneously. 9, 56 
 
Fig. 1.8 Principle of single-molecule, real-time DNA (SMRT) sequencing.31 
Other SBS based single molecule sequencing strategies are also being pursued. For 
example, Visigen Biotechnologies is trying to modify SMRT technology by using 
fluorescence resonance energy transfer (FRET) donor attached polymerase and different 
FRET acceptor modified nucleotides to identify the base by real time observance of 
FRET.57 As an alternative detection method, Ion Torrent’s semiconductor sequencer now 
sold by Life Technologies is trying to exploit semiconductor technology to create a high 
density array of micro-machined wells for the detection of released hydrogen ions during 
base incorporation, in an approach which is free of light, scanning and cameras.9  
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1.1.2.5 Sequencing by direct physical recognition of the DNA molecule  
Besides sequencing by synthesis based single molecule sequencing, efforts have 
been undertaken to develop a sequencing strategy involving direct physical recognition 
of the DNA molecule, avoiding the attachment of a fluorophore to the nucleotides and 
the associated limitations of the polymerase enzyme. This, together with SBS-based SMS, 
has been explored as so-called next-next (third) generation sequencing.56, 58 
1.1.2.5.1 Nanopore sequencing 
Nanopore sequencing was proposed in 1988 and its feasibility was first 
demonstrated by Deamer et al. in 1996,59, 60 which has stimulated nanopore research in 
the ensuing years.61 As shown in Fig. 1.9 A, the principle underlying nanopore 
sequencing is that a single stranded DNA (ssDNA) molecule can be electrically driven 
through a nanoscale pore (1.5-5 nm) in strict linear form under an applied voltage, 
resulting in a change of electrical signals, such as ionic current blockages, transverse 
tunneling currents, or capacitance, for nucleotide discrimination. The two most common 
classes of nanopores are protein pores in lipid bilayers, such as α-hemolysin (αHL) pores 
and Mycobacterium smegmatis porin A (MspA), and synthetic solid nanopores formed in 
a variety of thin films, including Si-based materials, graphene and carbon nanotubes. The 
development of nanopore sequencing is a challenging process due to the control of DNA 
velocity and orientation during translocation, construction of nanopores with comparable 
channel lengths to a single nucleotide (~ 0.4 nm), discrimination of individual 
  
23
nucleotides with subtle chemical and electrical differences, and the high background 
level. Nevertheless, various methods have been tested in order to employ nanopore 
sequencing.   
 
Fig. 1.9. Schematic of various Nanopore sequencing method. (A) Fundamental principle of 
nanopore sequencing; (B) Nanopore sequencing approach by Oxford Technology65; (C) duplexes 
halting translocation sequencing by MspA nanopore;66 (D) Nanopore single-molecule optical 
detection approach;69 (E) Schematic of the DNA transistor. The light blue regions with voltage 
labeled are the conductors, while the light green regions are insulators.67  
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Under the high applied potentials required for threading DNA molecules, freely 
moving DNA molecules pass through the wild-type αHL pore too quickly for bases to be 
identified. To solve this problem, Bayley and his colleagues used an engineered nanopore 
with a molecular adaptor to capture and identify the nucleotides, thereby slowing the 
movement of DNA.62 They reported the identification of unlabeled 5’-monophosphate 
molecules with an average accuracy of 99.8% using an αHL nanopore with a covalently 
attached cyclodextrin molecular adapter63 and also demonstrated three recognition sites 
in the transmembrane β-barrel of an engineered αHL pore for identification of all 4 bases 
in an immobilized single-stranded DNA molecule.64 They further utilized the enzyme to 
reduce the speed of DNA translocation, and initiated a nanopore-exonuclease approach, 
being co-developed by Oxford Nanopore Technologies. As shown in Fig. 1.9 B, an 
exonuclease was attached onto the protein pore. As the DNA strand is digested by 
exonuclease, released deoxynucleoside monophosphates are captured and identified 
within the pore. The sequencing of independent readings reflects the order in which the 
bases are cleaved from the DNA.64, 65 In addition, this group is also trying to develop so 
called “strand sequencing”, via a combination of nanopores with processive enzymes, 
wherein individual nucleotides passing through the nanopore are identified and then 
incorporated by an enzyme covalently attached to the nanopore. Again, the enzyme plays 
a role as the speed controller for DNA strand translocation.65  
As an alternative to the αHL nanopore, the MspA nanopore has emerged as an even 
more promising biological nanopore with its shorter blockade region, addressing axial 
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resolution limitations of the αHL nanopore and yielding better-resolved current 
signatures.9, 66 By using engineered MspA nanopores, Derrington et al. developed a 
duplex halting translocation sequencing approach. In brief, as shown in Fig. 1.9 C, a 
region of double-stranded DNA (dsDNA) is introduced into a target single-stranded DNA 
(ssDNA). When the DNA strand is passing the nanopore, the double-stranded section 
will cause the translocation to halt while holding the single-stranded region of interest 
within the pore’s constriction for nucleotide identification, and the double stranded 
region will then be denatured due to the voltage, allowing complete passage of the single 
strands. In this way, they were able to distinguish nucleotides through differences in 
conductivity, even in a homopolymer region. 
For the control of DNA velocity and orientation, the IBM “DNA transistor” offers an 
alternative approach for precise control of the DNA movement through the nanopore 
with single nucleotide accuracy.67, 68 As shown in Fig. 1.9 E, the DNA transistor is a 
silicon based, multilayer metal/dielectric nanopore device with voltage generated inside 
the nanopore. By utilizing the interaction of discrete DNA backbone charges with a 
modulated electric field inside the nanopore, it can trap and slowly release the individual 
DNA molecules. This enables optimal base orientation and sufficient sampling of a base.  
The similar chemical structure of the four nucleotides leads to their similar electronic 
signatures, which poses challenges to distinguish them in this way. This might be solved 
by either reducing background or amplifying signals through base modification or 
combination with other detection methods, such as optical detection.56 With the aim of 
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overcoming the challenges of high signal contrast required for single nucleotide 
differentiation, Soni and Meller developed a nanopore single-molecule optical detection 
approach,69 wherein the nucleotides A, T, G and C are first converted to a pair of 10-mer 
oligonucleotides with 2-unit codes of 0 and 1, the combination of which represents each 
respective nucleotide (for example, A is 1 1, G is 1 0, C is 0 0, T is 0 1). The converted 
DNA strand is then hybridized with two different 10-mer oligonucleotide “molecular 
beacons” designed to complement either 1 or 0, producing “amplified” fluorescence 
signals specific for each nucleotide. The emitted fluorescence of the molecular beacons is 
detected when the beacons are sequentially stripped off the complementary converted 
DNA strand passing through a nanopore.69 These investigators also demonstrated the 
parallel readout of signals from multiple nanopores, which could be potentially applied to 
massively parallel large nanopore arrays.70 
1.1.2.5.2 Tunneling and transmission electron microscopy based single molecule DNA 
sequencing  
The interest in transmission electron microscope (TEM) based DNA sequencing 
traces back to Feynman’s vision of directly reading DNA molecules by TEM in 1959, 
which stimulates people nowadays to study and achieve this goal despite many 
technological hurdles. Halcyon Molecular71 developed a pioneering approach that could 
chemically detect atoms associated with nucleotides in a DNA strand by using annular 
dark-field electron microscopy, together with a number of supporting technologies, such 
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as stretching DNA on a substrate. ZS Genetics is trying to label atoms within the 
nucleotides, whereby individual bases can be identified according to their size and 
intensity differences under a high-resolution electron microscope.9  
 
A B 
Fig. 1.10 (A) Reveo STM-based sequencing.49 (B) DNA sequencing by direct inspection of DNA 
using electron microscopy 9  
Scanning tunneling microscopy (STM) could also be used to detect DNA bases 
according to the characteristic electronic differences among the four bases. Xu et al. has 
reported the electronic fingerprints of DNA bases deposited on a gold surface, such as 
bandgap and molecular energy levels.72 Tanaka et al. later showed that guanine bases are 
brighter under STM by depositing the DNA molecule onto a copper surface with an 
oblique pulse-injection method.73 With the assistance of single-walled carbon nanotubes, 
theoretically 100% base identification could be achieved.74 Enhanced tunneling current 
was observed between a base specific modified STM tip and its complementary 
nucleotide. These indicate the possibilities of STM based DNA sequencing. Reveo is 
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now developing a technology called nano-knife-edge probes for reading sequence,49 
which utilizes the selective excitation of molecular vibrations by electron tunneling as its 
main principle. In their system, as shown in Fig. 1.10A, the DNA strand is immobilized 
and stretched in a 10 μm wide channel. Multiple nano-knife edge probes with 10 μm 
width which are tuned to recognize one specific nucleotide will pass over the DNA and 
identify the base according to the tunneling current generated when the probes touch the 
corresponding nucleotides.  
These tunneling and transmission electron microscopy based single molecule DNA 
sequencing ideas appear straightforward, but the execution is going to be a long journey 
due to many factors, including preparing well-ordered and stretched ssDNA on the 
surface, the high cost of the microscopes, the construction of modified STM tips, and so 
on. 
1.1.3 Conclusion 
Since Sanger’s introduction of the dideoxynucleotide chain terminator sequencing 
method, DNA sequencing has revolutionized the biological sciences and become one of 
the most powerful technologies in biology. Driven by the $1000 Genome project initiated 
by NHGRI, a variety of sequencing technologies have been explored, each with its own 
advantages and drawbacks. Among these new technologies, sequencing by synthesis with 
cleavable fluorescent nucleotide reversible terminators (CF-NRTs) has shown the most 
promise for next generation sequencing, and has potential applications for single 
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molecule sequencing in the third generation platforms. Based on some of the ideas 
sprouted from our laboratory, part of this thesis will focus on the improvement of SBS 
with CF-NRTs, with the hope of pushing this particular platform towards the $1000 
Genome goal. On the other hand, taking advantages of the high accuracy and high speed 
of mass spectrometry, we will continue to explore MS-based sequencing, aiming at its 
application in particular circumstances requiring high accuracy but short read-length.  
1.2 Introduction to SNP genotyping technology 
1.2.1 Background and Significance  
The successful sequencing of the human genome has ushered in a new era of fine 
mapping of subtle genetic variations for elucidating the fundamental molecular bases of 
diseases, drug response and genotype changes. The most abundant type of these 
variations are single nucleotide polymorphisms (SNPs), with more than 10 million in 
public databases, occurring approximately once every 100 to 300 bases.75 By definition, 
a SNP is a single nucleotide variation, including the substitution, insertion or deletion of 
individual bases, at a specific location in the genome that is found in more than 1% of the 
population.76 These are usually distinguished by geneticists and epidemiologists from 
mutations, which may also be single nucleotide polymorphisms, but usually occur at 
lower frequencies in the population as a whole, and often have more significant impacts, 
either beneficial or more commonly deleterious. Typically, SNPs present in human 
nuclear genome as heterozygous (1:1 wild-type to mutant ratio) or homozygous, but in 
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the mitochondrial genome as heteroplasmy (mixture of wild-type and mutant forms at 
various ratios) or homoplasmy due to its high copy numbers. SNPs are not evenly 
distributed across the genome. In coding regions, they occur less frequently, but may 
cause alterations in protein structure and hence biological function, leading to the 
development of disease or a change in environmental response. They are important 
genetic markers for pharmocogenomics, such as SNPs (more properly mutations) in the 
breast cancer genes BRCA1 and BRCA 2. In the non-coding regions, SNPs occur much 
more frequently. Though not altering the encoded protein, they may affect gene 
regulation, and serve as important genetic or physical markers for comparative or 
evolutionary genomic studies, or even forensics investigations. The analysis of SNPs in 
the human genome will provide the key to understand genetic differences between 
individuals and disease states, and eventually realize personalized medicine by the 
prediction of genetically related disease risk and drug response genes. Therefore, 
tremendous efforts have been made to develop a variety of methods that allow the 
efficient and accurate genotyping of SNPs.  
1.2.2 Overview of SNP genotyping technologies 
Though direct DNA sequencing is the most straightforward way to discover and 
analyze SNPs, it is more suitable for genome-wide SNP studies and unknown SNP 
discoveries. When analyzing highly targeted SNPs, it becomes too expensive, complex 
and unnecessary. The following section will focus on current SNP genotyping 
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technologies, most of which are employed in the analysis of known SNPs.  
1.2.2.1 SNP genotyping by enzymatic cleavage 
The use of restriction fragment length differences generated by DNA 
sequence-specific restriction endonucleases to identify DNA polymorphisms for human 
linkage studies was first demonstrated by Botstein et al.77 This, together with the 
introduction of PCR in the 1980s, has developed into a simple and convenient laboratory 
technique, polymerase chain reaction-restriction fragment length polymorphism 
(PCR-RFLP), for the detection of SNPs.78 DNA restriction enzymes can recognize 
specific sequences in DNA and catalyze endonucleolytic cleavages, yielding fragments 
with defined lengths. The introduction of one or more individual base differences will 
lead to the loss of a cleavage site or formation of a new one, resulting in DNA fragments 
with different lengths, which can be detected by gel electrophoresis. As shown in Fig. 
1.11 A, PCR primers are designed to allow amplification of a portion of the DNA 
template encompassing the polymorphic site. Then the DNA fragments amplified by 
PCR are digested with the restriction enzyme that will cleave template bearing different 
alleles differently, revealed as different fragment sizes by electrophoresis after staining 
with ethidium bromide (EB). To improve the sensitivity, radioactive nucleotides, like 
32P-labled nucleotides, are used in PCR reactions for radiographic detection.79 This 
PCR-RFLP method is applicable not only for SNPs but also for insertion/deletion 
polymorphism detection, however it has limitations in throughput, number of SNPs 
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detected as well as the availability of appropriate restriction enzymes for the analysis.  
 
Fig. 1.11. Schematic diagram of SNP enzymatic cleavage assay. (A) PCR-RFLP assay; (B) 
Invasive cleavage assay.  
Inspired by their discovery of thermostable flap endonucleases (FEN) in sequence 
mismatch sensitivity and structure-specific cleavage of DNA, Lyamichev and his 
colleagues developed the Invader® assay,80 wherein FEN is used to cleave a 
three-dimensional complex formed by the hybridization of allele-specific overlapping 
oligonucleotides to target DNA with a polymorphic site, followed by the detection of 
cleavage products using several different approaches, such as fluorescent detection or 
mass spectrometric detection. An example of a fluorescence resonance energy transfer 
(FRET) detection based Invader assay is illustrated in Fig. 1.11 B. Two oligonucleotides 
are used here. One oligonucleotide, containing a fluorophore at its 5’ end and an internal 
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quencher molecule, is the allele-specific probe, which consists of the complementary 
base to the SNP allele and additional sequence 5’ of the SNP site. The other 
oligonucleotide strand is called the Invader® oligo, which is complementary to the target 
sequence immediately 3’ of the polymorphic site, with a non-complementary base at the 
polymorphic site. When the two oligonucleotides hybridize to the target DNA, a 
three-dimensional invader structure over the SNP site is formed and can be recognized by 
the FEN enzyme. The enzyme cleaves the allele specific probe 3’ of the base if it is 
complementary to the polymorphic site (3’ of the overlapping Invader structure), thereby 
the cleavage reaction will separate the fluorophore from the quencher and generate a 
measurable fluorescent signal. If the allele specific probe does not match the SNP allele, 
then no overlapping Invader structure is formed, and the probe is not cleaved. This gives 
a highly specific signal.81, 82 Hall et al. further improved this strategy by combining two 
invasive cleavage reactions into a single homogeneous assay, which is called the Serial 
Invasive Signal Amplification Reaction (SISAR).83 However, this strategy also has 
limitations in throughput and multiplexing, since two allele-specific probes with both 
fluorophore and quencher molecules attached are required for the detection of one 
polymorphic site, making it cost-prohibitive for constructing probes for more SNP sites.  
1.2.2.2 SNP genotyping by allele specific hybridization 
As mentioned in the first section, allele specific hybridization has been mostly 
explored for SNP genotyping. Equivalent to sequencing by hybridization, in principle, 
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single base distinction can be achieved based on the thermal stability difference of 
double-stranded DNA between perfectly matched and mismatched target-probe pairs. 
Generally, the effectiveness in allele differentiation depends on many factors, such as 
length, sequence and GC content of the probes, secondary structures of the target, 
location of SNP in the probe, and hybridization conditions. And the selection of 
analyzable SNPs is highly dependent on the local SNP sequence, which, to some extent, 
limits the universal applicability of this method.  
Allele specific hybridization has been developed in different ways. High density 
DNA microarrays, like the Genome-Wide Human SNP Array by Affymetrix, are a typical 
hybridization based approach for genome-wide or large scale SNP screening. Briefly, 
taking the Affymetrix GeneChip as an example,84 a large set of nucleic acid probe 
sequences, matching one of the two SNP alleles, is immobilized in defined locations on 
the solid substrate, enabling acquisition of large amounts of genetic variation information 
in a single hybridization step. The DNA or RNA target is fragmented and labeled with a 
fluorophore, and then applied to the DNA array for hybridization with the surface-bound 
probes under controlled conditions, as shown in Fig. 1.12 A. The array is then imaged 
with a fluorescence-based reader to locate the target sequence. With the development of 
microfluidic and automation systems, DNA microarrays have enabled high throughput 
SNP detection; however, they are not suitable for fine mapping of SNPs due to their 





Fig. 1.12 Approaches of SNP genotyping by allele specific hybridization. (A) DNA microarray 
hybridization; (B) TaqMan assay.  
Another example is the TaqMan SNP assay,85 an oligonucleotide hybridization based 
assay capable of detecting the accumulation of PCR products in real time. As shown in 
Fig. 1.12 B, forward and reverse primers are designed to amplify the sequence of interest 
encompassing the SNP site, and two dye-labeled probes are used for allele-specific 
detection. Each allele specific probe is labeled with a different reporter dye at its 5’ end: a 
VIC® dye for the Allele 1 probe and the 6FAMTM dye for the Allele 2 probe, while their 
3’ ends are labeled with a non-fluorescent quencher (NFQ). This allows the detection of 
the fluorescent signal only if the fluorophore dye and NFQ are separated. A minor groove 
binder (MGB) is also introduced to the allele specific probes at the 3’ end, in order to 
  
36
improve the stability and specificity of the hybridization and enhance the ability of the 
assay to handle difficult sequences. As the DNA primer extends to the 5’ end of the allele 
specific probes, the 5’ to 3’ exonuclease activity of the Taq polymerase enzyme will 
degrade the nucleotide from the 5’ end, hence release the 5’-bound reporter dyes from the 
probe, which will light up for allele identification. It is a relatively easy and convenient 
assay, yet it is currently used mostly for singleplex reactions: one tube for one SNP. 
Though it might be multiplexed to 4 or 5 SNPs per reaction, it is hard to achieve 
detection of more SNPs at a time due to the limitation of using fluorophores. The 
introduction of miniaturized reactions has enabled over 3000 samples to be tested on a 
chip, however the main drawback for the TaqMan SNP assay remains in its incapability 
of achieving multiplexing of SNPs.86 
1.2.2.3 SNP genotyping by allele specific ligation  
Combining the hybridization of oligonucleotides to the sequence of interest and the 
specificity of the ligase enzyme to distinguish mismatched nucleotides in the DNA 
double helix, a ligation strategy for SNP detection was firstly developed by Landegren et 
al.87 In principle, only when two oligonucleotides hybridize to a single-stranded template 
DNA with perfect matching (the nucleotides at the junction are correctly base-paired with 
the target strand) and adjacent to each other (the 3’ end of one oligonucleotide lies 
immediately adjacent to the 5’ end of the other), DNA ligase will join them into a single 
oligonucleotide through the formation of a phosphodiester bond between the upstream 
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and downstream oligonucleotides. Three oligonucleotide probes are used, two of which 
are allele specific and bind to the SNP site. The third probe binds to the template adjacent 
to the SNP site, allowing ligation reaction if the allele specific probe perfectly matches 
the SNP site. The ligation products are then detected by various tools based on the 
labeling method for the oligonucleotides, which has been explored and gradually 
improved in different ways. In Landegren’s original idea, one of the oligonucleotides was 
biotinylated and the other labeled with 32P, so the biotinylated oligonucleotides would 
bind to a streptavidin coated solid support, and the radioactive oligonucleotides that have 
become ligated to the biotinylated oligonucleotides and remained on the support after 
washing were detected by autoradiography. Xue et al. introduced a silver enhancement 
chip-based platform for SNP screening, with one DNA probe immobilized on a glass 
substrate, and the other oligonucleotide probe attached to a gold nanoparticle (NP). The 
ligation allows the NP probe staying attached to the substrate, enabling detection by the 
naked eye or a flatbed scanner.88 Notwithstanding these developments, the most common 
approach nowadays is fluorescent labeling. Taking fluorescence labeled oligonucleotides 
as an example (Fig. 1.13 A), two allele specific probes were tagged with different 
fluorescent dyes, with each representing one allele. The third probe could be annealed 
downstream to the polymorphic site and is biotinylated for separation of ligated products 
from the reaction mixture. After the ligation reaction and solid phase capture, the allele 
specific probe that is complementary to the polymorphic site will stay attached to the 
solid surface through ligation with the biotinylated probe and generate a fluorescent 
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signal for detection, while the one that does not match the polymorphic site will be 
washed away.  
By combining ligation for allele discrimination and rolling circle amplification 
(RCA) for signal enhancement, Qi et al. proposed a method called ligation-rolling circle 
amplification (L-RCA).89 As shown in Fig. 1.13 B, short padlock probes coupled with 
generic primers are used, the circulation of which by T4 ligase or thermostable ligase can 
be used to discriminate alleles in target DNA sequences. The circulation product is 
amplified by DNA polymerase and visualized by UV illumination after staining. 
Pickering et al. further introduced energy transfer primers for rolling circle amplification, 
avoiding the gel electrophoresis.90 In their method, the circularized probes are detected 
by amplification using two primers: the first primer hybridizes to its complementary 
region on the probe backbone, and is extended by polymerase to generate a 
single-stranded concatamer of the original probe; while the second primer, which 
contains a 5’-hairpin loop end labeled with a fluorophore and quencher, binds to each 
tandem repeat of the original probe, resulting in strand displacement and branching of the 
RCA products, as well as a strong fluorescent signal due to the separation of the 





Fig. 1.13 Methods for SNP genotyping by ligation. (A) Fluorescence based ligation assay; (B) 
Ligation-rolling circle amplification assay. 
1.2.2.4 SNP genotyping by allele specific primer extension 
Allele specific primer extension has been widely explored for the development of 
effective and accurate genotyping tools. Generally, it involves allele-specific 
incorporation of nucleotides in primer extension with a DNA template, utilizing enzyme 
specificity to achieve allele discrimination. In principle, a primer is designed to anneal to 
the target DNA, with its 3’end immediately adjacent to the polymorphic site, and then 
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extended with nucleotides by polymerase enzyme. The identification of the base at the 
SNP site is based on the specific detection method, whether fluorescent or mass 
spectrometric detection. Compared to previous methods, it gives a more specific signal, 
because of the high fidelity of DNA polymerase in incorporating complementary 
nucleotides. It is also suitable for multiplex SNP detection, with multiple primers of 
different length designed for each target SNP site, and the primer selection and assay 
design is simple and flexible.91 
The approaches that are based on fluorescence detection involve the utilization of 
fluorescently labeled nucleotides. As shown in Fig. 1.14 A, after single base extension 
reaction, the primer is end labeled with fluorescent dyes by incorporating fluorescently 
tagged nucleotides, which could then be visualized to determine the base at the 
polymorphic site according to the reporter dye. The fluorescence based allelic extension 
approach has been implemented in different formats, including homogeneous detection 
and solid phase detection. For example, Illumina’s Infinium assay uses single-base 
extensions on a DNA array with a labeled base to call the SNP,86 and the SNaPshot® 
approach developed by Applied Biosystems uses capillary array electrophoresis to detect 
fluorescently labeled extension products using fluorescently labeled ddNTPs.91 In 
contrast to the direct detection of a fluorescence signal, the mini-sequencing assay 
developed by Perkin Elmer, fluorescence polarization-template-directed dye 
incorporation (FP-TDI), monitors the fluorescence polarity of the fluorescent nucleotide 
terminators. In their system, after PCR amplification of the SNP containing sequence, a 
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third primer (single base extension primer) is annealed immediately adjacent to the 
polymorphic site, and extended with allele specific fluorescent nucleotide terminators by 
polymerase. The mode of detection is to monitor the change in fluorescence polarization, 
according to the different fluorescence polarization properties of the incorporated and 
unincorporated nucleotides: under polarized fluorescent light, the incorporated nucleotide 
would cause the light to become depolarized, while the dyes incorporated into the primer 
will keep most of the light polarized. This avoids the extra step of clean-up of the excess 
nucleotides.86  
 
Fig. 1.14 Allele specific primer extension. (A) Fluorescence based detection; (B) Mass 
spectrometry based detection.  
The combination of high density bead array, allele-specific primer extension, adapter 
ligation and amplification assay protocols propelled the development of the GoldenGate 
genotyping assay by Illumina. In this system, two allele specific oligonucleotides (ASO) 
(P1 and P2) and one locus specific oligonucleotide (LSO) (P3) that will anneal 1-20 
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bases downstream of the SNP site are used, all of which contain universal PCR primer 
sites. The LSO also contains a unique code sequence complementary to a particular bead 
type. In their method, genomic DNA is first biotinylated and attached to the streptavidin 
beads. In a single base extension, the allele specific oligonucleotide (P1 or P2) that 
perfectly matches the target sequence at the SNP site is extended by polymerase up to the 
site of the locus-specific oligonucleotides (P3) and ligated to P3, providing the template 
for PCR reactions. In subsequent PCR reactions, two universal primers complementary 
to the priming sites in P1 and P1 are labeled with Cy3 and Cy5 respectively, which serve 
as the allele-specific fluorescence reporters. The final PCR product will bind to the bead 
array through the built-in encoding sequence in P3 for accurate genotype calling.92, 93  
The other big category of allele specific extension approaches couple with mass 
spectrometry, taking advantage of the high efficiency and accuracy of mass spectrometric 
detection. As shown in Fig. 1.14 B, SNP-specific primers are extended with 
dideoxynucleotides using PCR products as the template to yield extension products of 
different molecular weights, which then are analyzed by mass spectrometry to identify 
the incorporated nucleotides. The unmodified dideoxynucleotides and primers were first 
used to run single base extension in the PinPoint assay, the result of which also 
demonstrated the potential of MALDI-TOF based methods for multiplex SNP 
detection.94, 95 However, the peaks of excess primers and the small molecular weight 
difference between each nucleotide reduced the accuracy of the detection. Modifications 
to the extension primers or nucleotides were gradually developed to overcome these 
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problems and commercial platforms were developed.96-98 In the GOOD assay, primers 
with 3’ phosphorothioate modifications and α-S-ddNTPs were used to generate 
charge-tagged DNA fragments. This eliminates the need for sample purification before 
MS analysis and improves the resolution by using shorter extension fragments.96 
Nevertheless, the minuscule differences between ddNTPs remained the limitation for 
base discrimination. Mass-tagged ddNTPs were introduced as the alternative solution.99 
In combination with the solid phase capture (SPC) technique, the Ju group further 
introduced a modified SPC-SBE approach for isolation of extension products using 
molecular affinity between streptavidin and biotin, wherein the biotinylated nucleotides 
were used in single base extension, and the replacement of regular biotin-11-ddUTP with 
biotin-16-ddUTP (longer linkage between biotin and nucleotide) was shown to improve 
the resolution between C and T.100 However, the sample purification by solid phase 
capture before the MS analysis as well as the mass-tagged strategy still needs further 
improvement to realize high throughput, multiplex genotyping of high accuracy and 
sensitivity. We will discuss our modifications to accomplish this goal in Chapter 4.  
1.2.3 Conclusion 
Single nucleotide polymorphisms are the most common genetic variations, and the 
development of an accurate, precise, time-efficient and cost-effective SNP genotyping 
method is of particular interest to genetics, medicine and other areas of biology. Different 
types of SNP genotyping methods were reviewed, each with its advantages and 
  
44
limitations with respect to specific applications. For a particular project, one should 
choose the type of assay based on the number of SNPs and number of samples to be 
genotyped. The mass spectrometry based single base extension approach outperforms 
many of the others in terms of its speed, accuracy, and potential for multiplexing, which 
is particularly applicable for relatively small scale projects with a high accuracy and 
sensitivity requirement. Part of my thesis focuses on the development of a reversible 
solid-phase-capture single-base-extension approach for SNP genotyping and its 
application in heteroplasmy detection of mitochondrial DNA as the validation of its 
accuracy and sensitivity.  
1.3 Introduction to the detection of nucleic acids by 
oligonucleotide probes  
1.3.1 Background and significance 
DNA sequencing and genotyping technologies reveal the genetic information 
inherent in nucleic acids but are not able to tell us how these biomolecules are involved 
in processes within the cell. Visualization of DNA or RNA in cells and tissues can 
suggest possible roles of these molecules in physiological and pathological states, via the 
information about their location, kinetics, etc. For example, the real-time detection of 
specific mRNAs can provide information on their localization and expression level, 
hence suggest how they are involved in post-transcriptional processes in living cells.101, 
102 Nevertheless, direct observation of cellular DNA, especially RNA, remains 
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particularly difficult, mainly due to the non-specific interaction of probes with other 
cellular components, the high background signal inside the cell, and particularly for 
mRNAs, their abundance and short half-lives, and the accessibility of specific sites in 
mRNA molecules with highly ordered structures. Therefore, development of novel, 
sensitive and selective sensors for the detection of DNA and RNA is of particular interest 
in biology. In the following section, we will only discuss methods for visualizing nucleic 
acids inside cells, not for their quantitation.   
1.3.2 Overview of oligonucleotide probes for detection of nucleic acids 
The selective detection of specific DNA and RNA sequences can be achieved by 
using oligonucleotide-based antisense hybridization probes.103 In general, the sequences 
of these oligonucleotide probes are complementary to the target sequences, and the 
attachment of a reporter group to these probes enables their visualization by a 
spectroscopic technique, such as fluorescence spectroscopy.104 Two of the typical 
categories of these oligonucleotide probes are molecular beacons (MBs) and binary 
probes (BPs), as will be described in the following section.  
1.3.2.1 Molecular beacons 
The MB concept was introduced in 1996 by Tyagi and Kramer105 for nucleic acid 
hybridization assays and is among the most promising technologies under development 
for quantitative nucleic acid detection in vitro and in vivo. As shown in Fig. 1.15 A, a MB 
is a fluorophore and quencher labeled (or dual fluorophore-labeled) DNA hairpin 
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comprised of a probe region (loop) complementary to a target sequence and a 
self-complementary region of five to six nucleotides at the opposite ends (stem). In the 
absence of the target, the complementary parts of the probe hybridize and form a hairpin 
conformation, thereby bringing the fluorophore (donor) and quencher (acceptor) into 
close proximity.  This interaction results in strong fluorescence quenching through the 
deactivation of the fluorophore excited state through förster resonance energy transfer 
(FRET). In the presence of the target, the hairpin structure opens up and the loop region 
hybridizes to the target DNA sequence, resulting in the separation of the fluorophore and 
quencher accompanied with brightening of the fluorophore.  
An ideal MB should not exhibit any fluorescence emission in the “closed” hairpin 
conformation but a strong fluorescence emission in the “open” conformation when 
hybridizing with the target. The efficiency of target detection of a MB is measured by its 
signal-to-background ratio (S/B), which is the ratio of the fluorescent signal in the 
presence of the target to the fluorescent signal before the addition of the target.106 
Molecular Beacons have enabled increased assay detection by directly measuring the 
fluorescence changes rapidly after DNA probe hybridization and have been exploited in 
various biological applications. However, the opening of the hairpin and separation of the 
fluorophore and the quencher evoked by hybridization of this oligonucleotide to the 
target probe region is not easily adapted for in vivo studies because of interference from 
unbound probes, non-specific hybridization and autofluorescence from the biomolecules 
in the sample. These result in unacceptably high background signals and false positive 
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signals.105, 107, 108 Furthermore, in the probe-quencher configuration, the quenching of the 
fluorophore in the hairpin state makes it difficult to track the injection of MBs inside the 
cells.  
With dual fluorophore-labeled molecular beacons, a signal due to FRET from 
acceptor to donor will be observed in the hairpin state since the two fluorophores are 
thereby brought close to each other, and the hairpin conformation will evoke a strong 
donor emission. While this makes it possible to visualize the injection of MBs, 
non-specific opening of the MBs remains a significant challenge.104  
 
Fig. 1.15. Principle of oligonucleotide probes for detection of nucleic acid. (A) molecular beacons; 
(B) binary probes. 
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1.3.2.2 Binary oligonucleotide probes 
An alternative strategy to the use of molecular beacons is the binary oligonucleotide 
probes, which have been shown to display high specificity within living cells since the 
requirement for efficient FRET relies on the strict spatial requirements of the fluorescent 
donor and acceptor.109 As shown in Fig.1.15 B, the BP system is composed of two 
single-stranded DNA (ssDNA) molecules which are complementary to adjacent regions 
of a common target sequence where a donor and acceptor are attached at opposite ends. 
When the pair of BPs selectively hybridizes to their targets, the two oligonucleotide 
strands are drawn into close proximity and a distinctive FRET signal is elicited. The 
resulting FRET signal is different from that of the non-hybridized probes, and nonspecific 
binding to cellular components will be unlikely to promote FRET because of the strict 
spatial requirements. Therefore, higher specificity is shown to be an advantage of the BP 
over the MB approach. 
In the ideal 2-color binary probe system, only the fluorescence from the donor 
fluorophore is observed in the absence of the target, while in the presence of the target, 
only the fluorescence of the acceptor fluorophore is observed because of FRET from the 
donor. Hence, the BP system undergoes a color switch when changing from random 
distribution in the solution state to the hybridization state of binding to the target. Similar 
to molecular beacons, the efficiency of BPs could also be measured by S/B ratio, which 
can be generally described as the ratio of the fluorescence signal of the acceptor to that of 
the donor in the presence of target divided by the ratio of the fluorescence intensity of the 
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acceptor to that of the donor in the absence of the target (S/B = (FAcceptor+Target* 
FDonor)/(FDonor+Target*FAcceptor)).110 The S/B ratio relies on the efficiency of FRET, which 
depends on various parameters, including the distance between the donor and acceptor 
fluorophores and the spectral overlap between the donor emission and the acceptor 
absorption spectra.111 Theoretically, it requires that the emission band of the donor should 
overlap as much as possible with the excitation band of the acceptor, but the excitation 
band of the donor should be far from that of the acceptor to reduce direct excitation of the 
acceptor leading to a background signal. However, no available dye pairs fulfill the above 
criteria perfectly and sometimes it is necessary to compromise energy transfer efficiency 
in order to reduce direct excitation. The other challenge of binary probes is their slow 
kinetics of hybridization, because both probes need to hybridize to the target, resulting in 
a larger entropy loss compared with molecular beacons. Although people have been 
trying to construct different binary probes to address these problems, such as connected 
binary probes112 and pyrene excimer probes,104 and there are various biological 
applications of BPs so far, a fundamental improvement in the technology is still needed to 
allow tracking of typical mRNAs in living cells.  
1.3.3 Conclusion  
Due to the great potential of in vivo and vitro detection of nucleic acids, 
oligonucleotide-based probes, molecular beacons and binary probes, have engendered an 
intensive research field with novel and creative approaches. However, the effective use of 
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these probes requires overcoming challenges such as non-specific opening of MBs, 
injection and distribution visualization of MBs within the cell, a low S/B ratio in BPs due 
to direct excitation of the acceptor fluorophore and/or overlap of the fluorescence spectra 
of the dyes, low kinetics of BPs, cell autofluorescence, and others. Modification of the 
classical architecture of MBs or BPs has allowed for the enhancement of detection 
capabilities. However, many improvements are necessary to advance their application. 
Because of the high specificity of 2 dye-binary probes and the ease of tracking them in 
vivo, part of my thesis focuses on the development of novel binary probes with quantum 
dot-based donor molecules and organic dye-based acceptors to address some of the 
challenges of traditional binary probes. 
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Part I Mass Spectrometric DNA Sequencing and SNP 
Genotyping with Cleavable Biotinylated Dideoxynucleotides 
MALDI-TOF mass spectrometry offers an attractive option for DNA analysis due to 
its high accuracy, sensitivity and speed. In this section, as a significant improvement on 
non-cleavable biotinylated dideoxynucleotides, we described the design and synthesis of 
cleavable biotinylated dideoxynucleotides (ddNTP-N3-biotins) and their particular 
applications in solid phase capturable mass spectrometric sequencing and single base 
extension-based mass spectrometric detection of single nucleotide polymorphisms (SNPs) 
that are associated with mitochondrial disease. We also explore the use of a SNP 
genotyping microfluidic lab-on-a-chip device with the potential for high throughput, 
miniaturization and automation. 
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Chapter 2 Design and Synthesis of Cleavable Biotinylated 
Dideoxynucleotides for DNA Sequencing and Genotyping by 
MALDI-TOF Mass Spectrometry 
2.1 Introduction 
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry 
(MALDI-TOF MS) was developed by Tanaka and Kara in 1988,1, 2 with the initial 
application in proteomics studies. It was not until the introduction of a 
3-hydroxypicolinic acid (3-HPA) matrix by Becker’s group3 and the addition of 
ammonium ions to the matrix by Pieles et al.4 that nucleic acid analysis by MALDI-TOF 
MS started to gain momentum. The full potential for DNA analysis was demonstrated in 
19955 and for RNA in 1998,6 from which time MALDI-TOF MS has been widely used 
for rapid and accurate analysis of nucleic acids. In brief, as shown in Fig. 2.1, for 
MALDI-TOF MS analysis of DNA, the analytes, single-stranded nucleic acid molecules, 
need to be generated and deposited with the matrix molecules (typically ultraviolet (UV) 
or infrared (IR) light-absorbing small organic molecules, such as 3-HPA) on a flat sample 
plate and co-crystallized for the analysis. The analyte/matrix molecules are then 
irradiated by a laser, inducing energy desorption and ionization, after which the charged 
ions are accelerated under a constant electric voltage and pass through the flight tube to a 
detector at the opposite end. Molecules are distinguished by their time of flight, which is 
proportional to their individual masses. Hence, the masses of the charged ions are 
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determined from their time of flight to the detector, represented as m/z, mass per charge 
ratio.7  
 
Fig. 2.1. Principle of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry 
(MALDI-TOF MS).7 
MALDI-TOF MS based DNA analysis has the advantages of accuracy, speed and 
potential for automation. Compared with gel mobility and hybridization-based 
fluorescent labeling assays, the absolute mass value represents an intrinsic property of a 
molecule, and therefore more informative and accurate, free from secondary structure 
effects that typically plague gel electrophoresis and the false positive signals resulting 
from mismatch hybridization. The mass data acquisition can be accomplished in less than 
1 min, and the fragment “separation” process can be fully automated. Mass spectrometry 
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(MS) has been applied to a number of different areas of DNA analysis, such as 
sequencing, mutation and polymorphism analysis, and virus or bacteria detection,8 
among which MS-based Sanger sequencing and single base extension (SBE)-based 
single nucleotide polymorphism (SNP) genotyping have gained the most attention. 
Nevertheless, a major challenge of MALDI-TOF MS analysis is the stringent purity 
required for the DNA fragments introduced into the mass detector, which demands DNA 
fragments free of alkali and alkaline earth salts as well as other contaminants.9  
One of the approaches for purifying DNA samples is to utilize the strong, specific 
and stable interaction of biotin and streptavidin coupled with solid-phase capture.10 Fu et 
al. reported the use of a 5’ biotinylated primer for sample purification by streptavidin 
coated magnetic beads in their MS sequencing. The Ju lab introduced solid phase 
capturable dideoxynucleotides, biotinylated ddNTPs, in both their sequencing and 
genotyping strategy to further eliminate falsely stopped DNA (i.e., preliminarily 
terminated) fragments and excess primers.7, 9 This significantly improved the 
performance of MS analysis. Nonetheless, harsh conditions are required to cleave the 
biotin-streptavidin bond, such as treatment with formamide at a high temperature. This 
complicates downstream procedures, since the isolated products need to be ethanol 
precipitated prior to the desalting step for MS analysis. This is a tedious, time consuming 
process and is prone to sample loss. Though some groups have tried to develop mild 
approaches for breaking the bond between biotin and streptavidin,11 the presence of the 
biotin moiety in purified DNA fragments introduces its own complications in higher 
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resolution analysis since biotin contains a sulfur atom which exists as four major stable 
isotopes. All of these problems could be eliminated by taking advantage of biotinylation 
analogs with cleavable linker arms.12 As early as 1985, Shimkus et al. reported the use of 
a cleavable disulfide bond to link the biotin moiety to the nucleotide for the recovery of 
protein-DNA complexes.13 Olejnik et al. attached biotin to peptides and oligonucleotides 
through a photocleavable linker for isolation and subsequent purification.14 Bai et al. first 
introduced a nucleotide analog containing a photocleavable biotin that can be 
incorporated into the DNA strand by polymerase, which significantly facilitated the 
utilization of the cleavable linkers.12 In their study, they attached the biotin moiety to the 
5-position of 2’-deoxyribouridine 5’-triphosphate (dUTP) via a photocleavable 
2-nitrobenzyl linker, and demonstrated it to be a good substrate for Thermo Sequenase in 
single and multiple primer extension reactions.  
On the other hand, the decreasing resolving capacity of the mass spectrometer for 
larger DNA fragments requires appropriate mass differences to achieve high resolution 
and accuracy. This could be addressed by having different length linkers between the 
biotin and the nucleotide. For example, in their DNA sequencing analysis, Edward et al. 
replaced the biotin-11-ddUTP with biotin-16-ddUTP, to overcome the small mass 
difference between biotin-11-ddUTP and biotin-11-ddCTP (1 Da). The introduction of 
the longer linker arm shifted the mass difference to >80 Da, allowing better resolution in 
sequence determination.    
This part of the thesis describes the design, synthesis and evaluation of a complete 
  
65
set of further modified mass tagged, chemically cleavable dideoxynucleotides for 
application in DNA sequencing and SNP genotyping.   
2.2 Experimental Rationale and Overview 
The chemically cleavable biotinylated dideoxynucleotides are designed in such a 
way that the biotin moiety is covalently attached to the 5-position of the pyrimidines and 
the 7-position of the purines through chemically cleavable linkers of different lengths. As 
shown in Fig. 2.2, these chemically modified dideoxynucleotides are incorporated into 
the DNA strand by the polymerase which thereby generates DNA fragments with a 
cleavable biotin moiety at the 3’ end. The biotinylated DNA fragments are captured by 
streptavidin interaction, while other contaminants from the polymerase reaction are 
washed away. Then the fragments are released from the streptavidin-coated surface by 
cleaving the linker under mild chemical conditions, leaving the biotin attached to the 
surface.  
Here, a chemically cleavable biotinylated dideoxynucleotide set, ddNTP-N3-biotins 
(ddATP-N3-biotin, ddGTP-N3-biotin ddCTP-N3-biotin, and ddUTP-N3-biotin) was 
generated for the DNA polymerase extension reaction and DNA sequencing as well as 
genotyping by MS applications. The nucleotide analogs were designed to have a biotin 
moiety attached to the 5 position of pyrimidines (C and U) or the 7 position of purines (A 
and G) via an azido based linker, and the nucleotide precursors with two different length 
carbon linker arms were used to increase the mass differences among these nucleotide 
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analogs. Previously, we reported that chemically cleavable fluorescent 
dideoxynucleotides with azido based linkers could be used successfully for DNA 
sequencing by synthesis, and the fluorophores were shown to be completely removable 
under very mild cleavage conditions, using an aqueous tris(2-carboxyethyl) phosphine 
(TCEP) solution.15 Hence, azido linkers were chosen to attach the biotin to the 
nucleotides in the current design, since the linker can be cleaved by TCEP very 
efficiently and TCEP is compatible with the downstream desalting step. 
 
Fig. 2.2. Scheme of single base extension, solid phase capture and cleavage using chemically 
cleavable dideoxynucleotides 
It is demonstrated here that ddNTP-N3-biotins were able to be incorporated into 
DNA strands during the polymerase extension reaction, and that DNA strands with 
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biotinylated dideoxynucleotides at their 3’-end can be efficiently captured by streptavidin 
coated magnetic beads and then released from the beads with TCEP. Such nucleotide 
analogs that carry a biotin and a chemically cleavable linker will allow the isolation and 
purification of DNA fragments under mild conditions for MS-based sequencing and 
multiplex SNP detection, as well as facilitate DNA-protein complex purification in a 
non-denaturing fashion.  
2.3 Results and Discussion 
2.3.1 Design and synthesis of cleavable biotinylated dideoxynucleotides 
Synthetic work for the full set of cleavable biotinylated dideoxynucleotides 
(ddNTP-N3-biotins) was accomplished by Dr. Shiv Kumar in our organic chemistry 
laboratory. Introduction of a chemically cleavable biotin moiety into the nucleotides 
enabled highly effective isolation and purification of the DNA products, which could 
then be applied to MALDI-TOF MS for DNA sequencing and genotyping analysis. It has 
been shown previously that when the 5 position of the pyrimidines (C/U) and the 7 
position of the purines (A/G) were modified with bulky fluorescent dyes through 
azido-based linkers, DNA polymerase could still incorporate the modified nucleotides 
into the growing DNA strand, and the azido-based linker could be efficiently cleaved by 
the Staudinger reaction using an aqueous TCEP solution.15 Therefore, azido-based linkers 
were chosen for this study. Here, biotin-azido linkers were pre-synthesized. To enlarge 
the mass difference between the modified nucleotides, propargylamino-ddGTP and 
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propargylamino-ddUTP, available commercially, were modified with an extra linker 
module to produce a longer linker arm before connection to the shorter biotin-azido 
linkers previously prepared for all four nucleotides. This generated a set of cleavable 
biotinylated dideoxynucleotides, ddNTP-N3-biotins, shown in Fig. 2.3, which have a 
biotin moiety attached to the 5 position of the pyrimidines (C/U) and the 7 position of the 
purines (A/G) via chemically cleavable azido-based linkers which are longer in the U and 
G than in the A and C analogues.  
With increasing DNA fragment size, mass spectrum peak widths increase, resulting 
in a decreasing resolution of the mass peaks with larger DNA fragments. In addition, 
very high accuracy is required to demonstrate the existence of single base 
polymorphisms (SNPs). Hence, for the unambiguous determination of sequence in the 
higher mass range as well as heterozygote detection, it is important to design the 
modified nucleotides with clearly distinguishable mass tags.9, 16 
In this study, dideoxynucleotide precursors with two different carbon linker arms 
were chosen to increase the mass difference between different nucleotides before and 
after cleavage. Thus, the smallest mass difference between two modified 
dideoxynucleotides is 23 Da (A and C), whereas it is only 9 Da for standard terminators 
(A and T), and 16 Da for previously used biotinylated nucleotides (A and G). Also, the 
mass difference between A and G has been shifted from 16 Da to 129 Da, and the mass 
difference between C and G shifted from 39 Da to 152 Da. These mass-tagged linker 
halves still remain after cleavage since they are positioned before the azido group in the 
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full linker. The adjusted masses of these tagged nucleotides clearly provide better 
























































































































Fig. 2.3. Structures of cleavable dideoxynucleotides (ddNTP-N3-biotins). Note that the length of 
the portion of the linker between the base and the N3 group, the segment which remains attached 
to the extended DNA after TCEP cleavage, varies between the two purine (A and G) and the two 
pyrimidine bases (C and U) bases, enabling clear discrimination of their sizes by MALDI-TOF 
mass spectrometry. 
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2.3.2 Polymerase extension using ddNTP-N3-biotins, solid phase capture and 
cleavage 
In developing the MS genomic analysis assay, it was essential that the biotinylated 
nucleotides could be efficiently incorporated into the DNA strand during the polymerase 
reaction, the DNA strand bearing biotinylated nucleotides could be effectively captured 
on the streptavidin coated solid phase, and then efficiently released after cleavage while 
leaving the biotin behind on the solid phase. To verify this, single base extension 
reactions with four corresponding self-priming DNA templates were carried out in 
solution. As shown in Fig. 2.4 A, D, G, and J, 100% incorporation was confirmed with 
MALDI-TOF mass spectrometry by observing the total disappearance of the primer peak 
(7966 m/z) and the emergence of the extension product for each dideoxynucleotide (8889 
for ddATP-N3-biotin, 9018 for ddGTP-N3-biotin, 8866 for ddCTP-N3-biotin, and 8980 
for ddUTP-N3-biotin, m/z). Incubation of the extension products in TCEP solution led to 
the cleavage of the N3-based linker tethering the biotin to the dideoxynucleotides. As 
shown in Fig. 2.4 B, E, H, and K, the mass peaks for the extension products have 
completely disappeared, whereas single peaks corresponding to the cleavage products 
appear at 8416, 8545, 8393, and 8507 (m/z), respectively, which indicates 100% cleavage 
efficiency. To evaluate these modified nucleotides for the solid phase purification 
procedure, after performing the same single base extension reactions, the extension 
products were captured on streptavidin coated magnetic beads, released by TCEP, and 
subsequently analyzed by MALDI-TOF MS. The results are shown in Fig. 2.4 C, F, I and 
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L, where single peaks corresponding to released extension products again appear at 8416, 
8545, 8393, and 8507 (m/z), respectively, the expected masses of the cleavage products. 
The overall process of single base extension, solid phase capture and cleavage for each 
nucleotide is shown in the upper part of Fig. 2.4. Given ddA-N3-biotin as an example, the 
detailed process is illustrated in Fig. 2.5. After single base extension, DNA extension 
product (1) (Fig. 2.5 A) was first captured by streptavidin-coated magnetic beads. After 
cleavage by TCEP, the DNA extension products captured on streptavidin-coated 
magnetic beads generated released product (3) (Fig. 2.5 C), while the biotin moiety 
stayed on the surface of the beads. The portion that remained on the nucleotides served as 
an enhanced mass tag to increase the mass differences between each of the modified 
nucleotides. The detailed mechanism of TCEP cleavage is shown in Fig. 2.6. In the 
Staudinger reaction, TCEP reduces the azido group into an amino group, which generates 
an active intermediate that is hydrolyzed efficiently in aqueous solution. This leads to the 




Fig. 2.4. MALDI-TOF mass spectra of the DNA extension products, their subsequent cleavage 
products in solution, and released DNA products from streptavidin coated magnetic beads. (A) 
primers extended with ddATP-N3-biotin (1) (8889 m/z); (B) their cleavage products (2) (8416 m/z); 
(C) released products from solid phase (3) (8416 m/z); (D) primers extended with 
ddGTP-N3-biotin (4) (9018 m/z); (E) their cleavage products (5) (8545 m/z); (F) released products 
from solid phase (6) (8545 m/z) (G) primers extended with ddCTP-N3-biotin (7) (8866 m/z); (H) 
their cleavage products (8) (8393 m/z); (I) released products from solid phase (9) (8866 m/z); (J) 
primers extended with ddUTP-N3-biotin (10) (8980 m/z); (K) their cleavage products (11) (8507 
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Fig. 2.5. Polymerase extension reaction using ddATP-N3-biotin as a substrate and TCEP cleavage 
of DNA fragments containing ddA-N3-biotin on streptavidin coated beads. The DNA polymerase 
Thermo Sequenase incorporates ddATP-N3-biotin to generate the extension product (1). 
Cleavage by TCEP of the DNA extension products captured on streptavidin-coated beads 














































































































































Fig. 2.6. Staudinger reaction with TCEP to cleave the azido-based linker and release the DNA 
extension products from the streptavidin coated surface.  
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2.3.3 Comparison with non-cleavable biotinylated dideoxynucleotides  
The introduction of a chemically cleavable linker to the dideoxynucleotides was 
designed to facilitate the downstream process after solid phase capture. In order to verify 
the advantages of cleavable biotinylated dideoxynucleotides over noncleavable ones, 
taking ddATP-N3-biotin and biotin-11-ddATP as an example, comparison studies were 
performed. Very small amounts of starting material, 0.5 pmol, 1.0 pmol and 2.5 pmol of 
self-priming template 26dA, were chosen to carry out the reaction to better compare the 
resulting sensitivity using each nucleotide. As shown in Fig. 2.7, following the same 
single base reaction and solid phase capture procedures, the ddATP-N3-biotin terminated 
DNA strand was treated with TCEP, the product of which was taken directly to the 
desalting step since TCEP is compatible with the ZipTip procedure. In contrast, the 
biotin-11-ddATP extended DNA strand had to go through high temperature (95oC) 
treatment in the presence of formamide, which required ethanol precipitation before the 
desalting step. Due to the small amount of starting material, an overnight ethanol 
precipitation was required to recover the maximum amount of sample. Hence, the use of 
cleavable nucleotides simplified the overall procedure and saved time. The mass 
spectrometry results further demonstrated that using cleavable biotinylated nucleotides 
(ddATP-N3-biotin) leads to better sensitivity. As shown in Fig. 2.7 C, regardless of the 
amount of starting material, the signal generated from ddATP-N3-biotin was more than 3 
times higher than that from biotin-11-ddATP. The significant improvement of the 




Fig. 2.7. Comparison of cleavable biotinylated dideoxynucleotide (ddATP-N3-biotin) and 
non-cleavable biotinylated dideoxynucleotide (biotin-11-ddATP). (A) Chemical structures of 
ddATP-N3-biotin and biotin-11-ddATP; (B) the purification process for each nucleotide. Note: 
after cleavage, the biotin-11-ddATP incorporated DNA template requires an extra ethanol 
precipitation step; (C) mass spectrum of final product for starting template: a, 0.5 pmol, b, 1.0 
pmol, c, 2.5 pmol.  
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Furthermore, proper adjustment of the pH of the TCEP with ammonium hydroxide also 
avoids the production and retention of alkaline salts typically remaining after ethanol 
precipitation, which simplifies the overall desalting procedure. Additionally, though not 
demonstrated here, the released products from the solid phase do not contain the biotin 
moiety. This excludes the interference from the four isotopes of sulfur in the biotin 
molecule, and should result in a higher resolution and accuracy of the mass spectrum.  
2.4 Materials and Methods 
General information. All chemicals were purchased from Sigma-Aldrich unless 
otherwise indicated. 1H-NMR spectra were recorded on a Bruker DPX-400 (400 MHz) 
spectrometer. Electrospray ionization (ESI) mass spectra were recorded on a Bruker 
Daltonics Esquire 6000 mass spectrometer. Mass measurement of DNA was performed 
on a Voyager DETM MALDI-TOF mass spectrometer (Applied Biosystems by Life 
Technologies, San Diego, CA). HPLC was performed on a Waters system (Milford, MA) 
consisting of a Rheodyne 7725i injector, 600 controller and a 996 photodiode array 
detector. Oligonucleotides were purchased from Integrated DNA Technologies 
(Coralville, IA). Thermo Sequenase was from GE Healthcare (Piscataway, NJ). 
Streptavidin coated magnetic beads (Dynabeads® MyOneTM Streptavidin C1) were 
obtained from Life Technologies (San Diego, CA). 
2.4.1 Synthesis of ddNTP-N3-biotins 
The propargylamino-dideoxynucleotides (1-4) were either purchased from Perkin 
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Elmer Life and Analytical Sciences or prepared following the procedure described by 
Hobbs and Cocuzza.17 The longer linker arm dideoxy nucleotides (5-6) were prepared 
according to Duthie et al.18 and purified on HPLC (Fig. 2.8). Azido linker, 
(2-{2-[3-(2-amino-ethylcarbamoyl)-phenoxy]-1-azido-ethoxy}-ethoxyl)-acetic acid (7) 






















































































































a) 0.1 M carbonate-bicarbonate
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Fig. 2.8. Structures of 5- or 7-propargylamino-ddNTPs. 
Synthesis of biotin-N3-Linker Acid (8).  Azido linker (7, 74 mg, 0.2 mmol) was 
  
79
dissolved in anhydrous DMF (5 ml) and 1.5 ml of 1 M NaHCO3 aqueous solution. A 
solution of Biotin-NHS ester (75 mg, 0.22 mmol) in 4 ml of anhydrous DMF was added 
slowly to the stirred reaction mixture and was stirred overnight at room temperature. The 
reaction mixture was concentrated in vacuo and purified on a silica gel chromatography 
column using 25% methanol in methylene chloride to 40% methanol in methylene 
chloride. The appropriate fractions were combined and concentrated to give a white solid 
(72 mg, 60%). 1H NMR (400 MHz, D2O): δ 7.48-7.39 (m, 3H), 7.16 (d, 1H), 5.05 (t, 1H), 
4.48 (t, 1H), 4.29-4.20 (m, 3H), 4.00-3.90 (m, 4H), 3.78 (m, 2H), 3.53-3.45 (2d, 4H), 
2.91-2.87 (dd, 1H), 2.69 (d, 1H), 2.36 (t, 2H), 1.66-1.37 (m, 6H); FAB`-MS m/z: calcd for 
C25H36N7O8S (M+H+), 594.65; found 594.75 
General method for the synthesis of ddNTP-N3-biotins (10-13).  Biotin-N3-Linker acid 
(8, 4mg, 6.75 μmol) was co-evaporated with anhydrous DMF under reduced pressure and 
re-dissolved in anhydrous DMF (0.8 ml).  A solution of 
O-(N-Succinimidyl)-1,1,3,3-tetramethyluronium tetrafluoroborate (TSTU, 20 μmol) in 
anhydrous DMF (0.4 ml) was added to the stirred solution under an argon atmosphere 
and the reaction mixture was stirred at room temperature for 15 min. The appropriate 
amino-ddNTP (1, 2, 5 or 6, 10 μmol) in 0.1 M NaHCO3-Na2CO3 buffer (pH 8.7, 300 μl) 
was added to the activated ester and the reaction mixture stirred at room temperature 
overnight (Fig. 2.9). The mixture was purified by reverse-phase HPLC on a 150 X 4.6 
C18 column (Supelco, PA) using mobile phase: A, 8.6 mM triethylamine/100 mM 
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hexafluoroisopropyl alcohol in water (pH 8.1); B, methanol. Elution was performed with 
100% A isocratic for 10 min followed by a linear gradient of 0-50% B for 20 min and 
then 50% isocratic for another 20 min. The isolated pure adducts were characterized by 
the ESI-MS analysis and single base extension followed by MALDI-TOF MS analysis. 
ddATP-N3-biotin (10): HPLC retention time 30.7 min; TOF MS ES+ m/z: anal. 
Calculated for C39H52N12O18P3S (M-H-) 1101.89; found, 1101.2 
ddCTP-N3-biotin (11): HPLC retention time 30.1 min; TOF MS ES+ m/z: anal. 
Calculated for C37H51N11O19P3S (M-H-) 1078.85; found, 1078.2  
ddGTP-N3-biotin (12): HPLC retention time 30.8 min; TOF MS ES+ m/z: anal. 
Calculated for C45H63N13O20P3S (M-H-) 1231.04; found, 1230.3 
ddUTP-N3-biotin (13): HPLC retention time 30.68 min; TOF MS ES+ m/z: anal. 
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Fig. 2.9. Synthesis and structures of biotin-N3-linker attached ddNTPs 
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2.4.2 Polymerase extension using ddNTP-N3-biotins, solid phase capture and 
cleavage 
The four cleavable biotinylated dideoxynucleotides, ddNTP-N3-biotins 
(ddATP-N3-biotin, ddGTP-N3-biotin, ddCTP-N3-biotin, and ddUTP-N3-biotin) were first 
characterized by performing four separate single base extension reactions, each with a 
different self-priming DNA template allowing the four dideoxynucleotide analogs to be 
incorporated. The following four self-priming DNA templates (26-mer hairpin DNA with 
a 4-base 5’-overhang) were used for the extension: 5’-GACTGCGCCGCGCCTTGGCG- 
CGGCGC-3’ for ddATP-N3-biotin, 5’-GATCGCGCCGCGCCTTGGCGCGGCGC-3’ for 
ddGTP-N3-biotin, 5’-ATCGGCGCCGCGCCTTGGCGCGGCGC-3’ for ddCTP-N3- 
biotin, and 5’-GTCAGCGCCGCGCCTTGGCGCGGCGC-3’ for ddUTP-N3-biotin. Each 
of the extension reactions consisted of 40 pmol self-priming DNA template, 60 pmol of 
the corresponding ddNTP-N3-biotin, 1X Thermo Sequenase reaction buffer and 2 U of 
Thermo Sequenase in a total volume of 20 μl. The reaction mixture was incubated at 
65oC for 15 min. For the incorporation test, the extension products were desalted by 
using ZipTips and analyzed by MALDI-TOF mass spectrometry. The matrix solution was 
made by dissolving 35 mg 3-hydroxypicolinic acid with 6 mg ammonium citrate in 800 
μl 50% acetonitrile. For the cleavage, each extension product was mixed with 20 μl 
tris(2-carboxyethyl) phosphine (TCEP) solution (100 mM, pH 9.0 adjusted with 
ammonium hydroxide) and incubated at 65oC to yield DNA cleavage products which 
were characterized by MALDI-TOF MS. To evaluate solid phase capture efficiency and 
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DNA recovery from the solid phase, the same single base extension reactions were 
performed, and 20 μl of each of the single base extension products was incubated with 20 
μl streptavidin coated magnetic beads which had been prewashed with 1X binding and 
washing (B/W) buffer (5 mM Tris-HCl, 0.5 mM EDTA, 1 M NaCl, pH 7.5) three times, 
resuspended in 20 μl 2X B/W buffer, and allowed to incubate for 1 h at room temperature. 
The streptavidin coated magnetic beads bearing extended self-priming DNA templates 
were washed three times with 1X B/W buffer and three times with deionized water, then 
suspended in 20 μl TCEP solution and incubated at 65oC for 25 min. This process 
removed the biotin moiety from the dideoxynucleotides and hence released extended 
self-priming templates from the magnetic beads. The supernatant was collected and 
desalted through ZipTip for MALDI-TOF MS characterization.  
2.4.3 Comparison of ddATP-N3-biotin and biotin-11-ddATP  
A self-priming DNA template 5’-GACTGCGCCGCGCCTTGGCGCGGCGC-3’ 
which can be used to incorporate modified ddATP was chosen for the single base 
extension reaction. 0.5 pmol, 1.0 pmol, and 2.5 pmol of template was used for 
ddATP-N3-biotin and biotin-11-ddATP (Perkin Elmer) respectively. For the parallel 
comparison study, besides DNA template, each extension reaction also contained 
ddATP-N3-biotin or biotin-11-ddATP, the amount of which was 1.5 times that of the 
DNA template, 2 U of Thermo Sequenase and 1X Thermo Sequenase reaction buffer in a 
total volume of 20 μl. The reaction mixture was incubated at 65oC for 15 min. For 
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ddATP-N3-biotin extended products, the same procedures as described in the last section 
were followed with mass spectrometric analysis directly after cleavage and ZipTip 
desalting. However, for biotin-11-ddATP extended products, a different cleavage 
treatment as well as downstream process was carried out. Briefly, after the solid phase 
capture and bead washing, the streptavidin coated magnetic beads bearing extended DNA 
templates were suspended in 10 μl of 95% formamide at 94oC for 10 min. The released 
products were precipitated overnight with 100% ethanol at 4oC and centrifuged at 14,000 
rpm for 40 min, followed by a 70% ethanol wash with centrifugation at 14,000 rpm for 
20 min. Then the products were analyzed by mass spectrometry after ZipTip desalting.  
2.5 Conclusion 
A set of mass tagged, chemically cleavable biotinylated dideoxynucleotide analogues, 
ddNTP-N3-biotins, were synthesized and evaluated for their application for rapid and 
efficient recovery of DNA fragments captured on a solid surface under mild conditions. 
These dideoxynucleotide analogues were shown to be good substrates for the DNA 
polymerase, allowing accurate and fast incorporation by Thermo Sequenase. Biotin 
terminated DNA extension products generated from ddNTP-N3-biotin incorporation 
could be captured on a streptavidin-coated solid surface, and subsequently released by 
using TCEP rather than harsh reagents. The cleavable linkers in the nucleotide analogues 
not only facilitated the DNA fragment recovery after solid phase capture, but also acted 
as mass tags to enlarge the mass differences among the nucleotides for better resolution. 
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It was also demonstrated that these chemically cleavable biotinylated dideoxynucleotides 
had substantial advantages over the conventional non-cleavable biotinylated 
dideoxynucleotides in terms of downstream workflow, cleavage efficiency and sample 
recovery. This set of biotinylated dideoxynucleotide analogues will be a valuable tool for 
DNA sequencing and genotyping by MALDI-TOF MS, as well as other genetic analysis. 
Examples of their utility for sequencing and genotyping are presented in the next two 
Chapters, with our work to develop a lab-on-chip microfluidic device for increasing the 
throughput of these protocols in Chapter 5.  
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Chapter 3 DNA Sequencing by MALDI-TOF Mass 
Spectrometry using Cleavable Biotinylated 
Dideoxynucleotides 
3. 1 Introduction 
With the completion of the first human genome project as example and reference, 
resequencing of target genes at high throughput, high fidelity and high sensitivity will 
greatly contribute to the understanding of the molecular basis of disease and the 
development of new therapeutics. While next generation sequencing approaches have 
become the methods of choice for very large scale projects such as resequencing of the 
whole genome or every exon, or for deep transcriptome sequencing, in many cases one is 
only interested in sequencing a limited area (one or a few genes or coding regions) and 
obtaining a rapid result with high accuracy.  In these cases, next generation sequencing 
is unwarranted and too expensive, leaving only the traditional electrophoresis-based 
Sanger sequencing approach most conveniently performed with fluorescent 
dideoxynucleotides.  Though the latter is well established, producing generally high 
quality and long sequence reads, it has some limitations. In addition to its being time 
consuming and carrying an overall high cost per read, in certain regions in which SNPs 
fall within or just beyond a homopolymer run, sequence quality becomes problematic. 
Moreover, despite substantial improvements in recent years, due to the resolution of the 
separation matrices and gel-based artifacts caused by secondary structures in GC rich 
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sequence, difficulties exist in identifying the first few bases after the priming site. One 
option that can overcome some of these limitations is to take advantage of mass 
spectrometry to distinguish the four nucleotides incorporated during the polymerase 
reaction. 
Matrix-assisted laser desorption ionization time-of-flight mass spectrometry 
(MALDI-TOF MS) has been explored widely for DNA sequencing, such as mass 
analysis of Sanger sequencing products,1 mass laddering sequencing by enzymatic 
digestion,2 RNA/DNA sequencing by base specific enzyme cleavage,3 and mass analysis 
of oligonucleotide synthesis failure products,4 among which direct mass analysis of 
Sanger sequencing products is the most straightforward approach, simply involving the 
replacement of gel electrophoresis determination of the size of DNA fragments with the 
exact molecular weight determination of the fragments. It also has the potential for 
sequencing longer DNA templates whereas the methods described above are only 
applicable for short oligonucleotides.  
The idea of combining the Sanger cycle sequencing reaction with MS analysis 
originated with Fitzgerald et al. in 1993.5 They first demonstrated the use of MALDI MS 
to analyze mock Sanger sequencing reaction mixtures of synthetic oligodeoxy- 
nucleotides ranging from 17 to 41 bases. In theory, the four nested sets of DNA 
fragments that are generated in Sanger sequencing reactions terminated with A, C, G or T 
dideoxynucleotides would each be subjected to MALDI analysis, and the four mass 
spectra would be overlaid to obtain the full sequence information (Fig. 3.1). However, 
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resolution and sensitivity were hurdles for further application of the method at that time. 
With the introduction of the delayed ion extraction technique for MALDI MS, Roskey et 
al. were able to sequence a synthetic ssDNA template by performing four separate  
 
 
Fig. 3.1. The mass spectra of mock A, C, G, and T sequencing reactions containing mixtures of 
synthetic oligonucleotides. (A) Individual spectra; (B) The spectra are overlaid and displayed on 





dideoxy termination reactions, one for each dideoxynucleotide terminator analog, to 
generate four mass spectra for obtaining full sequence information as described in 
Fitzgerald’s method.6 Mouradian et al. further reported MALDI analysis for sequencing 
an M13 bacteriophage single stranded template that was used in actual Sanger 
sequencing.7 Furthermore, the potential of sequencing DNA templates of 130 bases and 
more by generating larger quantities of long DNA ladders was reported by Taranenko and 
colleagues.8 One of the major challenges lies in the stringent purity requirement for 
MALDI-TOF MS analysis, which requires the analyte be free of alkaline salts and other 
contaminants. People have used the biotin- streptavidin interaction for purification of 
sequencing products. For example, Köster et al. succeeded in sequencing synthetic 
ssDNA using streptavidin-coated magnetic beads and biotinylated sequencing primers for 
purification of DNA ladders, removing deoxynucleoside and dideoxynucleoside 
triphosphates, enzyme and buffer salts before the MS analysis.9 However, peaks 
corresponding to primer dimers were still observed, and the premature or false stops 
which are generated in Sanger-sequencing reactions when a DNA fragment terminates 
after incorporating a deoxynucleotide rather than a dideoxynucleotide were frequently 
observed. These extra peaks prevented the accurate interpretation of the sequence. 
Furthermore, the approach of four separate reactions, one for each dideoxynucleotide 
terminator, is cumbersome. And the small mass differences between the nucleotides also 
interfere with the accurate identification of nucleotides. Aiming at a single tube 






Fig. 3.2. Solid-phase-capture (SPC) sequencing. (A) A SPC-sequencing scheme to isolate pure 
DNA fragments for MS analysis; (B) A DNA sequencing mass spectrum generated after extension 
with biotinylated terminators.11  
spectra, our group developed a solid phase capture (SPC) sequencing strategy by using 
biotinylated dideoxynucleotides.10 As shown in Fig. 3.2, four deoxynucleotides (dNTPs) 
and four biotinylated dideoxynucleotides (ddNTP-biotins) generated by attaching biotin 





were used in a Sanger sequencing reaction. Then the reaction products were subjected to 
streptavidin-coated magnetic beads for capturing biotin terminated fragments, whereas 
the false termination fragments, excess primers and other contaminants could be washed 
away. Finally, the Sanger sequencing fragments could be cleaved from the 
streptavidin-coated surface by formamide treatment at high temperature, followed by 
ethanol precipitation and desalting before the MS analysis. By using this approach, our 
group was able to unambiguously identify 24 consecutive bases. 
Nevertheless, despite the improvements over the previous methods, the solid-phase 
capture sequencing still encountered problems in the release of fragments for MS 
analysis. The formamide treatment for breaking the streptavidin-biotin interaction 
requires the inclusion of an ethanol precipitation step, resulting in significant sample loss. 
Since the generation of sufficient termination products especially in the high mass range 
is crucial to achieve longer read-length with high resolution, it is very important to 
develop an alternative cleavage method which could reduce the sample loss before the 
MS analysis. In addition, the use of nucleotides with larger mass differences is also very 
important for unambiguous identification of nucleotides. Therefore, in this chapter, the 
newly synthesized, mass-tagged, chemically cleavable biotinylated dideoxynucleotides, 
described in Chapter 2, were utilized in MS-based solid phase capture sequencing by 
synthesis, with the hope of achieving higher efficiency and longer sequencing 
read-length. Our results demonstrate that read-lengths of over 30 bp are achievable on 
both synthetic and biological DNA templates.  
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3.2 Experimental Rationale and Overview 
As described in Chapter 2, we have developed and characterized a set of 
mass-tagged, chemically cleavable biotinylated dideoxynucleotides (ddNTP-N3-biotins), 
wherein the biotin moiety was linked to the nucleotide through a mass tagged, azido 
based linker. These nucleotide analogs have proven to be good substrates for the enzyme 
Thermo Sequenase, and are efficiently cleaved by TCEP in a procedure that is 
compatible with the downstream desalting step. This allows purification of DNA 
products under mild conditions, which facilitates and simplifies sample handling. The 
mass tags on these analogs were designed to enhance the base discrimination for MS 
analysis, especially within the higher mass range. In this chapter, these nucleotide 
analogs were further evaluated by their application in solid phase capture sequencing. 
The overall scheme of the cleavable solid phase capture sequencing strategy is described 
in Fig. 3.3. A Sanger sequencing reaction consisting of DNA template, sequencing primer, 
natural deoxynucleotides (dNTP), biotinylated dideoxynucleotides (ddNTP-N3-biotins) 
and Thermo Sequenase is first carried out to generate biotin terminated DNA-sequencing 
fragments. These biotinylated sequencing products are isolated from the reaction mixture 
containing excess primers, false stopped fragments, enzyme and salts via solid phase 
capture using streptavidin beads. These sequencing products are then released from the 
beads by cleavage of the linker between the biotin and the nucleotides, leaving biotin still 
bound to the bead surface. Thereafter, the sequencing products are subjected to 
MALDI-TOF MS analysis for sequence identification, without interference from excess 
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primers or falsely stopped fragments. This reversible solid-phase-capture sequencing 
approach was implemented as described in this chapter to sequence assorted DNA 
fragments.  
 
Fig. 3.3. Scheme for purification of DNA-sequencing fragments for MALDI-TOF MS analysis. 
DNA-sequencing fragments are isolated from the sequencing solution containing excess primers, 
falsely stopped fragments and salts by streptavidin-coated magnetic beads. Then the sequencing 
fragments are cleaved from the beads with TCEP for MALDI-TOF MS analysis, leaving the 
biotin moiety still bound to the surface.   
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3.3 Results and Discussion 
The use of MALDI-TOF MS for the analysis of Sanger dideoxy base termination 
sequencing reactions has proven more difficult than fluorescence-based analysis of 
sequencing products due to the limited amounts of termination products typically 
produced. Therefore, the ratio of dideoxynucleotides to deoxynucleotides is critical, and 
the amount of DNA template and primers as well as number of sequencing cycles will 
also effect the sequencing product generation. Hence, different parameters have been 
tested and optimized to obtain reliable sequencing results.  
3.3.1 DNA sequencing on synthetic template  
We first investigated the application of the cleavable biotinylated dideoxynucleotides 
in sequencing of a synthetic single stranded DNA template. The resulting mass spectrum 
is shown in Fig. 3.4. The first peak in the spectrum is the primer peak plus the first 
nucleotide that is complementary to the corresponding nucleotide in the DNA template. 
The mass difference between each peak and the prior dNTP-extended primer can be 
measured to determine the identity of the base at each position, as each 
dideoxynucleotide with its attached half linker has a unique molecular weight 
corresponding to that peak. The read-length of over 37 bases is an improvement on the 
previous non-cleavable biotinylated dideoxynucletide-based sequencing results, which is 





Fig. 3.4. Mass-sequencing spectrum generated using ddNTP-N3-biotins on a synthetic template. 
The nested insets show increasing magnifications of the lower intensity region.  
3.3.2 DNA sequencing on biological template 
To further investigate its biological application, this reversible SPC-sequencing 
approach has been verified by sequencing a PCR product. A portion of the RHOD gene 
was first amplified by PCR on an anonymous sample, the result of which is shown in Fig. 
3.5. To remove the excessive primers and dNTPs, exonuclease/alkaline phosphatase 
treatment and column purification were performed. After carrying out sequencing steps, a 
read-length of 32 bases was achieved, as shown in Fig. 3.6. The appearance of a few 
extra peaks might have been caused by incomplete purification of the PCR products 
since the spectrum obtained with the synthetic template was free of  such extraneous 
peaks; however, they do not interfere with the sequence determination, since they do not 
correspond to any obvious mis-extended products based on the known sequence of the 
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RHOD gene. At the same time, traditional Sanger sequencing was performed on these 
PCR products to confirm the sequencing results, the result of which confirmed the 
accuracy of the MS sequencing (Fig. 3.7). As a proof-of-principle experiment, the 
sequencing of this PCR product proves the potential of using these nucleotides for 
sequencing biological samples. With improvements in post-PCR cleanup and further 
optimization of sequencing conditions, longer read-lengths with lower background 
signals might be achieved.  
 
 
Fig. 3.5. Gel electrophoresis of PCR amplification within RHOD gene. The expected fragment 
size is 150 bp. 1. Low molecular weight ladder (LMW); 2, PCR reaction products (+); 3, Negative 




   
Fig. 3.6. Mass-sequencing spectrum generated using ddNTP-N3-biotins on a PCR product. The 
nested insets show increasing magnifications of the lower intensity region.  
 
 
Fig. 3.7. Sanger sequencing for RHOD gene fragment, the result of which is consistent with that 
obtained by the MS-based sequencing.  
3.4 Materials and Methods 
3.4.1 Sanger DNA sequencing reaction 
A synthetic 90mer template with sequence related to a portion of the RHOD (Ras 




CAACCT-3’, and the corresponding primer 5’-TGTACCGCTC-3’, were first used to test 
the sequencing method using ddNTP-N3-biotins. Another template, a 150 bp double 
stranded PCR product that contains a portion of the RHOD gene 5’-CAACT- 
ACGCTCCACTGACCCCCAAGGAGGGAGCAGCGCTGTGGACAGACCAAGT-CC
CCAGTGCCTCTCCGAAGCCTCCTCACACCCTCCCCCGCCCTGCTTCTCC-TCAG
AGCTACACCCCCACGGTGTTTGAGCGGTACATGGTCAACCT-3’ was generated by 
PCR.  
3.4.2 PCR reactions for generating biological template 
The primers for the PCR reaction were: forward primer 5’-CAACTA- 
CGCTCCACTGACCC-3’ and reverse primer 5’-AGGTTGACCATGTACCGCTC-3’. 
The PCR reaction was carried out in a 50 μl PCR cocktail mixture containing 10 ng 
template (DNA extracted from anonymous sample), 10 nmol dNTPs, 30 pmol reverse 
and forward primers, 1 U of JumpStartTM REDTaq® DNA Polymerase (Sigma-Aldrich) 
and 1X corresponding polymerase reaction buffer. PCR products from this reaction were 
re-amplified to generate a higher yield of PCR fragments if desired. The amplification 
was performed under the following conditions: incubation at 94oC for 2 min, followed by 
36 cycles of 94oC for 20 s, 58oC for 30 s, 72oC for 30 s and final extension at 72oC for 5 
min. The PCR product was subsequently treated with ExoSAP-IT (USB) and further 




3.4.3 DNA sequencing on biological template  
The corresponding primer for sequencing the PCR product was 
5’-CCACTGACCC-3’. Sanger sequencing reactions contained 2000 pmol each of dATP, 
dGTP, dCTP and dTTP; 20 pmol each of ddATP-N3-biotin, ddGTP-N3-biotin, 
ddCTP-N3-biotin and ddUTP-N3-biotin; 6 U of Thermo Sequenase; 1X Thermo 
Sequenase reaction buffer; 60 pmol synthetic DNA template (or ~ 2 μg PCR products); 
300 pmol primer (200 pmol for PCR product) in a total volume of 20 μl. The sequencing 
reactions were subjected to 60 cycles of 94oC for 30 s, 30oC for 1 min (36oC for PCR 
product) and 65oC for 30 s in preparation for solid phase capture and MS analysis. For 
comparison, traditional Sanger sequencing using fluorescently labeled terminators was 
performed using standard protocols (see Materials and Methods in next Chapter for 
details). 
3.4.4 Solid-phase purification of DNA-sequencing products for mass spectrometry 
measurements 
The scheme for the solid-phase purification of DNA sequencing fragments is 
included in Fig. 3.3. The detailed procedure is described as follows. 20 μl 
DNA-sequencing products were combined with 40 μl streptavidin-coated magnetic beads 
that were prewashed with 1X B/W buffer and then re-suspended in 20 μl of 2X B/W 
buffer, and allowed to incubate for 1 h at room temperature. After solid phase capture, the 
beads containing the biotinylated DNA fragments were washed three times with 1X B/W 
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buffer, and three times with deionized water. Then the beads were suspended in 30 μl 
TCEP and incubated at 65oC for 25 min. In this way, the biotin moiety was removed 
from the dideoxynucleotides and different lengths of DNA-sequencing fragments were 
released from the magnetic beads. The supernatant containing DNA sequencing 
fragments was desalted twice with a ZipTip and characterized by MS.   
3.5 Conclusion 
Taking advantage of our newly synthesized mass-tagged, cleavable biotinylated 
dideoxynucleotides, we have developed a reversible-solid-phase-capture MS sequencing 
approach and demonstrated its feasibility by obtaining a read-length of 37 bases on a 
synthetic template and a similar read-length on a biological sample. This approach has 
great potential in DNA sequencing by MS, especially for decoding short difficult 
stretches of DNA containing polymorphisms where fluorescence-based Sanger 
sequencing is inadequate, and next generation sequencing approaches are unnecessarily 
expensive. Considering its read-length, this MS based sequencing can also be used in 
RNA sequencing, such as miRNA sequencing, wherein identification of only a few bases 
is required. In addition, this approach has advantages over the traditional Sanger 
approach when sequencing in sites containing mini-indels or when sequencing through 
regions containing SNPs in pooled samples. Moreover, with the development of mass 
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Chapter 4 SNP Genotyping of Mitochondrial DNA by 
MALDI-TOF MS using Cleavable Biotinylated 
Dideoxynucleotides 
4.1 Introduction 
The abundant sequencing data produced by the current sequencing platforms 
provides the opportunity to look intelligently at the genome with the fine interrogation of 
sequence variations, to explore the connections between genes and phenotypes, and to 
discover biomarkers for subtle differences among individuals or populations. As the 
predominant genetic variations, single nucleotide polymorphisms (SNPs) are of 
particular interest, and the development of an accurate, precise, time-efficient and 
cost-effective SNP genotyping method has emerged as one of the most highly desired 
genomic analysis tools. Various technologies have been developed for SNP genotyping 
for the human nuclear genome, yet accurate detection of SNPs with multiplex potential 
remains a challenge, especially in the mitochondrial genome due to its own complex 
genetics. 
Mitochondria contain a rich number of vital enzymes, and are pivotal in cellular 
energy metabolism and the regulation of programmed cell death, or apotosis.1 As shown 
in Fig. 4.1, the human mitochondrial genome is a double stranded, circular DNA 
molecule of 16569 bp, which encodes 13 structural proteins, two ribosomal RNAs 
(rRNAs) and 22 transfer RNAs (tRNAs).2, 3 Unlike the nuclear DNA (nDNA), the 
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mitochondrial DNA (mtDNA) is maternally inherited, has high copy number per cell and 
appears as a mosaic of mutant and wild type genomes (heteroplasmy).4 So far, more than 
200 pathogenic point mutations in tRNA and rRNA genes as well as protein coding 
regions have been reported, and the hypervariable region of mtDNA is also highly 
polymorphic.5, 6 All these features demand precise interpretation of mtDNA mutation 
data for disease treatment, population association studies and forensic investigations.3, 7-9 
Nonetheless, compared to the nuclear genome, it requires even higher sensitivity and 
accuracy SNP detection.  
 
Fig. 4.1. The human mtDNA map, showing the location of selected pathogenic mutations within 
the 16,569-base pair genome. Genes are designated by the abbreviations outside the ring, and 
mitochondrial syndrome abbreviations and key mutation sites are displayed inside the ring (e.g., 
MERRF mutation at position 8344). 
  
106
A variety of technologies have been developed for mtDNA genotyping, including the 
MitoChip,10 PCR-RFLP analysis,11 the TaqMan real-time genotyping assay,12 and direct 
Sanger sequencing,10, 13 yet each has some drawbacks.14, 15 Most are time consuming and 
fail to detect low heteroplasmy levels (<10%); some, such as PCR-RFLP and the TaqMan 
assay, are labor intensive when detecting mutiplex SNPs; and false positives often exist 
due to the limitations of the detection methods. While next-generation sequencing is 
becoming popular for genotype analysis,14-16 considering its cost and work flow, it is 
more suitable for genome-wide studies than targeted SNP genotyping. In addition, its 
relatively high error rate contributes to false positives and inadequate detection of low 
level heteroplasmy. Therefore, it is very important to develop a rapid, accurate, sensitive 
and cost-effective method for SNP genotyping of mitochondrial DNA.  
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry 
(MALDI-TOF MS) allows rapid and accurate sample measurement, and provides high 
resolution and sensitivity. It has been employed for SNP genotyping coupled with 
hybridization,17 strand invasion dependent cleavage of oligonucleotides18 and single base 
extension (SBE);19-23 the latter, in particular, has emerged as a very powerful method for 
multiplex SNP detection. Generally, in single base extension, SBE primers designed to 
anneal adjacent to targeted SNP sites are extended by dideoxynucleotides that are 
complementary to the nucleotides at the polymorphic positions. The nucleotides can be 
identified by measuring the molecular weight of primer extension products. In this 
MS-based analysis, it is critical to isolate and stringently purify DNA primer extension 
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products from excess primers in the reaction mixture for high-fold multiplex SNP 
analysis and unambiguous detection. Hence, in previous work aimed at multiplex 
genotyping, we have developed a solid phase capture step for single base extension 
(SPC-SBE) by using biotinylated dideoxynucleotides to generate 3’ biotin 
dideoxynucleotide terminated DNA strands, thereby allowing solid phase isolation of 
SBE products on streptavidin-coated beads.23-26 However, the release of biotin terminated 
primers from streptavidin coated surfaces requires harsh conditions, such as treatment 
with formamide at a high temperature, to break the biotin-streptavidin bond. This 
complicates downstream procedures due to the requirement for ethanol precipitation 
steps which are tedious and can result in sample loss. Furthermore, the relatively small 
mass differences between each dideoxynucleotide reduces the effective peak resolution, 
which poses challenges for low level heteroplasmy detection due to potential peak 
overlaps. 
The introduction of our newly synthesized mass-tagged, cleavable biotinylated 
dideoxynucleotides, ddNTP-N3-biotins (ddATP-N3-biotin, ddGTP-N3-biotin 
ddCTP-N3-biotin, and ddUTP-N3-biotin), as described in Chapter 2, provides a potential 
way to address all these challenges. The presence of the azido group in the linker permits 
cleavage of the biotin to be accomplished by tris(2-carboxyethyl)phosphine (TCEP) 
under DNA-friendly aqueous conditions, and the length of the linker is adjusted to 
increase the mass differences among these nucleotide analogs. The combination of these 




In this study, we validated our chemically cleavable SPC-SBE approach in testing 
mtDNA samples for the myoclonic epilepsy with ragged red fibers (MERRF) syndrome. 
MERRF syndrome is a maternally inherited multisystemic disorder, as is often the case 
for mitochondrial diseases.27, 28 Some of the most commonly used point mutations for 
clinical diagnosis of MERRF are m.8344A>G (A8344G),29 m.8356T>C (T8356C)30 and 
m.8363G>A (G8363A)31 in the mitochondrial MT-TK gene encoding tRNALys, and 
m.3243A>G (A3243G)32 and m.3255G>A (G3255A)33 in the mitochondrial MT-TL1 
gene encoding tRNALeu. Among these, A8344G is the most common mutation in MERRF, 
present in over 80% of affected individuals,27 while A3243G and G3255A are mutations 
shared with MELAS (myopathy, encephalopathy, lactic acidosis and stroke) 
syndrome.33-35  
A 5-plex genotyping assay was developed to simultaneously identify variants at all 
five of these sites in mtDNA samples. It was demonstrated that the SPC-SBE approach 
using cleavable biotinylated ddNTPs was able to quantify heteroplasmy levels and detect 
as low as 2.5% heteroplasmy. This enables the rapid and accurate identification of 
mtDNA SNP variants at high sensitivity and specificity, offering great potential for 
mitochondrial disease diagnosis and other genetic testing demands.  
4.2 Experimental Rationale and Overview 
In this Chapter, the set of mass tagged, chemically cleavable biotinylated 
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dideoxynucleotides synthesized in our lab has been introduced into our previously 
developed solid-phase-capture (SPC)-single-base-extension (SBE) approach for SNP 
genotyping, taking into account the advantages of these nucleotide analogues, mild 
cleavage conditions compatible with the downstream processes leading to higher sample 
recovery, and enlarged mass differences for higher nucleotide discrimination. As shown 
in Fig. 4.2, our cleavable SPC-SBE SNP genotyping method is described as follows. The 
target regions of genomic DNA spanning the SNPs were first amplified by PCR to 
generate sufficient template for detection of SNPs. Single base extensions with cleavable 
biotinylated dideoxynucleotides (ddNTP-N3-biotins), SBE primers designed to anneal 
adjacent to the SNP loci, and Thermo Sequenase were carried out to produce biotinylated 
end labeled extension products. Solid phase capture was performed to purify the 
extension fragments from the reaction mixture, and SBE products were then released 
from the streptavidin surface by treatment with TCEP and subjected to MALDI-TOF MS 
analysis after a direct desalting step, leaving the biotin moiety still bound to the surface.  
To employ this cleavable SPC-SBE method, the mitochondrial DNA carrying SNPs 
leading to MERRF were chosen as the genomic DNA target for the evaluation, as 
mitochondrial genotyping requires higher sensitivity and accuracy. Both a uniplex and 
5-plex genotyping method was developed, with particular focus on the A8344G locus for 
evaluating the features of our protocol in low heteroplasmy detection, and quantification 




Fig. 4.2. The SPC-SBE approach for multiplex genotyping by MALDI-TOF MS using cleavable 
biotinylated dideoxynucleotides. DNA fragments that contain target SNP positions are generated 
by uniplex or multiplex PCR, and serve as templates for single base extension reactions. A set of 
SBE primers that are adjacent to SNP sites are used to generate single base extension products 
which are then isolated from the reaction mixture containing unextended primers, salts and other 
contaminants by streptavidin-coated magnetic beads. SBE products are then cleaved from the 
beads with TCEP in preparation for MALDI-TOF MS analysis, leaving the biotin moiety still 
bound to the bead surface.  
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4.3 Results and Discussion 
4.3.1 PCR amplification of targeted region in mitochondrial DNA 
For the PCR reaction, stringent annealing conditions were chosen to prevent 
non-specific amplification. Different amplification conditions were tested after the initial 
design of the PCR primers. According to the melting temperature of the PCR primers, 
three different annealing temperatures were tested, 53oC, 55oC and 58oC, with the same 
amount of starting DNA sample. Two different amounts of starting DNA sample were 
used at the same annealing temperature of 55oC. As shown in Fig. 4.3A, the desired 
fragments were successfully amplified under all conditions. The highest temperature of 
58oC was chosen for all the PCR reactions in this study.  
Though mitochondria have much higher copy numbers, the DNA extract is a mixture 
of mitochondrial DNA and the 6 orders of magnitude larger nuclear genome. To verify 
the specific amplification of mitochondrial DNA, PCR amplification of a mitochondrial 
DNA-negative cell (rhoo cell) 28, 36 was performed under the same condition. Both 10 ng 
and 100 ng of rhoo DNA were tested. The results shown in Fig. 4.3 b confirmed specific 
amplification from the mitochondrial genome, since the mitochondrial DNA negative 
sample failed to show any amplification bands. For most PCR reactions in this study, 
58oC was set as the annealing temperature and 100 ng of DNA template was used. The 
uniplex PCR results for different mitochondrial samples are shown in Fig. 4.4. These 
conditions were used for PCR amplification of an artificial mixture for quantitative 




Fig. 4.3. Gel electrophoresis of PCR condition testing. A. PCR on mitochondrial DNA at different 
annealing temperatures and template concentrations: 1. Low Molecular Weight (LMW) ladder, 2, 
55oC (100ng), 3, 58oC (100ng), 4, 53oC (100ng), 5, 55oC (10ng); B. PCR on mitochondrial 
DNA-negative sample: 1. LMW ladder, 2, 100ng, 3, 10ng, 4, positive control (mitochondrial DNA 
sample, +), 5, negative control (no template, -) 
 
 
Fig. 4.4. PCR amplification of region 1 containing MERRF SNP at mitochondrial genome 
position 8344 on different samples: channel 1, 8344 wild type sample (8344WT), 2, anonymous 
healthy donor (WT-2), 3, 8344 mutant sample (8344MT), 4 patient sample (PT), 5, mitochondrial 
DNA-negative cell line (Rho0), 6, negative control (-), 7, 3255 mutant sample (3255MT), 8, 




Fig. 4.5. 2-plex PCR on different samples: channel 1, mitochondrial DNA-negative (Rhoo) cell 
line (Rhoo); 2, anonymous healthy donor (WT-2); 3, 8344 wild type sample (8344WT); 4, 8344 
mutant sample (8344MT); 5 patient sample (PT); 6, 3255 mutant sample (3255MT); 7, negative 
control. 
Based on these conditions, we further developed a 2-plex PCR strategy to amplify 
the region covering all the target SNPs of interest. As shown in Fig. 4.5, two bands 
corresponding to two regions in the mitochondrial DNA were accurately amplified, with 
the expected sizes of 157bp and 339 bp. Again, there was no non-specific amplification 
of a mitochondrial DNA negative sample.  
4.3.2 A8344G uniplex genotyping 
A8344G is one of the most frequent mutations in the MERRF syndrome. 
Genotyping by the SBE-SPC approach using cleavable biotinylated dideoxynucleotides 
was first validated for this site in 6 different samples: homoplasmic wild type 8344WT, 
homoplasmic mutant type 8344 MT, and homoplasmic mutant type 3255MT cybrids, 
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patient sample 8344PT, anonymous healthy sample 8344WT-2 and a mitochondrial 
DNA-negative cell line (rho0). As shown in Fig. 4.6, the nucleotide at position 8344 was  
 
Fig. 4.6. Mass spectrometric detection of nucleotide variation at mtDNA locus 8344 from (a) 8344 
wild-type sample; (b) anonymous healthy subject; (c) 8344 mutant sample; (d) 3255 mutant 
sample; (e) patient sample; (f) mitochondrial DNA-negative cells. Letters in red refer to the 
mutant type.  
identified correctly for each sample, and no false-positive peak appears for the rho0 DNA 
sample. The molecular weight of the 8344 SBE primer is 4648 Da, therefore, the peak at 
5098 m/z corresponds to an extension product with ddATP-N3-biotin (WT) after cleavage, 
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while the peak at 5227 m/z corresponds to an extension product with ddGTP-N3-biotin 
(MT) after cleavage. Fig. 4.6 3a and b are indicative of the homoplasmic wild type form 
(A) at locus 8344, Fig. 4.6 3c shows the homoplasmic mutant type form (G) at locus 
8344, Fig. 4.6 3d shows the wild-type and Fig. 4.6 3e confirms the presence of 
heteroplasmy (A/G), which was in good concordance with a separately performed RFLP 
assay. Sanger sequencing of each DNA sample further confirmed the accuracy of this 
method (Fig. 4.7)  
We further evaluated the specificity of this chemically cleavable SPC-SBE approach 
by analyzing a mitochondrial DNA-negative cell line (rho0). No single base extension 




Fig. 4.7. Sanger sequencing results on different samples. (a) 8344 wild-type sample; (b) 
anonymous healthy subject; (c) 8344 mutant sample; (d) 3255 mutant sample; (e) patient sample.  
4.3.3 5-plex genotyping  
Since multiple SNP sites are routinely screened in the clinical diagnosis for the 
MERRF syndrome, a 5-plex genotyping assay was developed. As shown in Fig. 4.8, 
nucleotides at these five SNP sites were identified unambiguously for all the samples, 
while the negative result in the mass spectrum for the rho0 cells further confirms the 
specificity of the assay. The molecular weights of primer peaks and their potential 
extension products are listed in Table 4.1 in the Materials and Methods section of this 
chapter. To ensure sufficient mass differences between the various primers, reverse SBE 
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primers that anneal to the complementary strand were selected for mutation sites 
G3255A,33 T8356C,30 and G8363A.31 Therefore, in the mass spectrum for the mutant 
type, transitions from C to U at locus 3255, A to G at locus 8356 and C to U at locus 
8363 were expected. As shown in Fig. 4.8, in accordance with the uniplex genotyping 
results, only 8344MT and PT have A to G mutations at locus 8344. Though lacking the 
mutation at position 8344, 3255MT has a C to T mutation at position 3255 (Fig. 4.8 d), 
consistent with previous information. No false positives were detected on the rho0 DNA 
sample (Fig. 4.8 f). According to Table 4.1 and the mass spectrometric results (Fig. 4.8), 
samples 8344MT, PT and 3255MT were diagnosed as MERRF, while 8344 WT and 
WT-2 were determined to be clear of the disease, which is consistent with known 




Fig. 4.8. Mass spectrometric results of 5-plex SNP genotyping for MERRF syndrome. (a) 8344 
wild-type sample; (b) anonymous healthy donor; (c) 8344 mutant sample; (d) 3255 mutant 
sample; (e) patient sample; (f) mitochondrial DNA-negative cell line. Red labels refer to the 
mutated forms. 
4.3.4 Quantitative mutation analysis for mitochondrial sample 
In the mitochondrial genome, DNA mutations often coexist with wild-type DNA. In 
contrast to heterozygous mutations in nuclear DNA, mutated and wild-type forms of 
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mtDNA rarely occur at 1:1 ratios. Instead, heteroplasmy (ratio of wild-type to mutant 
mitochondrion in cell or tissue source) can occur at any ratio between 0:100 and 100:0. 
And this proportion will drift in time and space following cell division.7 Different levels 
of heteroplasmy are strongly associated with different clinical manifestations, and the 
disease phenotype becomes evident when mutated forms of the mitochondrial DNA 
exceed a threshold level.37 Hence, for better understanding of the disease, quantitative 
analysis is of particular interest. Taking A8344G as an example, the capability of 
performing quantitative analysis for mtDNA heteroplasmy was evaluated. Before mixing 
homoplasmic WT and MT samples in ratios to mimic heteroplasmic states, real time 
PCR was first performed to estimate the amount of mitochondrial DNA in these samples. 
The results shown in Fig. 4.9 indicated that the 8344MT and 8344WT samples contained 
the same amount of mitochondrial DNA. Nonetheless, considering possible preferential 
amplification of wild-type and mutated forms, purified homoplasmic PCR products were 
combined to generate another set of artificial mixtures for quantitative analysis. 
Regardless of whether the DNA was mixed before or after PCR to generate these 
standard curves, the results indicated that the PT sample contains ~ 80% to 90% 
heteroplasmy at locus 8344. Quantitative results for the post-PCR mixing experiment and 
the direct sample mixing experiment is shown in Fig. 4.11 A and B, respectively. The 
graph was generated from the normalized signal intensities of MT and WT peaks in the 
mass spectra. By comparing the mass spectrum of the patient sample (right-most bars) 
with the resulting standard curve, it was suggested that its heteroplasmy falls within the 
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range of 90% to 80%, which is consistent with the information provided for this patient. 
The results demonstrated that this cleavable SPC-SBE approach was able to estimate the 
heteroplasmy level from the quantitative calibration curve. 
 
Fig. 4.9. Real-time PCR for quantitative analysis of A8344G homoplasmic wild type and mutant 
type samples. A. The Ct value versus the concentration of DNA for both MT and WT samples; B. 
Direct comparison between MT and WT using linear regression.  
.  




Fig. 4.11. Quantitative analysis of position 8344 heteroplasmy in mitochondrial DNA based on 
various mixture ratios of purified PCR products (A) and original biological samples (B).  
4.3.5 Sensitivity of SPC-SBE MALDI-TOF MS for detecting low heteroplasmy of 
mitochondrial DNA 
For early detection, it is necessary to discriminate a very small amount of mutated 
mtDNA in a majority of wild-type background. The large mass differences between our 
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new modified nucleotides were designed to generate sufficient distance between 
wild-type and mutated SBE product peaks in the mass spectrum. Our solid phase capture 
approach and efficient cleavage chemistry removed interference around the major 
product peak. These modifications make it possible to detect low level heteroplasmy with 
very high resolution. Taking 8344 mutation detection as an example, the sensitivity of 
this assay was validated. With sample mixing based on two types of information (real 
time PCR or measurement of PCR product concentration), as low as 2.5% heteroplasmy 
was correctly identified, as shown in Fig. 4.12 A and B. Similarly, as low as 2.5% 
wild-type in a mutant background was detectable. This further confirms the accuracy of 
the assay. For comparison, Sanger sequencing and PCR-RFLP assays were also 
performed. As seen in Fig. 4.12 C, neither 5% of mutant (a) nor normal mtDNA (b) were 
convincingly detected by Sanger sequencing analysis. In a PCR-RFLP assay, a 127 bp 
PCR product was digested with the restriction endonuclease HaeIII. The use of 
mismatched primer in the PCR reaction enabled the production of extra restriction site 
for HaeIII if A is mutated to G at position 8344. Therefore, for wild type mitochondrial 
DNA sample, HaeIII cut PCR products into two fragments: 69 and 57 bp. While for PCR 
product from mutant type mitochondrial DNA, the 69 bp fragment is further cleaved into 
a 48 bp and a 21 bp fragment. Therefore, the final digested fragments for normal DNA 
are 57 and 69 bp, whereas for mutant DNA are 57, 48 and 21 bp. As shown in Fig. 4.12 
D, this ethidium bromide (EB)-stained PCR-RFLP assay also failed to detect 5% 
heteroplasmy. Thus the MS-based chemically-cleavable SPC-SBE approach apparently 
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outperformed these two approaches in terms of sensitivity.  
Since mtDNA mutations might accumulate with time, the high sensitivity and 
accuracy of low heteroplasmy level detection will be very helpful for routine health 
screening in terms of disease prevention. Although the pathogenic threshold is usually 
above 70%,7 dominant mutations also exist. For example, it has been reported that the 
pathogenic threshold of a particular mitochondrial disorder was only 4 to 8%,38 in which 
case low heteroplasmy detection becomes critical. Radio-labeled RFLP or real time PCR 
assays might meet the need; nonetheless, the mass-based chemically-cleavable SPC-SBE 
approach outperforms them in terms of simplicity, lower cost, reduced labor and the 





Fig. 4.12. Detection of low 8344 heteroplasmy levels for sensitivity testing. (A) Detection of 5% 
and 2.5% heteroplasmy, based on original sample DNA mixing, by MALDI-TOF MS; (B) 
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Detection of 5% and 2% heteroplasmy, based on purified PCR products mixing, by 
MALDI-TOF MS (A) and (B) shows the reproducible detection of <5% heteroplasmy. (C) Sanger 
sequencing analysis for 5% and 95% mixtures; (D) PCR-RFLP analysis for wild-type，mutant 
type，5% heteroplasmy and anonymous patient sample. LMW refers to low molecular weight.  
4.4 Materials and Methods 
General Information. DNA samples were extracted from homoplasmic 8344 wild 
type (8344WT), homoplasmic 8344 mutant type (8344 MT), and homoplasmic 3255 
mutant type (3255MT) cybrids, a mitochondrial DNA-negative cell line (rho0 ), a 
MERRF patient with the 8344 point mutation (8344PT), and an anonymous healthy 
donor (8344WT-2). The cleavable dideoxynucleotides were synthesized in our 
laboratory. 
4.4.1 PCR amplification 
The PCR primers were initially designed with Primer3 
(http://frodo.wi.mit.edu/primer3) but further adjusted after BLAST search in order to 
avoid non-specific amplification of nuclear DNA. A uniplex PCR reaction was performed 
to amplify region 1 containing three of the SNP sites: A8344G, T8356G and G8363A, 
while a 2-plex PCR reaction was used to amplify regions 1 and 2 simultaneously, the 
latter of which covers the other two SNP sites: A3243G and G3255A. The primers were 
5’-GACCGGGGGTATACTACGGT-3’ (region 1, forward), 5’-GGAGGTAGGTGGT- 
AGTTTGTG-3’ (region 1, reverse), and 5’-GACCGGGGGTATACTACGGT-3’ (region 2, 
forward), and 5’-GGAGGTAGGTGGTAGTTTGTG-3’ (region 2, reverse). Therefore, 
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the DNA fragments that are amplified from the 2-plex PCR reaction include all 5 of the 
above frequently mutated SNP sites used for the clinical diagnosis of MERRF syndrome. 
The uniplex PCR reaction was carried out in 30 μl of a PCR cocktail mixture containing 
100 ng mitochondrial DNA, 10 nmol dNTPs, 8 pmol each of reverse and forward 
primers (region 1, forward and reverse) (oligonucleotides purchased from Integrated 
DNA Technologies, Coralville, IA or Eurofins MWG Operon, Huntsville, AL), 0.5 U 
JumpStartTM REDTaq® DNA Polymerase (Sigma-Aldrich, St. Louis, MO) and the 
corresponding 1X polymerase reaction buffer. The 2-plex PCR reaction consisted of 100 
ng mitochondrial DNA, 12 nmol dNTPs, 7 pmol of each reverse and forward primer, 0.5 
U JumpStartTM REDTaq® DNA Polymerase and 1X polymerase reaction buffer in a total 
volume of 30 μl. Amplification was performed under the following conditions: 
incubation at 94oC for 2 min, followed by 25 cycles of 94oC for 20 s, 58oC for 30 s, 72oC 
for 30 s and final extension at 72oC for 3 min. After PCR, 1 μl of PCR product from each 
sample was run on a 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA) to 
visualize the product quality. To remove excess dNTPs and primers, PCR products were 
subsequently treated by ExoSAP-IT (USB/Affymetrix, Cleveland, OH), with incubation 
at 37oC for 15 min and enzyme deactivation at 80oC for 15 min. 
4.4.2 Quantification of mtDNA in the samples  
The amounts of mitochondrial DNA in the homoplasmic samples, 8344MT and 
8344WT, were quantified by TaqMan real-time PCR. Region 1, which is specific to the 
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mitochondrial genome, was chosen to compare the relative quantities of mtDNA between 
these two samples. Ten-fold serial dilutions from 10 ng/µl to10-5 ng/µl were carried out 
on both 8344MT and 8344WT samples before real-time PCR. The real time PCR 
reaction cocktail consisted of 1 µl of diluted DNA sample, 4 pmol each of reverse and 
forward primer and 10 µl of diluted SYBR green mixture (Applied Biosystems/Life 
Technologies, San Diego, CA) in a total volume of 20µl. The reaction was performed 
under the following conditions: incubation at 50oC for 2 min and 95oC for 2 min, 
followed by 40 cycles of 95oC for 15 s, 60oC for 30 s. Ct values for each dilution of both 
samples were collected and the graph of Ct values against concentration was plotted to 
determine the relative amount of mtDNA in samples 8344MT and 8344WT. Based on the 
quantification results, the 8344MT and 8344WT samples were mixed in a series of ratios 
(2.5%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 97.5% mutant type) 
for heteroplasmy quantitation and sensitivity analysis, targeting the SNP at position 
A8344G.  
Taking into account the potential for preferential PCR amplification, purified 
homoplasmic PCR products instead of the original DNA sample were used to produce 
the artificial mixtures. Briefly, 8344MT and 8344WT mtDNA samples were first 
amplified by uniplex PCR reactions to separately generate homoplasmic mutant and 
wild-type PCR products. Then PCR products were treated with ExoSAP-IT and purified 
twice using the MinElute PCR Purification Kit (Qiagen, Valencia, CA). The PCR product 
concentrations were measured with a NanoDrop 2000 spectrometer (Thermo Scientific, 
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Wilmington, DE, USA), after which they were combined in the above ratio series.  
4.4.3 Single base extension using cleavable biotinylated dideoxynucleotides for 
MALDI-TOF MS detection 
The primers for each SNP site are listed in Table 4.1. SBE reactions with the uniplex 
PCR products included 3 μl ExoSAP-IT treated PCR products (or ~80ng purified PCR 
products), 10 pmol of 8344 primers, 15 pmol ddATP-N3-Biotin, 45 pmol 
ddGTP-N3-Biotin, 4 U Thermo Sequenase (GE Healthcare, Piscataway, NJ), and 1X 
Thermo Sequenase reaction buffer in 20 μl total volume. For 5-plex genotyping, multiple 
single base reactions (MSBE) included 4 μl ExoSAP-IT treated 2-plex PCR products, 36 
pmol 8344Primer, 20 pmol 8356Primer, 26 pmol 8363Primer, 26 pmol 3243Primer, 34 
pmol 3255Primer, 67.5 pmol ddATP-N3-biotin, 90 pmol ddGTP-N3-biotin, 90 pmol 
ddCTP-N3-biotin, 90 pmol ddUTP-N3-biotin, 6 U Thermo Sequenase, and 1X reaction 
buffer in a 20 µl total volume. All reaction mixtures underwent 30 cycles of the extension 
reaction in a single tube at 94oC for 20s, 42oC for 45 s, 68oC for 90 s and a final 
extension at 68oC for 3 min. The SBE products were then purified by solid phase capture 
on streptavidin-coated magnetic beads to remove unextended primers, salts and other 
contaminants. Briefly, 20 μl SBE or MSBE products were combined with 20 μl 
streptavidin-coated magnetic beads (Dynabeads®MyOneTM Streptavidin C1, 
Invitrogen/Life Technologies) that were prewashed with 1X B/W buffer, then 
resuspended in 20 μl of 2X B/W buffer, and allowed to incubate for 1 h at room 
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temperature. After solid phase capture, the beads containing the biotinylated DNA 
fragments were washed three times with 1X B/W buffer, and three times with deionized 
water. The beads were suspended in 20 μl tris(2-carboxyethyl)phosphine (TCEP) 
(Sigma-Aldrich) aqueous solution (pH 9.0, adjusted with ammonium hydroxide) and 
incubated at 65oC for 15 min to cleave the biotin. The supernatant containing SBE 
fragments was desalted with a ZipTip (Millipore, Bellerica, MA) and characterized with 
a Voyager DETM MALDI-TOF mass spectrometer (Applied Biosystems). The entire 
process is shown in Fig. 4.1.  
Table 4. 1SBE sites and corresponding SBE primers to generate DNA extension products. 
















8344 TTAAAGATTAAGAGA 4648.2 5098.2 5227.2 5075.2 5189.2 
8356 GGGGCATTTCACTGTA 4912.3 5362.3 5491.3 5339.3 5453.3 
8363 ATTTAGTTGGGGCATTT 5246.5 5696.5 5825.5 5673.5 5787.5 
3255 TAAAGTTTTAAGTTTTATG 5846.9 6296.9 6425.9 6273.9 6387.9 
3243 GGTTTGTTAAGATGGCAG 5609.7 6059.7 6188.7 6036.7 6150.7 
Note: Reverse SBE primers were used for sites 8356, 8363, and 3255. The masses of the extension 
products shown in bold black refer to wild-type; those in bold red refer to the mutant type. 
4.4.4 Direct Sanger DNA Sequencing and PCR-RFLP Assay 
The Sanger sequencing reaction mixture included 0.5 µl of BioDye Terminator 3.1 
cycle sequencing mix (Applied Biosystems), 1X buffer 3.1, and 5 pmol forward or 
reverse primer. The reaction was carried out as follows: 25 cycles of 94oC for 20 s, 55oC 
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for 45 s, 68oC for 90 s and final extension at 68oC for 3 min. After clean-up of 
sequencing products by sodium acetate/ethanol precipitation and solubilization in 
formamide at 94oC, Sanger sequencing was performed on an ABI3730xl DNA analyzer 
(Applied Biosystems).  
The primers used in the PCR-RFLP assay were 5’-TTAAGTTAAAGATTAAGA- 
GG-3’ (forward), and 5’-TATTTTTAGTTGGGTGATGAGGAA-3’ (reverse), wherein 
the 3’ end of the forward primer is mismatched to locus 8343 in the mitochondrial 
genome, generating a restriction site for HaeIII if position 8344 is mutated from A to G. 
The PCR reaction mixture consisted of 100 ng mitochondrial DNA, 10 nmol dNTPs, 10 
pmol each of reverse and forward primers, 0.5 U JumpStartTM REDTaq® DNA 
Polymerase and the corresponding 1X polymerase reaction buffer. The amplification was 
carried out with 30 cycles of 94oC for 1 min, 50oC for 1 min, 72oC for 1 min. Then 20µl 
of PCR product was treated by adding 10 U HaeIII (New England Biolabs, Ipswich, 
MA), 4 μl of 10X buffer4 and  15 μl H2O at 37oC. The product size was checked by 
separation in a 15% polyacrylamide gel (Bio-Rad, Hercules, CA). 
4.5 Conclusion 
Expanding on our previously established SPC-SBE method, we introduced our new 
synthesized chemically cleavable biotinylated dideoxynucleotides into the SBE reactions, 
which enabled highly effective isolation and purification of the SBE products and 
achieved higher resolution through larger mass differences between the nucleotides and 
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their corresponding SBE products. This SPC-SBE approach coupled with MALDI-TOF 
mass spectrometry enables rapid, accurate and sensitive analysis of mitochondrial DNA 
single nucleotide polymorphisms and different levels of heteroplasmy. This methodology 
is highly targeted and cost-effective, and is compatible with automated micro/nanofluidic 
systems, enabling high-throughput SNP screening. As a genetic testing tool, it will have 
applications in various areas, including disease treatment, haplotype analysis, genetic 
barcoding, evolutionary studies and forensic investigations. 
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Chapter 5 Exploration of the Integrated Microdevice for SNP 
Genotyping by MALDI-TOF Mass Spectrometry 
5.1 Introduction 
Single nucleotide polymorphisms (SNPs) are of significant interest in the life 
sciences, as they provide the genetic fingerprint of an individual as well as potential 
biomarkers for disease diagnosis and predisposition. The detection of SNPs, SNP 
genotyping, has become one of the most powerful and indispensable tools in genomic 
analysis. A plethora of methods have been applied for SNP genotyping using different 
detection platforms, among which mass spectrometry-based single base extension has 
been shown to be a promising method due to its utilization of the intrinsic property of 
molecular mass for nucleotide discrimination, ease of data acquisition, capability for 
quantitation, improved accuracy and multiplex capacity. The MS-based SBE genotyping 
strategy was further improved by our cleavable solid phase capture (SPC) 
single-base-extension (SBE) approach with the use of cleavable biotinylated 
dideoxynucleotides (ddNTP-N3-biotins), as described in Chapter 4, allowing the rapid, 
accurate, sensitive and quantitative detection of SNPs. However, the use of manual 
benchtop procedures limits its applications, especially for large scale sample handling in 
a time efficient manner. True implemention of our reversible SPC-SBE SNP genotyping 
method requires a state-of-the-art integrated platform capable of high-speed, 
high-throughput, and automatic detection at low cost.  
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Lab-on-a-chip (LOC) technologies for the development of biological/chemical 
analysis tools hold great promise. Though not developed until the 1990s, lab-on-a-chip 
technology soon revolutionized bio-analytical protocols since this miniaturization system 
offers great advantages in terms of integration, speed, efficiency and portability. 
Moreover, the miniaturized microfluidic device allows the use of small sample volumes, 
and hence lower reagent consumption and energy requirements.1, 2  
Genetic analysis microfluidic systems have been extensively explored to integrate 
DNA analysis steps, including DNA extraction,3, 4 PCR amplification1, 5 and capillary 
electrophoretic (CE) separation6 at the microliter to nanoliter scale. Various types of 
genotyping microdevices based on different mechanisms have been reported, including 
restriction fragment analysis, DNA sequencing, hybridization, allele-specific 
amplification or heterduplex analysis.7 For example, Choi et al. have developed an 
integrated microdevice for short tandem repeat analysis combined with capillary 
electrophoresis.8 However, to our knowledge, no such device has been constructed for a 
SPC-SBE genotyping approach with mass spectrometic detection. This is mostly because 
in the previous reported SPC-SBE method,9 the release of extension products required 
harsh treatment (formamide) and ethanol precipitation, which are hard to integrate into a 
microdevice. The introduction of cleavable nucleotide analogs in our SNP genotyping 
approach addresses these problems, which, together with recently developed 
lab-on-a-chip techniques, makes it promising to construct a fully integrated SNP 
genotyping microfluidic platform.  
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In this chapter, a proof-of-concept microfluidic device for SNP genotyping using 
cleavable biotinylated nucleotides is presented, thanks to the collaboration with Dr. 
ThaiHuu Nguyen and Jing Zhu in Dr. Qiao Lin’s microfabrication laboratory. This device 
primarily consists of a micro-reaction chamber for single base extension and cleavage 
reactions with an integrated micro heater and temperature sensor for on-chip temperature 
control, a microchannel loaded with streptavidin magnetic beads for solid phase capture, 
and a microchannel packed with C18-modified reversed-phase silica particles as a 
stationary phase for desalting before MALDI-TOF analysis. We have evaluated the 
microdevice by performing each functional step, including single base extension, solid 
phase capture and cleavage, and desalting, the results of which demonstrate the 
feasibility of developing a fully integrated cleavable SPC-SBE based microfluidic SNP 
genotyping device.  
5.2 Experiment Rationale and Overview 
As shown in Fig. 5.1, our typical cleavable SPC-SBE genotyping approach can be 
divided into four major steps, where step 1 and step 3 require temperature control, while 
step 2 and step 4 are essentially solid phase extraction and purification.  
Single base extension with non-reversible terminators is similar to PCR 
amplification, except that it is a unidirectional linear amplification reaction with the 
primer growing by only one base (though more bases can be added in a random fashion 
when both dNTPs and ddNTPs are included). The cleavage step simply requires 
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incubation at 65oC. These two steps can be carried out in a single chamber, with similar 
design to a PCR microdevice. As shown in Fig 5.2, the heater was designed in the form 
of a closed circle to provide adequate heating for the entire chamber.  
 
Fig. 5.1. Overall scheme of cleavable SPC-SBE approach for SNP genotyping. 
 The mobility of magnetic beads under the magnet provides the flexibility in the 
design. As shown in Fig 5.2, streptavidin magnetic beads will be placed in a loading 
channel and moved into the central chamber using the magnet when required. The solid 
phase capture is designed to take place inside the central chamber, followed by bead 
washing and the temperature controlled cleavage reaction.   




Fig. 5.2. (A) Schematic of the microfluidic SNP genotyping device. C1 is the central chamber for 
the single base extension and cleavage reaction, C2 is the streptavidin bead loading channel, and 
C3 is the C18 reverse-phase channel. P1 to P5 represent the outlet/inlet ports for sample loading 
and waste collection. The light blue rectangle indicates the PDMS layer. (B) A close-up view of the 
temperature sensor; (C) A close-up view of the central heater; (D) A close-up view of a filter; (E) 
Photograph of microdevice. (F) A light microscopic blow up view of the temperature sensor.  
 Our previous experience with the desalting step is to utilize the commercially 
available Millipore ZipTips, in which the pipet tips are loaded with octadecyl carbon 
chain coated (C18) silica particles as the micro-column reverse-phase to facilitate the 
sample recovery.10. 11 The basic principle is the affinity of DNA molecules for these C18 
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coated particles. When DNA molecules flow through the C18 reversed-phase channel, 
DNA molecules will be adsorbed onto the C18 surface whereas the salts will not, and the 
DNA molecule can then be eluted from the C18 surface using an organic solvent (e.g., 
50% acetonitrile). Based on this principle, we designed a C18 silica particle packed 
channel for desalting, with filters in between to prevent particle loss (Fig 5.2. A, D). 
To fully implement the entire process and enable the controlled continuous 
microflow, each design component needs to be connected in turn to an on/off switch . 
The most straightforward way to accomplish this is to employ a valving system. Due to 
the ease of fabrication and amenability for miniaturization, elastomeric 
polydimethylsiloxane (PDMS) has been exploited as a microvalve material with different 
actuation mechanisms.12-14 The principle is that the thin PDMS membrane will deform 
under pressure, hence press down into the microfluidic channel to modulate fluid flow. It 
has been reported that filling the PDMS control channel with air could act upon the 
underlying fluidic channel to form such a valve.14 In a similar strategy, we designed our 
PDMS valves by air deflection of a thin PDMS film on a glass substrate. Small holes 
were drilled in the glass substrate corresponding to the valve position and connected to 
air supply tubing, allowing these sections of the thin PDMS film on the glass substrate to 
deform and thereby close the valve.   
 In summary, as shown in Fig. 5.2, our SNP genotyping microdevice is composed of a 
central reaction chamber for single base extension and cleavage (C1), a streptavidin bead 
loading channel (C2) and a C18 reverse-phase desalting channel (C3), with 5 inlet/outlet 
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ports for sample injection and waste collection. Around the central chamber, four PDMS 
film based pressure valves were designed to control the microfluidic flow, and the filters 
were set at the two ends of the C18 microchannel for maintaining the C18 stationary 
phase. In this study, as the proof of concept, the microdevice was evaluated by 
performing separate experiments for each step shown in Fig. 5.1. Briefly, single base 
extension (SBE) was first carried out in the central reaction chamber, followed by solid 
phase capture of SBE products in the same chamber via the incubation with streptavidin 
beads moving from the bead loading channel. Next, the cleavage reaction was performed 
in the central chamber, and finally cleavage products were flowed through the C18 
reversed-phase microchannel for desalting. 
5.3 Results and Discussion 
5.3.1 Temperature Sensor Calibration 
In our microdevice system, the resistance temperature detector (RTD) configuration 
was used. The relationship between temperature and resistance of a metal is described in 
the Callendar-Van Dusen equation (Equation 5.1),15 wherein the resistance at temperature 
T (R(T)) is the sum of the resistance at 0oC (R0) , A R0T and BR0T2, with A and B 
coefficients characteristic of the material. 
)1()( 20 BTATRTR ++=  Equation 5.1 
By replacing the resistance at 0oC with the reference temperature (e.g., room 











−=  Equation 5.2  
Therefore, the temperature coefficient of resistance (TCR) value can be determined 
by calculation of a temperature sensor calibration curve with temperature on the x-axis 
and resistance on the y-axis, as shown in Fig 5.3. The TCR value of 2.4×10-3/oC was 
obtained by calculation of the slope after linear regression fitting.  
 
Fig. 5.3. Temperature sensor calibration. The formula shown is the linear regression fitting result, 
with y referring to resistance (Ohms) and x referring to temperature (oC). 
5.3.2 On-chip testing  
To verify the feasibility of implementing our cleavable SPC-SBE approach in this 
microfluidic platform, the microdevice was evaluated by performing individual SNP 
genotyping steps separately, with the hope of thoroughly understanding the 
characteristics of each part before full integration.  
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5.3.2.1 On-chip single base extension  
SBE was first carried out to evaluate the feasibility of performing single base 
extension in our microdevice, with a standard dideoxynucleotide, ddTTP, as shown in Fig. 
5.4 A. 100% incorporation was confirmed with MALDI-TOF mass spectrometry by 
observing the total disappearance of the primer peak (5163 m/z) and the emergence of 
the ddTTP extension product (5453 m/z) (Fig. 5.4 B). This demonstrated heat transfer 
capability and the accuracy of temperature control of our microdevice, which confirms 
the feasibility of on-chip SBE reaction. Though the experiment was performed under the 
same thermo-cycling conditions as in a conventional thermal cycler, the number of cycles 
and the time for each step (denaturation, annealing, extension) might be further reduced, 
because the large surface-to-volume ratio in the microdevice will facilitate the heat 
transfer and temperature equilibration, enabling swift thermal responsiveness of the 
sample to the controller during the SBE process. .  
 
Fig. 5.4. Results of on-chip single base extension reaction. (A) Scheme of SBE reaction with 
ddTTP; (B) MALDI-TOF mass spectrum of the SBE extension products. 
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5.3.2.2 On-chip solid phase capture  
 
Fig. 5.5. On-chip solid phase capture and cleavage result. (A) Scheme of the whole process 
including SBE, SPC and cleavage; (B) MALDI-TOF mass spectra of the products. 
To evaluate the ability to perform on-chip solid phase capture and cleavage, the SPC 
and cleavage experiments were carried out on a single ddUTP-N3-biotin extended 
product. As shown in Fig. 5.5 A, biotin terminated SBE products with a molecular weight 
at 6186 m/z were generated by SBE reaction using ddUTP-N3-biotin in a thermal cycler 
using a standard protocol. This SBE product was then incubated with streptavidin beads 
for extracting extended products. The magnet was able to freely move the magnetic 
beads into the chamber for mixing the beads and SBE solution, which facilitated 
effective functional surface interaction with DNA molecules. The cleavage reaction by 
TCEP released the extension products from the solid bead surface while leaving the 
biotin moiety on the surface, the molecular weight of which was 5713 m/z. The 
observation of a mass peak at 5713 m/z (Fig. 5.5 B) indicated that the magnetic beads 
loaded into the channel were capable of capturing enough products and releasing the 
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cleavage products, which further verified the feasibility of on-chip SPC and cleavage.  
5.3.2.3 On-chip desalting 
The C18 reversed phase channel is very important for MS-based SPC-SBE analysis; 
its purpose is to remove of salts from the cleavage solution while maintaining enough 
pure sample for mass spectrometric analysis. Theoretically, the capture efficiency and 
sample recovery rate increases with an increasing number of C18 particles, yet the back 
pressure will build up beyond the operational range due to tight packing. On the other 
hand, while the particle size is inversely related to the dynamic capacity, in order to 
reduce the back pressure, the particle size needs to be relatively large.10 Therefore, 
relatively larger size C18 silica particles (40 to 75 μm) were first chosen for the 
preliminary test to see if it they could achieve the required sensitivity for mass 
spectrometry. The portion of the channel packed with C18 particles is shown in Fig. 5.6 
A. Different amounts of DNA in TCEP solution were tested to evaluate desalting 
efficiency. The results indicated that the microchannel was able to recover 0.5 pmol, 
1pmol, 10 pmol and 100 pmol DNA sample and gave clean spectra without evidence of 
salt disturbance (the result with the 0.5 pmol DNA/TCEP solution is shown in Fig 5.6. B). 
The fact that as little as 0.5 pmol of DNA sample was able to be recovered from the C18 
channel and generate a strong signal intensity in mass spectrometric analysis 
demonstrated its promise in detecting low levels of mutation, as this is much lower that 




Fig. 5.6. (A) The microchannel packed with C18 coated particles. (B) Mass spectrum after 
on-chip desalting of 0.5 pmol DNA/TCEP solution.  
5.4 Materials and Methods 
General information. All chemicals were purchased from Sigma-Aldrich unless 
otherwise indicated. The cleavable biotinylated dideoxynucleotides were synthesized in 
our laboratory. Oligonucleotides were purchased from Integrated DNA Technologies 
(Coralville, IA). Thermo Sequenase was from GE Healthcare (Piscataway, NJ). 
Streptavidin coated magnetic beads (Dynabeads® MyOneTM Streptavidin C1) were 
obtained from Life Technologies (San Diego, CA). Photo resist S1818, SU-8 2150, and 
SU-8 2010 were from Microchem (Newton, MA), and Sylgard 184 
poly(dimethylsiloxane) (PDMS) was from Dow Corning. Microscope grade glass slides 
(2” x 3”) were from Fisher Scientific. C18 particles, C18 Spherical Silica Gel with size 
distribution from 40 μm to 75 μm, were from Sorbent Technologies (Norcross, GA). 
Primary instruments used for photolithography were a Süss MicroTec MJB8 Mask 
Aligner, Edwards BOC/Auto 306 Thermal Evaporator, and a Diener Plasma Etch System.  
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Device temperature control was performed using integrated resistive heating and sensing 
elements connected to a DC power supply (Agilent E3631A), a digital multimeter 
(Agilent 34410A), and a proportional-integral-derivative (PID) controlled LabVIEW 
program (National Instruments).  
5.4.1 Microfluidic Device fabrication 
 
 
Fig. 5.7. A simplified device process flow referring to cross section a-a’ in Fig. 5.2. (a) Metal 
Cr/Au deposition on glass slide. (b) Lithography for metal patterning and hole drilling in the 
slide. (c) Thin PDMS layer bonding. (e) PDMS channel fabrication. (f) PDMS channel demolding. 
(f) Bonding and packaging.  
The temperature control chip was fabricated by standard semiconductor fabrication 
techniques. The glass substrate were first diced to the size of 2x2 cm and cleaned by 
immersing in Nano Strip (MicroChem) overnight. Subsequently, 5 nm chromium and 
100 nm gold films were deposited via thermal evaporation (Fig 5.7 a) and then patterned 
by photolithography and wet etch. The glass slide was drilled with four holes 
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corresponding to the four pressure valve locations (Fig 5.7 b). The metal films, including 
heater and sensor, were then passivated with a thin PDMS film (~100 nm), which also 
serves as the valve under the air actuation (Fig 5. 7 c).  
The PDMS microfluidic chamber was fabricated using soft lithography techniques. 
Negative photoresist SU-8 2050 was spin-coated onto a 4 inch silicon wafer to create a 
mold master of 50 μm thickness. After a soft bake, the pattern of the mask was 
transferred to the SU-8 coated silicon wafer by mask aligner (MA-6, Karl Suss GmbH, 
Germany) followed by hard-baking and development. Then SU-8 2150 was spin-coated 
onto the same wafer to create 375 μm thick patterns/features through similar procedures. 
As depicted in Fig.5.7.d, a PDMS pre-polymer solution was mixed at a volume ratio of 
10:1, distributed on the silicon mold and degassed by vacuum for ~30 min, followed by 
curing at 65oC for 40 min, to generate the PDMS sheet with defined channels shown in 
Fig.5.10 e. Finally, the PDMS layer was removed from the wafer mold and aligned and 
bonded to a thin passivation film covered temperature control chip (Fig.5.7 c) following 
O2 plasma treatment of the bonding interface for 15s. 
Following the above procedures, the complete device shown in Fig. 5.2.E was 
fabricated. The volume of the central microchamber is around 12 μl (6 mm in diameter 
and 425 μm in height), and volumes of the streptavidin bead loading channel and C18 
reversed-phase channel are around 15 and 5.5 μl respectively. An integrated Cr/Au 
resistive heater and temperature sensor were used in conjunction with off-chip 
programming (Labview) to control the temperature.  
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The PDMS microfluidic chamber has its advantages in the ease of fabrication, low 
cost and robustness, however, it will also cause some critical problems, including sample 
evaporation and bubble formation during heating, as well as non-specific adsorption. To 
address these problems, parylene coating was used as it was reported to have lower 
permeability to moisture and long-term stability.16 The coating was achieved by 
depositing Parylene C Dimer (di-chloro-di-para-xylylene) into the channels by chemical 
vapor deposition using a PDS 2010 LABCOTER deposition system.  
For the complete microdevice package, the streptavidin magnetic beads were washed 
with and suspended in 2X binding buffer, and directly loaded into the channel with the 
magnet on the bottom holding the beads. The C18 particles were washed with methanol 
three times, loaded into the channel and dried by heating at 80oC overnight.  
5.4.2 Experimental setup 
An illustration of the experimental setup is presented in Fig. 5.8. The integrated 
heater and temperature sensor are connected to off-chip PC programming for temperature 
control. The sample loading is controlled by the syringe pump at a stable fluid rate. The 
fluid flow through the microchannel is controlled by the four PDMS pressure valves in 





Fig. 5.8. (A) Microfluidic experimental test setup with closed-loop feedback temperature control. 
(B) Bottom view of microdevice; (C) Valving system set-up.  
As referred to in Fig. 5.8 C, with the help of Mirkó Palla in our laboratory, the 
complete valving system was constructed as follows. Four tubes were inserted into the 
holes of the glass substrates (Fig. 5.8 B), each connected to one port of a solenoid valve, 
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the outlet of which was connected to a gas supply with a pressure controller. The 
solenoid valve was controlled by three mechanical power switches, allowing selective 
actuation of subsets of the PDMS valves. Theoretically, the operation of the valve is 
dependent on the thickness of the PDMS layer, the height of the microchannel and the air 
pressure.  
5.4.3 Microdevice performance testing  
5.4.3.1 Temperature Sensor Calibration 
The temperature coefficient of resistance (TCR) value for the microdevice was 
obtained by calibration using the temperature sensor. The device was place in an oven 
and the temperature was allowed to increase in approximately 5oC intervals from room 
temperature to 95oC. The steady state temperature and the resistance of the sensor were 
recorded to generate the temperature sensor calibration curve, and the TCR value was 
determined by calculation of the slope of the curve after linear regression fitting.  
5.4.3.2 Single base extension 
In the single base extension test, dideoxynucleotides instead of biotinylated 
nucleotides analogs were used. The magnetic beads and C18 particle loading channels 
were sealed by PDMS. 20 pmol of synthetic DNA template, Exon8 of the p53 gene, 
(5’-GAAGGAGACACGCGGCCAGAGAGGGTCCTGTCCGTGTTTGTGCGTGGAG
TTCGACAAGGCAGGGTCATCTAATGGTGATGAGTCCTATCCTTTTCTCTTCGT
TCTCCGT-3’, the letters in bold indicating the primer annealing site), 40 pmol of primer 
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(5’-GATAGGACTCATCACCA-3’), 60 pmol of ddTTP, 1X Thermo Sequenase reaction 
buffer and 2 unit of Thermo Sequenase were degassed in vacuum before being gently 
injected into the reaction chamber. The use of excess reagent was used to fill in the inlet 
and outlet channels to avoid generation of air bubbles, and two drops of mineral oil were 
applied to the outlets and inlets to prevent evaporation. The on-chip reaction was 
performed in the central reaction chamber for 20 cycles of 90oC for 15 s, 40oC for 1 min, 
and 70oC for 30s, and the products were removed from the reaction chamber and 
analyzed using MALDI-TOF MS.   
5.4.3.3 Solid phase capture and cleavage test 
To mimic solid phase capture, SBE reaction products from a thermal cycler were 
used. 10 μl of reaction mixture consisting of 10 pmol template, 20 pmol ddTTP, 30 pmol 
ddUTP-N3-biotin, 1X Thermo Sequenase reaction buffer and 2 U Thermo Sequenase 
were carried out under the following condition: 20 cycles of 90oC for 15 s, 40oC for 1 
min, and 70oC for 30 s. Streptavidin magnetic beads were preloaded into the bead 
loading channel (C2). After injecting the post SBE reaction mixture into the central 
chamber (C1), the magnetic beads were brought into the central chamber by movement 
of the magnet incubation allowed to proceed for around 30 min. Then beads were washed 
with H2O and treated in TCEP solution at 65oC for 15 min. The cleavage products were 
collected and analyzed by MALDI-TOF MS. 
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5.4.3.4 C18 reversed phase desalting 
To test the desalting capability of the C18 reversed phase microchannel on the 
microdevice, 0.03 g of C18 particles were prewashed with methanol 3 times and 
resuspended in methanol for injection. The packed C18 particles were dried by heating at 
80oC overnight. To mimic the cleavage products, the oligonucleotides (17mer, the primer 
for the above SBE reactions) were dissolved in 20 μl TCEP solution to generate a series 
of diluted solutions, using 1 pmol, 10 pmol and 100 pmol oligonucleotides. The C18 
channel was first washed with 50% acetonitrile (ACN) at a flow rate of 20 μl/min for 5 
min, followed by 0.1 M Triethylammonium acetate buffer, pH 5.5 (TEAA) washing for 
10 min. Then the “cleavage products” were slowly flowed through the C18 channel at 0.5 
μl/min. The washing steps were performed consecutively with 0.1M TEAA and dH2O at 
a flow rate of 50 μl/min. Then the purified “cleavage products” were slowly eluted from 
the C18 channel with 50% ACN at a flow rate of 1 μl/min. The final products were 
collected and analyzed by MALDI-TOF MS.   
5.5 Conclusion 
Following our successful demonstration of cleavable solid phase capture-single base 
extension SNP genotyping approach in detecting mitochondrial SNP at high accuracy 
and high sensitivity, we further explored the use of a SNP genotyping microfluidic 
lab-on-a-chip device with the potential for high throughput, miniaturization and 
automation. As a proof of concept, we have designed, constructed and evaluated our 
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prototype SNP genotyping microdevice by performing individual functional steps, which 
could be later integrated in the mature microdevice. We have demonstrated 100% single 
base incorporation on-chip, sufficient capture and release of the biotin terminated single 
base extension products, and high sample recovery from the C18 reverse-phase 
microchannel with as little as 0.5 pmol DNA molecules. This demonstrated the feasibility 
of the microdevice toward the goal of an integrated, miniaturized, and high throughput 
platform for SNP genoyping, and also for potential mass spectrometry-based sequencing 
by synthesis. 
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Part II Strategies to Improve Sequencing by Synthesis with 
Cleavable Fluorescent Nucleotide Reversible Terminators 
DNA sequencing plays a tremendously important role in biology. DNA sequencing 
by synthesis, the dominant method in second-generation sequencing platforms, and being 
explored as well for third generation sequencing, has emerged as one of the most 
important sequencing technologies. Nevertheless, to meet the goal of the $1000 Genome, 
the current short sequencing read-length is still a bottleneck. This section of the thesis 
will describe some strategies to improve the sequencing by synthesis from two 
perspectives, extending the sequence read-length by primer “walking”, and increasing 
throughput as well as overall coverage with the emulsion-bead-on-chip approach. 
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Chapter 6 Development of Primer “Walking” Strategy to 
Increase the Read-Length of Sequencing by Synthesis 
6.1 Introduction  
DNA sequencing by synthesis (SBS), with its enormously increased throughput 
relative to conventional Sanger sequencing, has gained tremendous interest for achieving 
the $1000 human genome goal. In particular, sequencing by synthesis with cleavable 
fluorescent nucleotide reversible terminators (CF-NRTs) has offered the most promise, 
with its higher accuracy and lower fluorescent background as compared to other SBS 
technologies. Over a number of years, investigations in the Ju laboratory have built a 
collection of complete sets of nucleotide analogs for successful sequencing by synthesis. 
The key to this development is the use of four reversible nucleotide terminators, one 
for each of the bases of DNA, such that in each cycle of SBS, (1) a polymerase reaction 
should add with precision only the next base thanks to the presence of a 3’ OH blocking 
group on the nucleotides which prevents further extension, (2) detection of the 
incorporated base, and (3) conversion of the blocked (protected) nucleotide back to a 
normal nucleotide to allow further rounds of nucleotide incorporation. Ideally, each of the 
4 nucleotide analogues should be tagged with distinguishable characteristics, exhibit 
efficient incorporation by DNA polymerases and efficient deprotection under mild 
conditions.1 Earlier work in the literature exploring the SBS method was mostly focused 




Fig. 6.1. Schematic illustration of rationales for cleavable fluorescent nucleotide reversible 
terminators (CF-NRTs). (A) Stereo diagram of the polymerase active site for incorporating an 
incoming ddCTP;4 The ring in red refers to the base (cytosine), and the ring in blue refers to the 
sugar. The 5 position of the base and the 3’ position of the sugar are indicated by arrows. (B) 
General structure of our design of CF-NRTs.  
nucleotides, with the hope that 3’-OH would be regenerated to allow subsequent 
nucleotide addition after the fluorophore was removed.2, 3 However, no success had been 
reported. As we look into the polymerase-DNA-nucleotide complex4 (Fig. 6.1), it is 
apparent that the 3’ position on the deoxyribose is very close to the amino acid residues 
in the active site of the polymerase so that any large modification would tend to inhibit 
polymerase function, while the 5 position of the nucleotide has a reasonable amount of 
space for introducing big molecules. These findings are also consistent with the report 
that some modified DNA polymerases are highly tolerant to nucleotides with extensive 
modifications with bulky groups at the 5-position of the pyrimidines (T and C) and the 
7-position of the purines (G and A).5, 6 Based on this rationale, our group first proposed 
the design and synthesis of cleavable fluorescent nucleotide terminators produced by 
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tethering a unique fluorescent dye to the 5-position of the pyrimidines (T and C) and the 
7-position of the purines (G and A) via a cleavable linker, and attaching a small cleavable 
chemical moiety to cap the 3’-OH group (Fig. 6.1 B).7 
Since this discovery, our lab has explored many sets of cleavable fluorescent 
nucleotide reversible terminators (CF-NRTs) and nucleotide reversible terminators 
(NRTs) or their analogues for sequencing by synthesis, including 2-nitrobenzyl linker 
based photocleavable fluorescent nucleotide analogues,8 allyl linker based nucleotide 
analogues9, 10 and azido based nucleotide analogues,11, 12 with azido based nucleotide 
analogues (3’-O-N3-dNTPs and 3’-O-N3-dNTP-N3-fluorophores) having shown the most 
promise so far. For NRTs, the 3’ OH of the dNTPs was capped with the azidomethyl 
group (Fig. 6.2), while for CF-NRTs, each nucleotide was attached to a unique 
fluorophore via an azido linker and capped at the 3’ position with the azidomethyl group 
(Fig. 6.3). The advantages of using an azido based linker lies in its mild cleavage 
conditions: the azido group can be efficiently converted into an amine group by 
tris(2-carboxyethyl) phosphine (TCEP), an odorless and stable agent often used to digest 
peptide disulfide bonds, and finally regenerate the OH group at the 3’ position after 
hydrolysis. The process of sequencing by synthesis using this set of nucleotide analogs is 
described in Fig. 6.4. In brief, starting with a cluster of self-priming DNA templates 
immobilized on a solid surface, the incorporation step is begun with a mixture of 
3’-O-N3-dNTPs and 3’-O-N3-dNTP-N3-fluorophores. A small portion of the DNA 
molecules that incorporate CF-NRTs will give a sufficient fluorescent signal for base 
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identification, while the greater portion of the DNA templates incorporates NRTs. To 
synchronize all the templates, a capping step with NRTs is subsequently performed, 
followed by a cleavage step. Both the 3’-capping group (azido) and the fluorophores are 
cleaved away by TCEP to recover the 3’-OH group for the next round of signal 
generation. In this manner, as the sequencing cycle progresses, the bases will be 
identified sequentially one by one. Using this set of CF-NRTs/NRTs, our lab has been 































































































































































































Fig. 6.3. Molecular structures of  3’-O-N3-dATP-N3-ROX ， 3’-O-N3-dUTP-N3-R6G ， 





Fig. 6.4. Scheme of sequencing by synthesis using CF-NRTs (3’-O-N3-dNTP-N3-fluorophores) and 
NRTs (3’-O-N3-dNTPs). 
An alternative set of non-reversible cleavable fluorescent nucleotide terminators 
(ddNTP-N3-fluorophoores) have also been developed11 (Fig. 6.5), which have special 
utility for the hybrid Sanger-SBS approach to be described. This 4-color hybrid SBS has 
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intermediate properties between Sanger sequencing and the standard SBS reactions. The 
rationale is that the identity of the incorporated nucleotide is determined by the unique 
fluorescent emission from the four fluorescent dideoxynucleotide terminators 
(ddNTP-N3-fluorophores, Fig. 6.5), while the role of the 3’-O-N3-dNTPs is to further 
extend the DNA strand to continue the determination of the DNA sequence. In general, as 
shown in Fig. 6.6, sequencing reactions on a chip were initiated by extending the 
self-priming DNA templates using a solution containing four 3’-O-N3-dNTPs, four 
ddNTP-N3-fluorophores, and 9oN DNA polymerase. The incorporated nucleotide is 
identified by fluorescence detection. Then a synchronization reaction using the four 
3’-O-N3-dNTPs in relatively high concentration was performed to reduce the amount of 
un-extended priming strands after the initial extension reaction. Both the fluorescent 
groups and 3’ capping azidomethyl moiety are cleaved away by TCEP for the next 
sequencing cycles. Here, the DNA strand extended by ddNTP-N3-fluorophores will no 
longer participate in subsequent polymerase reaction cycles because they are 
permanently terminated, while the DNA strand that incorporates the 3’-O-N3-dNTPs will 
turn back into the natural nucleotide and continue with the next cycle. Therefore, the 
ratio between the amount of ddNTP-N3-fluorophores and 3’-O-N3-dNTPs during the 
polymerase reaction is crucial in determining how much of the ddNTP-N3-fluorophores 
are incorporated and thus the corresponding fluorescent emission strength. With a finite 
amount of immobilized DNA template on a solid surface, as the sequencing cycles 
continue, the amount of the ddNTP-N3-fluorophores needs to be gradually increased to 
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maintain the fluorescence emission strength for detection. The advantage of this strategy 
is that the extension with the mixture of 3’-O-N3-dNTPs/ddNTP-N3-fluorophores does 
not have a negative impact on the enzymatic incorporation of the next nucleotide 
analogue, because after cleavage to remove the 3’-OH capping group, the DNA products 
extended by 3’-O-N3-dNTPs carry no modification groups. Guo et al.11 in our lab 
performed hybrid SBS on a chip-immobilized DNA template using the 
3’-O-N3-dNTPs/ddNTP-N3-fluorophores combination and obtained a read-length of 
around 30 bases on self-priming DNA templates. 
 
Fig. 6.5. Molecular structures of cleavable fluorescent dideoxynucleotide terminators: 




Fig. 6.6. A hybrid SBS scheme for 4-color sequencing on a chip using the nucleotide reversible 
terminators (3’-O-N3-dNTPs) and cleavable fluorescent dideoxynucleotide terminators 
(ddNTP-N3-fluorophores).   
The above two strategies using azido based nucleotide analogues has demonstrated 
their great potential in DNA sequencing. However, the relatively short read-lengths 
obtained pose a challenge for DNA sequence assembly and de novo sequencing. 
Increasing read-length is of significance for fragment assembly, not only for sequencing 
by synthesis, but for all the other next-generation sequencing technologies. Despite the 
general progress in technology across different fields, including surface chemistry, 
nucleotide biochemistry, polymerase engineering, detection methodology and others, 
alternative strategies need to be developed to increase the read-length with current 
chemistries and methods.  
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To overcome the limitations of the short read-length, paired-end and mate-pair 
sequencing have been developed and are currently used in some commercial sequencing 
platforms. The paired-end approach developed by Illumina is to sequence both the 
forward and reverse strand of each molecule.13 As shown in Fig. 6.7 A, after the first 
stage of sequencing, the synthesized sequence is washed away by chemical melting, and 
bridge amplification cycles are repeated to generate the reverse strand, after which the 
starting strand is selectively removed before annealing another sequencing primer for the 
second read. Using this paired-end sequencing approach, approximately twice the 
amount of data can be generated. 
Another approach, called mate-pair sequencing, involves the preparation of special 
libraries. As shown in Fig 6.7 B, the long target DNA molecules are connected at each 
end to sticky-end adapters (referred to as internal adapters), allowing the ends of the 
molecule to come into close proximity by circularization. The circularized DNA 
molecule is then processed using restriction enzymes or fragmentation to generate the 
mate-pair segment, the two combined molecular ends, which are end ligated to the outer 
adapters and sequenced, theoretically from both types of adapters. This allows the 
sequence of both ends of the target DNA to be determined sequentially and in each 
direction, providing information about relative location and orientation of a pair of reads 
useful for assembly. For instance, if the starting fragments average 3 kb in length, the 
mate pair reads will also be approximately that distance apart, enabling one to scaffold 





Fig. 6.7. Approaches to overcome short read-length. (A) Paired-end sequencing; (B) Library 
preparation for mate-pair sequencing 
These two approaches have helped to improve the read-length and data analysis. 
However, the extra PCR cycles for the paired-end method and special library preparation 
for the mate-pair approach bring extra complexity to the process. It is desirable to 
develop a new strategy that is simple and effective to increase the read-length. In this 
chapter, we describe a SBS integrated primer walking strategy we have developed to 
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increase the read-length of SBS several fold. Here, the already-extended “sequenced” 
primer is stripped away after the first stage of SBS. Then a new primer is re-annealed to 
the DNA template and extended to the approximate end of the first round SBS with the 
use of three natural nucleotides (dATP, dCTP and dGTP) and one nucleotide reversible 
terminator (NRT, 3’-O-N3-dGTP). This primer walking process results in a long natural 
DNA strand primed for the next stage of SBS. The repeated SBS and primer resetting 
will eventually increase the read-length of SBS several fold. As a proof of principle, 53 
bp of read-length was achieved by the combination of SBS and primer walking, with the 
use of cleavable fluorescent nucleotide reversible terminators (instead of 
ddNTP-N3-fluorophores) and nucleotide reversible terminators for the sequencing cycles. 
6.2 Experimental Rationale and Overview 
The fundamental rationale behind the primer walking strategy is to recover the initial 
template after one round of sequencing and start the next round anew at a downstream 
base to cover more bases. In general, as shown in Fig. 6.8, six steps are involved in this 
approach: (1) annealing of the first primer, (2) performing a 1st round of 4-color SBS, (3) 
denaturing the sequenced section of the template to recover a single-stranded DNA for 
the second primer annealing, (4) annealing of a fresh primer identical to the first primer 
to the template, (5) walking of the primer by extending the primer with the walking 
nucleotides mixture to the approximate end of the first round sequence, (6) sequencing 
from that point. Theoretically, steps 1 through 6 can be carried out repeatedly until the 
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target DNA is sequenced in its entirety. The advantage of primer resetting lies in its 
ability to restore all the templates after the denaturation step, so the next stage of SBS 
can restart downstream from the first stage of SBS with potentially the same amount of 
sequenceable DNA as the previous round. Therefore, the read-length of sequencing is 
increased to the combination read-length of the first and second stages of SBS. The main 
challenges of the primer walking strategy are as follows: first, to obtain similar 
read-length on linear template compared to self-priming template, which is under the 
control of primer hybridization efficiency and stability; second, to strip away the 
extended primer after the first round of SBS under mild conditions, efficient enough but 
not damaging to the templates; third, to develop an effective walking method. The first 
two challenges can be addressed by optimizing the hybridization and denaturation 
conditions, while for the third one, there are three possible approaches: walking with 
nucleotide reversible terminators (NRTs), with three natural nucleotides, or with three 
natural nucleotides in combination with one NRT. The first approach only utilizes the 
NRTs, therefore, the extension stops after every single base extension and resumes after 
the cleavage reaction. This helps to prevent mis-incorporation, yet it requires the same 
number of repeated cycles as the first round SBS, which slows the walking process. The 
second approach is to employ two sets of natural nucleotide mixtures as substrates in 
rotation. For example, the first set of natural nucleotides is composed of dATP, dGTP, 
dCTP, and the second set consists of dATP, dGTP, dTTP. Using the first set, the 
polymerase reaction stops before base “A” in the template due to lack of the 
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complementary base dTTP, and will resume after bringing in the second mixture 
containing dTTP, resulting in a polymerase reaction that stops at the base “G” in the 
template due to the lack of dCTP. The idea of using natural nucleotides alone simplifies 
and speed up the whole process, but because of the presence of only three nucleotides, 
the enzyme sometimes incorporates an incorrect dNTP instead of stopping at the 
expected position. The third approach combines the advantages of NRTs and natural 
nucleotides. The incorporation is conducted using three natural dNTPs (e.g. dATP, dCTP, 
dTTP) and one NRT (3’-O-N3-dGTP). Therefore, the polymerase extension will continue 
until it incorporates the NRT, and resumes after the cleavage reaction to regenerate the 
3’-OH. Repeated cycles of such incorporation and cleavage will fill the gap between the 
first and second rounds of SBS at a relatively fast speed. In this study, only the second 





Fig. 6.8. General scheme of primer walking strategy for extending the read-length. 
6.3 Results and Discussion 
6.3.1 Optimization of primer annealing to DNA template on solid surface 
Previous sequencing by synthesis performed in our lab was mostly carried out with a 
loop template, where the self-priming sequence inside the DNA template strand 
guaranteed that each template could be analyzed and the primers would not fall off as the 
cycles progressed, giving the maximum possible signals. However, to perform the SBS 
on a linear template, one requires external primers to anneal to the DNA template for the 
initiation of sequencing. This poses challenges with regard to the annealing efficiency of 
primer hybridization to the template as well as the stability of the primer-template duplex: 
in most cases steric hindrance will prevent primer hybridization to the surface-bound 
linear template in the first place and the primers tend to shear off after undergoing 
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multiple washing steps. To generate a sufficient signal, it is crucial to specifically anneal 
primers to as many of the templates in the ensemble as possible and for the interaction to 
be stable enough to survive many cycles. Different conditions were tested by varying the 
concentrations of the salt and primer, the length of primer, and annealing temperature. As 
shown in Fig. 6.9, the base calling signal strength is highly related to the concentration of 
primers during the hybridization, and the results with both the 37mer and 52mer primer 
indicated that use of 3.5 μM primers in a total volume of 10 μl generated the strongest 
signal. This concentration was then used for all the annealing steps. Though the data are 
not shown here, by setting up parallel experiments, it was demonstrated that higher salt 
concentration actually contributed to better hybridization efficiency, multiple incubations 
with fresh hybridization mixture also led to better hybridization results, and an annealing 
temperature of 65oC gave a more specific signal with lower background compared to two 
lower temperatures, 60o and 55oC. After several cycles of sequencing by synthesis, it was 
also demonstrated that a primer length of 37 bases gave a continuous stable signal.  
The amount of template on the surface is also a very important factor in performing 
SBS with a linear template. It was expected that CodeLink HD (HD) slides could bear 
more DNA linear templates than CodeLink (CL) slides, but this did not necessarily mean 
that there would be more primer annealed templates available for sequencing 
(sequenceable tempates) if the steric hindrance was greater due to the higher surface 
density. Furthermore, CodeLink slides are easier to visualize in our array scanner. 
Therefore, it was worthwhile to investigate the effects of surface-bound template 
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concentration. Parallel experiments were set up and the results demonstrated that HD 
slides gave better signals than CL slides in single base extension reactions (Fig. 6.10). 
 
Fig. 6.9. The effects of primer concentration: one base extension with fluorescent nucleotide 
reversible terminators (ddNTP-N3-fluorophores) after hybridization of primers at different 
concentrations. (A) 37mer primer (B) 52mer primer. 
 
Fig. 6.10. Comparison of CL and HD slides: one base extension after primer hybridization. 
6.3.2 Sequencing by synthesis on linear DNA template 
Compared to sequencing on loop templates, the difficulties of sequencing a linear 
DNA template lies in the lower signal strength due to fewer sequenceable templates and 
the stability of the primer/template duplex over multiple cycles. This difficulty is 
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amplified in hybrid SBS sequencing, since in each cycle the incorporation of nucleotide 
terminators to the primers leads to loss of those templates from further reactions. In this 
study, hybrid SBS sequencing chemistry was used for testing linear template sequencing, 
as it has a higher requirement for stability of primer/template duplexes and the optimized 
conditions could be directly used for SBS with fluorescent nucleotide reversible 
terminators.   
 
Fig. 6.11. 4-color hybrid SBS data on a linear template (Template1) using 
ddNTP-N3-fluorophores and 3’-O-N3-dNTPs. 
With respect to the stability of the DNA duplex, temperature is the key factor. The 
lower the temperature, the more stable the duplex. However, the temperature should be 
high enough for the enzyme to achieve efficient incorporation. Previously, for sequencing 
on loop templates, 65oC was used for extension reactions. Based on this, different 
temperatures, 65oC, 60oC, 55oC and 50oC, were tested under the same conditions. 
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Though the data are not shown here, 55oC turned out to give the longest read-length in 
hybrid SBS cycles. On the other hand, for hybrid SBS itself, the ratio of fluorescently 
labeled nucleotide terminators and reversible nucleotide terminators must be carefully 
controlled in order to reach reasonable read-lengths. As shown in Fig. 6.11, a total 
read-length of 25 bp was achieved, which is similar to the read-length obtained with the 
loop template.11 
6.3.2 Primer resetting and walking for extending read-length 
As described above, the primer walking strategy involves denaturing primers away 
from the templates after the first round of sequencing, re-annealing a fresh primer to the 
template and extending the primer to the approximate end of the first round of 
sequencing. Each step was tested and optimized in this study.  
Different methods could be applied to denature the DNA duplex, such as high 
temperature (>90oC), strong alkaline solution (e.g. 0.1-0.5 M NaOH), or formamide 
treatment. NaOH was excluded in the testing due to its possible chemical damage to the 
surface. Considering the potential damage to the DNA templates on the surface by high 
temperature or concentrated formamide, the combination of elevated but not high 
temperatures with dilute formamide (80%) was employed in the denaturation step. 
Different temperatures were tested in order to completely remove the first round 
sequencing primer. Since the first run of sequencing was stopped at the incorporation 
step prior to cleavage of the fluorophore, the denaturation efficiency should be reflected 
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by the amount of loss of fluorescence signal. However, the integrity of the DNA template 
on the surface could only be analyzed after primer resetting and SBS cycles. Hence, after 
denaturing the primer, the fresh primer was annealed and single base extension was 
performed. The integrity of the DNA template was compared with the fluorescence 
intensity after the first fluorescent nucleotide was incorporated. Different conditions were 
tested in this study to achieve better denaturation efficiency while keeping the surface 
interactions intact. The results demonstrated that 80% formamide incubation at 65oC 
gave the best result. It was also discovered that replenishing the denaturation mixture 
multiple times at shorter intervals helped to achieve higher overall specific signals. To 
effectively remove the non-specific binding of the fluorophores from the surface, 0.1% 
SDS was added to the denaturation mixture.  
The key of the primer walking strategy is to fill in the primer with natural 
nucleotides to the end of the first round of sequencing. As discussed in the following 
section, walking with three natural nucleotides and the combination of natural 
nucleotides with reversible terminators were both tested in this study.  
6.3.2.1 Primer walking using three natural nucleotides 
The rationale behind primer walking using three natural nucleotides is that the DNA 
polymerase reaction will stop due the lack of a complementary nucleotide and will 
resume in the presence of a complementary nucleotide. For example, if the downstream 
sequence after the primer is 5’-ATGCTAG---3’, in the present of three natural 
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nucleotides (dATP, dTTP and dGTP), the primer is only extended to 5’-ATG. Polymerase 
stops incorporating due to the absence of dCTP. With the introduction of the alternative 
nucleotide mixture (dCTP, dATP, dTTP), the primer will be continually extended to 
5’-ATGCTA up to the G site. By alternating the two incorporation mixtures, the primer 
was extended (“walked”) to the end of the first round of sequencing.  
The high fidelity and accuracy of the DNA polymerase is crucial for carrying out 
template walking with three natural nucleotides. Most importantly, the polymerase must 
not incorporate a miscellaneous nucleotide where the complementary nucleotide is 
missing. Various DNA polymerases were tested to find the most suitable ones for this 
application. Starting with a single base extension reaction, a self-priming template 
(SP26dT, M.W. 7966) and a single natural nucleotide, dTTP, were tested. It was expected 
that primer extension would stop right after the polymerase incorporated dTTP due to the 
absence of the next complementary nucleotide, dGTP. Hence, the expected molecular 
weight of the SP26T after a single base extension should be 8270. Four different 
commercially available DNA polymerases were tested: 9oN Therminator II, Pfu DNA 
Polymerase (with 3’-5’ exonuclease activity), Tgo DNA polymerase and Thermo 
Sequenase, and the extension products were analyzed by MALDI-TOF MS. As shown in 
Fig 6.12, the four polymerases behaved differently during the single base extension 
reactions. 9oN enzyme was not able to stop after incorporating the first dTTP but 
mis-incorporated an extra dTTP to yield a DNA product with two Ts (M.W. 8606). 
Instead of displaying incorporation activity, both the Pfu and Tgo polymerases cleaved 
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the loop primer from the 3’ to 5’ direction due to their exonuclease activity. Though not 
presented completely in Fig. 6.12 C, Tgo polymerase digested more than 15 bases off the 
primer. Thermo Sequenase was the only polymerase to correctly incorporate a single 
dTTP and promptly stopped ahead of a mismatch at the second, displaying a single peak 
at 8270. Therefore, Thermo Sequenase was chosen for further testing.  
 
Fig. 6.12. MALDI-TOF MS spectra of single base extension products using self-priming SP26T 
template and dTTP with DNA polymerase (A) Therminator II (9oN), (B) Pfu DNA polymerase, (C) 
Tgo DNA polymerase and (D) Thermo Sequenase. 
In order to fulfill the requirement of walking, Thermo Sequenase was further 
evaluated for its ability to correctly incorporate three natural nucleotides. In primer 
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walking, the walking rate depends on polymerase fidelity in the presence of all but one 
natural nucleotide. The same self-priming template, SP26T was used, together with three 
nucleotides, dATP, dGTP and dTTP. Since the sequence immediately downstream of the 
primer is 5’-TGAC-3’, the polymerase was expected to stop incorporation at the third 
base (A). However, the MALDI-TOF MS spectrum result indicated that mis- 
incorporation of the fourth base occurred, as shown in Fig. 6.13 A, the extra peak at 8217 
corresponding to the mis-incorporation of a dTTP. Although the majority of extension 
products had the correct three nucleotides incorporated (m/z 8912), this protocol still 
could not be used for walking. We hypothesized that the presence of excessive dNTPs in 
the reaction mixture during the extension reaction lowered the fidelity of Thermo 
Sequenase, resulting in the incorporation of the extra base. Hence, a PyroE solution, 
which contains Apyrase, an enzyme used to eliminate un-reacted dNTPs during 
pyrosequencing, was added to the extension mixture to digest the excess dNTPs. The 
result, as shown in Fig. 6.13 B, demonstrated that the combination of Thermo Sequenase 




Fig. 6.13. MALDI-TOF MS spectra of self-priming SP26T template extended with dATP, dGTP 
and dTTP using (A) Thermo Sequenase (B) Thermo Sequenase and PyroE solution.   
 
Fig. 6.14. MALDI-TOF MS spectrum of Primer5163 extended with dTTP, dGTP and dCTP using 
Thermo Sequenase and PyroE solution 
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To truly integrate primer walking with natural nucleotides in the SBS platform, the 
extension reaction needs to be carried out on linear templates instead of self-priming 
templates, in order to remove the primers for the next round of sequencing. This was 
tested using a synthetic linear template, Exon8, and related primer5163. Three 
nucleotides, dTTP, dGTP, dCTP, were used. The first several bases after the priming site 
are 5’-TTAGA-3’, therefore, the use of nucleotides dTTP, dGTP, dCTP will enable the 
primer to walk to the second base (T) and stop due to the lack of dATP. The molecular 
weight of the primer is 5163 Da, and after extension with two Ts, the mass of the primer 
should have increased to 5771. However, the result (Fig. 6.14) showed that Thermo 
Sequenase failed to stop incorporation in the absence of complementary nucleotides. 
Instead, it mis-incorporated either a dTTP or dGTP at the position that is supposed to be 
A, generating peaks of 6076 and 6101 respectively. Though additional peaks are not 
labeled in the figure, it is apparent that Thermo Sequenase continued incorporating 
incorrect bases far beyond the A position. Though different modifications were tested, 
including varying the temperature, the amount of enzyme, nucleotide concentration, the 
amount of PyroE solution and others, we were not able to obtain the correct number of 
incorporated nucleotides. Hence, we decided to explore the next option, that is, primer 
walking with three natural nucleotides and one nucleotide reversible terminator. 
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6.3.2.2 Primer walking using three natural nucleotides and one reversible nucleotide 
terminator 
The strategy of using three natural nucleotides in combination with one nucleotide 
reversible terminator is to regulate the primer walking by halting the primer extension 
with nucleotide reversible terminators (NRTs, 3’-O-N3-dNTPs). When a primer extends 
with an NRT, primer walking will stop. With the cleavage of the 3’-azidomethyl capping 
moiety on the NRT, the 3’-OH group is recovered and ready for the next round of 
walking. Unlike template walking with three natural nucleotides, the use of reversible 
terminators effectively stops the DNA polymerization, hence increasing the accuracy of 
the DNA polymerase and reducing the chance of mis-incorporation. For example, if a 
walking nucleotide mixture, consisting of three natural nucleotides (dATP, dCTP and 
dTTP) and one nucleotide reversible terminator (NRT, 3’-O-N3-dGTP) is used, all 
walking primers should be synchronized at the G nucleotide after the incorporation of the 




Fig. 6.15. MALDI-TOF MS spectrum of Primer5163 extended with dTTP, dGTP, dCTP and 
3’-O-N3-dATP using 9oN polymerase 
MALDI-TOF MS was first used to test the primer walking reactions in solution and 
investigate the incorporation kinetics for condition optimization. A walking mixture of 
three natural nucleotides (dATP, dCTP and dTTP) and one NRT (3’-O-N3-dGTP) was 
used, as the sequence immediately downstream of the primer is 5’-TTAG-3’; therefore, 
the expected mass after walking should be 6454 m/z. As shown in Fig. 6.15, it was 
demonstrated that the incorporation of 3’-O-N3-dGTPs completely stopped the primer 
extension, though there were some incomplete incorporation products before this major 
peak. This can be addressed by increasing the dNTPs to 3’-O-N3-dGTP ratio. 
 To keep the test simple, direct sequencing after three walking cycles was first 
explored, without the involvement of first round sequencing and denaturation. Again, the 
hybrid SBS chemistry was used for the test. As shown on Fig. 6.16 A, primers were first 
hybridized to the linear templates on the chip, and then extended by polymerase reaction 
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using three dNTPs (dCTP, dATP, dTTP) and 3’-O-N3-dGTP. The extension process 
stopped after the first G. To synchronize the un-extended primers, a capping step with 
3’-O-N3-dGTP was performed. Upon cleavage of the 3’-O-azidomethyl group, the 3’-OH 
of the primer was regenerated and ready for the next cycle of walking. Here, 3 walking 
cycles were performed, which traversed 25 bases. After walking, 24 bases of DNA 
sequence were correctly identified after carrying out the “second” round hybrid SBS, as 
shown in Figure 6.16 B. This demonstrated the feasibility of the primer walking strategy.  
To further explore the feasibility of the primer walking strategy, collaborating with 
Dr. Yu in our lab,5 the complete process, including first round SBS sequencing, primer 
resetting and walking, and second round SBS sequencing, was carried out by SBS 
chemistry using cleavable fluorescently labeled nucleotide reversible terminators 
(CF-NRTs, dNTP-N3-fluorophores). As shown in Fig. 6.17, the first 30 basses were 
sequenced during the 1st round of SBS. After stripping away the sequencing primer, the 
original primer was reannealed to the template, followed by four cycles of primer 
walking using a mixture of three natural dNTPs (dATP, dCTP, and dTTP) and one NRT 
(3’-O-N3-dGTP). Upon reaching the base at the end of the previous sequencing round, 
SBS was re-initiated to correctly identify the next 23 consecutive bases, which, together 
with the 30 bases in the first round, achieved an overall read-length of 53 bases. In this 
experiment, we used reversibly blocked CF-NRTs (3’-O-N3-dTNP-N3- fluorophores) in 




Fig. 6.16. Four-color DNA sequencing by hybrid SBS after primer “walking”. (A) A scheme for 
primer walking followed by hybrid SBS sequencing. The primer hybridized to the linear 
templates was extended by polymerase using three dNTPs (dCTP, dATP, dTTP) and 
3’-O-N3-dGTP, and extension stopped after the first G. After a capping step to achieve 
synchronization, the 3’-OH of the extended primer was regenerated by removing the 3’-O-N3 
group. Hybrid SBS sequencing started after 3 walking cycles. (B) Four-color sequencing data 








Fig. 6.17. Implementation of primer walking strategy for extending the read-length. (A) Scheme 
of SBS integrated primer walking. Not shown are capping in between each sequencing 
incorporation cycle. (B) 4-color SBS sequencing data obtained by combining 1st and 2nd round 
SBS using CF-NRTs. The first 30 bases were sequenced during the 1st round of SBS. 23 bases 
were sequenced in the second round, which generated the overall read-length of 53 bases.  
6.4 Materials and Methods 
General Information. All chemicals were purchased from Sigma-Aldrich (St. Louis, 
MO) unless otherwise specified. Cleavable fluorescent nucleotide reversible terminators 
(CF-NRTs, dNTP-N3-fluorophores), nucleotide reversible terminators (NRTs, 
3’-O-N3-dNTPs) and fluorescent dideoxynucleotide terminators (ddNTP-N3-fluorophores) 
were synthesized in our lab. Natural deoxynucleotides (dNTPs) and dideoxynucleotides 
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(ddNTPs) were purchased from Sigma-Aldrich. Oligonucleotides used for primers and 
templates were from Integrated DNA Technologies (Coralville, IA). TherminatorTM II 
DNA polymerase (9oN) was purchased from New England Biolabs (Ipswich, MA), Pfu 
DNA polymerase from Agilent Technologies (Santa Clara, CA), Tgo DNA polymerase 
from Roche Applied Science (Indianapolis, IN), and Thermo Sequenase from GE 
Healthcare (Piscataway, NJ). CodeLink® Activated Microarray Slides and CodeLink® 
HD Activated Microarray Slides for DNA template immobilization were obtained from 
GE Healthcare as well. Seven different DNA templates were spotted on the slides in 
multiple replicates, one row for each type of template, with three rows of loop templates 
as the positive control. The sequence information for the DNA templates is shown in 
Table 6.1. Mass measurement of DNA was performed on a Voyager DETM MALDI-TOF 
mass spectrometer (Applied Biosystems by Life Technologies, Carlsbad, CA). The DNA 
array was analyzed under a four-color ScanArray Express Scanner (PerkinElmer Life 
Sciences, Boston, MA). 
Table 6.1 Sequence information for the DNA templates on slide 
Template 1 
5’-CAC TCA CAT ATG TTT TTC ATG GTA CCG TCA TAG TCA GTG ACA TGC 
GAC TTA AGG CGC TTG CGC CTT AAG TCG CAT GTC AC-3’ 
Template 2 
5’-AAT GAA TGT ATC ACT ACT CAG ATC GTT ACT GAA CAT CTG CAT GGT TCA 
CCT CGC TGT GAC GTG CCC ATG CGA GTG CGA GTG CAC GTG GCG CAG 
CAG GTC A 
Template 3 
5’-GCA TGG TTC AAA TGA ATG TAT CAC TAC TCA GAT CGT TAC TGA ACA TCT 
CCT CGC TGT GAC GTG CCC ATG CGA GTG CGA GTG CAC GTG GCG CAG 
CAG GTC A-3’ 
Template 4 
5’-CAC TCA CAT ATG TTT TTT AGC TTT TTT AAT TTC TTA ATG ATG TTG TTG 




5’-CTG AAC ATC TGC ATG GTT CAA ATG AAT GTA TCA CTA CTC AGA TCG TTA 
CCT CGC TGT GAC GTG CCC ATG CGA GTG CGA GTG CAC GTG GCG CAG 
CAG GTC A-3’ 
Template 6 
5’-CAG ATC GTT ACT GAA CAT CTG CAT GGT TCA AAT GAA TGT ATC ACT ACT 
CCT CGC TGT GAC GTG CCC ATG CGA GTG CGA GTG CAC GTG GCG CAG 
CAG GTC A -3’ 
Template 7 
5’-ATC ATG TCA TGA ATC ACA CTC ACA TAT GTT TTT CAT GGT ACC GTC ATA 
GTC ACG ACT TAA GGC GCT TGC GCC TTA AGT CG-3’ 
Note: Template 1, 4 and 7 are self-priming loop templates. The letters in black bold indicate the 
primer hybridization site, and the letters in orange bold indicate the self-priming site.  
6.4.1 Primer hybridization  
To optimize the primer hybridization, different conditions were tested. The annealing 
buffer is based on 1X ThermoPol Reaction buffer (10 mM (NH4)2SO4, 10 mM KCl, 2 
mM MgSO4), with the addition of primers, and salt. Different concentrations of primers, 
from 0.5 μM to 3.5 μM, in 0.5 μM intervals, were tested. Primers with different lengths, 
20mer, 37mer and 52mer, were compared under the same conditions. Annealing buffers 
with and without NaCl (0.5 M) were compared. Different annealing temperatures, 55oC, 
60oC and 65oC, were tested. The comparison analysis was based on the fluorescent signal 
from single base extension with ddNTP-N3-fluorophores after the hybridization. 
Generally, a 10 μl reaction mixture consisting of 0.2 μl solution A (3 μM 3’-O-N3-dATP, 
0.5 μM 3’-O-N3-dGTP, 3 μM 3’-O-N3-dCTP and 3 μM 3’-O-N3-dTTP) and 7.3 μl 
solution B (200 nM ddATP-N3-ROX, 100 nM ddGTP-N3-Cy5, 50 nM 
ddCTP-N3-Bodipy-FL-510 and 100 nM ddUTP-N3-R6G), 1 U of 9oN DNA polymerase, 
20 nmol of MnCl2 and 1X Thermopol II reaction buffer was added to the spot at 65oC for 
15 min. After washing the chip with SPSC buffer containing 0.1% Tween-20 for 1 min, 
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the surface was rinsed with dH2O, dried briefly and then scanned to detect the 
fluorescence signal. The finalized hybridization condition used for the experiment was as 
follows: 10 μl of hybridization mixture consisting of 3.5 μM 37mer primer, 1X 
ThermoPol Buffer and 0.5 M NaCl were incubated with the template spots on the slide 
for 30 min at 65oC, and the hybridization process was repeated three times to achieve 
higher efficiency. For the comparison of the different slide surfaces, the same optimized 
hybridization condition was applied for both slides.  
After a series of tests, the procedures for hybrid SBS on the linear template was 
established as follows. For the incorporation step, a 10 μl reaction mixture composed of 
solution A consisting of 3’-O-N3-dCTP (1.4 μM), 3’-O-N3-dTTP (1.5 μM), 
3’-O-N3-dATP (1.8 μM) and 3’-O-N3-dGTP (1.3 μM), and solution B consisting of 
ddCTP-N3-Bodipy-FL-510 (120 nM), ddUTP-N3-R6G (160 nM), ddATP-N3-ROX (40 
nM) and ddGTP-N3-Cy5 (80 nM), 1 unit of 9oN DNA polymerase, 20 nmol of MnCl2 and 
1X Thermopol II reaction buffer was incubated with linear template on the slide at 55oC 
for 15 min. A capping step was followed to synchronize any unincorporated templates. 
An extension solution consisting of 60 pmol each of 3’-O-N3-dTTP, 3’-O-N3-dATP, 
3’-O-N3-dGTP, and 97.5 pmol of 3’-O-N3-dCTP, 1 unit of 9oN DNA polymerase, 20 
nmol of MnCl2 and 1X Thermopol II reaction buffer was added to the same spot and 
incubated at 55oC for 15 min. After washing the chip with SPSC buffer (sodium 
phosphate and sodium chloride buffer with 0.2% Tween) for 1 min, the surface was 
rinsed with dH2O, dried briefly and then analyzed under the 4-color scanner for the 
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fluorescent signal. To perform the cleavage, 10 μl of TCEP (100 mM, pH 9.0) was added 
to the spot and incubated at 55oC for 10 min. After washing, the chip was scanned again 
to compare the intensity of fluorescence after cleavage with the original fluorescence 
intensity. This process was followed by the next cycle of polymerase extension using the 
3’-O-N3-dNTP/ddNTP-N3-fluorophores, fluorescence detection, synchronization, 
washing, and cleavage processes performed as described above. To obtain DNA 
sequencing data, the SBS cycles were repeated multiple times using the various ratios of 
solution A and solution B. The volumes of solution A and B in each SBS cycle were 
adjusted to achieve relatively even fluorescence signals (Table 6.2). 










1st 7.3 0.2 14th 6.7 0.8 
2nd 7.3 0.2 15th 6.6 0.9 
3rd 7.3 0.2 16th 6.3 1.2 
4th 7.3 0.2 17th 5.7 1.8 
5th 7.3 0.2 18th 5.2 2.3 
6th 7.3 0.2 19th 4.7 2.8 
7th 7.2 0.3 20th 4.0 3.5 
8th 7.2 0.3 21st 3.5 4.0 
9th 7.1 0.4 22nd 3.0 4.5 
10th 7.1 0.4 23rd 2.5 5.0 
11th 6.9 0.6 24th 2 5.5 
12th 6.8 0.7 25th 0.5 7.0 
13th 6.8 0.7    
6.3.2 Primer resetting and walking 
The final protocol used for denaturing the extended primer from the first round was 
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to incubate the chip in a solution consisting of 50 mM Tris-HCl buffer (pH 7.5), 80% 
formamide and 0.1% SDS at 65oC for 30 min, twice. The efficiency of the denaturation 
was checked under the scanner, with complete denaturation expected to lead to complete 
loss of the fluorescent signal. Slightly different conditions were tested, such as varying 
the incubation temperature and time, before the final protocol was settled upon.  
6.3.2.1 Primer walking using three natural nucleotides 
Various commercially available DNA polymerases (9oN, Pfu, Tgo and Thermo 
Sequenase) were tested for their fidelity and accuracy in the single base extension 
reaction using dTTP. Each extension reaction was carried out with a mixture consisting 
of a self-priming DNA template SP26T (5’-GTCAGCGCCGCGCCTTG- 
GCGCGGCGC-3’, 40 pmol), 200 pmol of dTTP, 1X enzyme reaction buffer, and 1 unit 
of the DNA polymerase. For 9oN polymerase, 20 nmol of MnCl2 was used as the cofactor. 
The reaction mixture was incubated at 65oC for 2 min. After ethanol precipitation and 
desalting with ZipTips (Millipore), the extension products were analyzed by 
MALDI-TOF MS. 
 Based on the single base extension results, Thermo Sequenase was chosen for primer 
walking with three natural nucleotides in solution. The three-base extension reaction 
consisted of 40 pmol SP26T, 200 pmol each of three natural nucleotides (dTTP, dGTP 
and dATP), 1X Thermo Sequenase reaction buffer and 1 unit of Thermo Sequenase with 
incubation at 65oC for 15 min. The resulting products were analyzed by MALDI-TOF 
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MS as described above. Due to the presence of mis-incorporation products, the same 
extension was further tested with the addition of 2 μl PyroE solution (Pyrosequencing 
enzyme mixture, Roche), the products of which also underwent MALDI-TOF MS 
analysis.  
 To most mimic the primer walking, linear templates instead of self-priming 
templates were tested. 20 pmol of the linear template, Exon8, (5’-GAA GGA GAC ACG 
CGG CCA GAG AGG GTC CTG TCC GTG TTT GTG CGT GGA GTT CGA CAA 
GGC AGG GTC ATC TAA TGG TGA TGA GTC CTA TCC TTT TCT CTT CGT TCT 
CCG T-3’, the letters in bold indicating the primer hybridization site), 60 pmol of a 
17mer primer (P5163, 5’-GAT AGG ACT CAT CAC CA-3’), 200 pmol each of three 
natural nucleotides (dTTP, dCTP, dGTP), 1X Thermo Sequenase reaction buffer, 1 unit of 
Thermo Sequenase and various amount of PyroE solution were used for the extension 
reactions. The reactions were performed for 10 cycles of 94oC for 20 s, 45oC for 30 s and 
68oC for 40 s, and the products were analyzed using MALDI-TOF MS.  
6.3.2.2 Primer walking using three natural nucleotides and one reversible nucleotide 
terminator 
The MALDI-TOF based analysis was first performed to verify the feasibility of this 
strategy in solution. 20 pmol of Exon8, 40 pmol of P5163, 100 pmol each of three natural 
nucleotides (dTTP, dCTP, dATP), 500 pmol of 3’-O-N3-dGTP, 20 nmol of MnCl2, 1X Pol 
II buffer, and 1 unit of 9oN enzyme, were combined and underwent 20 cycles of 94oC for 
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20 s, 45oC for 30 s and 68oC for 40 s, and the products were analyzed using 
MALDI-TOF MS.   
Primer walking was then carried out by adding 10 μl walking solution consisting of 
200 pmol of each dNTP (dATP, dCTP, dTTP), 550 pmol 3’-O-N3-dGTP, 1 unit of 9oN 
polymerase, 20 nmol of MnCl2 and 1X ThermoPol II buffer and incubated at 55oC for 15 
min. To synchronize the unextended templates, two capping steps were carried out. First, 
a 10 μl solution consisting of 100 pmol 3’-O-N3-dGTP, 1 unit of 9oN polymerase, 20 
nmol of MnCl2 and 1X ThermoPolII buffer were added and incubation proceeded at 65oC 
for 20 min. Then the second capping step was carried out with a 10 μl solution consisting 
of 100 pmol of each ddNTP (ddATP, ddCTP, ddGTP, ddTTP), 2 unit of 9oN enzyme, 20 
nmol of MnCl2 and 1X ThermoPolII buffer at 55oC for 15 min. The cleavage reaction 
with 10 μl TCEP at 55oC for 15 min was then carried out to recover the 3’-OH group for 
the next walking cycles.  
Direct hybrid SBS was first carried out after 3 walking cycles without first round 
sequencing. Following the same procedures as described in the hybrid SBS on linear 
template section, the volumes of solution A and B in each SBS cycle were adjusted to 
obtain relatively even fluorescence signals (Table 6.3). 
To fully implement the primer walking strategy, in collaboration with Lin Yu, the 
complete process of SBS integrated primer walking was performed by using SBS 
chemistry, with dNTP-N3-fluorophores/3’-O-N3-dNTPs (CF-NRTs/NRTs). After the first 
round of sequencing, 30 bases were identified. The extended primer was denatured away, 
  
195
and fresh primer re-annealed to the template. Four walking cycles were performed to 
extend the primer to the site where the first round sequencing stopped. A second round of 
sequencing was then carried out to double the original read-length. 












1st 7.3 0.2 14th 6.4 1.1 
2nd 7.2 0.3 15th 6.2 1.3 
3rd 7.2 0.3 16th 5.9 1.6 
4th 7.2 0.3 17th 5.6 1.9 
5th 7.1 0.4 18th 5.4 2.1 
6th 7.1 0.4 19th 5.3 2.2 
7th 7.1 0.4 20th 5.1 2.4 
8th 7.1 0.4 21st 4.9 2.6 
9th 7.1 0.4 22nd 4.6 2.9 
10th 7.0 0.5 23rd 4.1 3.4 
11th 6.9 0.6 24th 3.8 3.7 
12th 6.8 0.7 25th 3.0 4.5 
13th 6.6 0.9 26th 1.5 6.0 
6.4 Conclusion 
In this chapter, we developed a novel primer walking strategy to increase the 
read-length of DNA sequencing by synthesis. The combination of three natural 
nucleotides and one NRT effectively regulated the primer walking: the primer extension 
temporarily paused when the NRT was incorporated, and resumed after removing the 3’ 
capping group to restore the 3’-OH group. The advantage of using this nucleotide 
mixture is that DNA polymerase could function with higher fidelity and accuracy, 
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templates were synchronized with the NRT serving as the last base in each walking cycle, 
and the primer resetting had the ability to restore all the templates after the denaturation 
step. We have successfully demonstrated the integration of this primer walking strategy 
into the sequencing by synthesis platform, and were able to obtain a total read-length of 
53 bases, nearly doubling the read length of the previous sequencing. This primer 
walking strategy could not only be used in sequencing by synthesis with CF-NRTs or 
hybrid sequencing by synthesis, but also has universal application for other sequencing 
methods. Though much optimization is still needed, it is believed that the implementation 
of this primer strategy with the automated platforms could bring us closer to the $1000 
genome goal.    
References 
1. Metzker ML. Emerging technologies in DNA sequencing. Genome Research, 2005, 15, 
1767-1776. 
2. Welch MB, Burgess K. Synthesis of fluorescent, photolabile 3’-O-protected nucleoside 
triphosphates for the base addition sequencing scheme. Nucleosides Nucleotides, 1999, 18, 
197-201. 
3. Lu G, Gurgess K. A diversity oriented synthesis of 3’-O-modified nucleotide triphosphates for 
DNA “sequencing by synthesis”. Bioorganic & Medicianl Chemistry Letters, 2006, 16, 
3902-3905.  
4. Pelletier H, Sawaya MR, Kumar A, Wilson SH, Kraut J. Structures of ternary complexes of rat 
DNA polymerase β, a DNA template-primer, and ddCTP. Science, 1994, 264, 1891-1903. 
5. Rosenblum BB, Lee LG, Spurgeon SL, Khan SH, Menchen SM, Heiner CR, Chen SM. New 




6. Zhu Z, Chao J, Yu H, Waggoner AS. Directly labeled DNA probes using fluorescent nucleotides 
with different length linkers. Nucleic Acids Research, 1994, 22, 3418-3422. 
7. Ju, J., Li, Z., Edwards, J., Itagaki, Y. 2003, US Patent 6,664,079. 
8. Seo TS, Bai X, Kim DH, Meng Q, Shi S, Ruparel H, Li Z, Turro NJ, Ju J. Four-color DNA 
sequencing by synthesis on a chip using photocleavable fluorescent nucleotides. Proceedings of 
the National Academy of Science of the United States of the America, 2005, 102 (17), 5926-5933. 
9. Bi L, Kim DH, Ju J. Design and synthesis of a chemically cleavable fluorescent nucleotide, 
3'-O-allyl-dGTP-allyl-bodipy-FL-510, as a reversible terminator for DNA sequencing by 
synthesis. Journal of the American Chemistry Society, 2006, 128(8), 2542-2543. 
10. Ju J, Kim DH, Bi L, Meng Q, Bai X, Li Z, Li X, Marma MS, Shi S, Wu J, Edwards JR, Romu A, 
Turro NJ. Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide 
reversible terminators. Proceedings of the National Academy of Science of the United States of 
the America, 2006, 103(52), 19635-19640. 
11. Guo J, Xu N, Li Z, Zhang S, Wu J, Kim DH, Sano Marma M, Meng Q, Cao H, Li X, Shi S, Yu L, 
Kalachikov S, Russo JJ, Turro NJ, Ju J. Four-color DNA sequencing with 3'-O-modified 
nucleotide reversible terminators and chemically cleavable fluorescent dideoxynucleotides. 
Proceedings of the National Academy of Science of the United States of the America, 2008, 
105(27), 9145-9150. 
12. Lin Y. Novel strategies to increase read length and accuracy for DNA sequencing by synthesis. 
Dissertation (Ph.D.), Columbia University, 2010  
13. Kircher M, Kelso J. High throughput DNA sequencing - concepts and limitations. Bioessays, 





Chapter 7 Exploration of an “Emulsion PCR-Bead-on-Chip” 
Approach to Improve the Throughput of Sequencing by 
Synthesis 
7.1 Introduction 
There is an ever-growing demand for DNA sequencing, which has spawned the 
second generation DNA sequencing industry, mostly represented by DNA sequencing by 
synthesis (SBS) technologies, including pyrosequencing, sequencing by ligation, and 
SBS with fluorescent nucleotide reversible terminators. The prospective goal of the 
$1000 genome has driven the optimization of these technologies from different 
perspectives, yet the typically short read-length remains a major challenge. To address 
this problem, in Chapter 6, we introduced a primer walking strategy to extend the 
read-length of SBS. Nevertheless, the capacity of SBS could also be improved by the 
number of templates sequenced at a time, since the full read-length of SBS is determined 
by the product of single fragment read-length and number of sequenced fragments. 
Current sequencing by synthesis technologies with cleavable fluorescent reversible 
terminators coupled with the use of a high density DNA array present tremendous 
potential for ultra-high throughput DNA sequencing. However, to realize 
massively-parallel sequencing and meet the challenge of the $1000 genome, further 
innovations are needed.  
Sequencing on beads, a platform based on current sequencing methods and emulsion 
  
199
PCR technology, appears very promising. The first advantage of this system is that it 
circumvents the need for generating a clone library, thus reducing the complexity of the 
sequencing process, time, need for tracking and storage requirements, and also avoiding 
inherent biases of vectors that might decrease the replication fidelity and sequencing 
accuracy.1 This cell-free system was achieved by emulsion PCR, a method that uses 
water-in-oil emulsions to separately and individually amplify millions of DNA templates 
in miniaturized compartments each containing a single bead. After amplification, the 
DNA molecules bound to the beads provide excellent templates for high-throughput 
sequencing; since each bead bears thousands of copies of the same PCR product, the 
signal-to-noise ratio obtained by hybridization or enzymatic assay is extremely high.2, 3 
Because different beads contain the products of different compartmentalized PCR 
reactions, thousands of different templates could be sequenced at the same time after 
immobilizing ePCR beads in a single layer that allows enzymatic manipulation and 
imaging. 
One successful example is 454-sequencing developed and commercialized by 454 
Life Science (Brandford, CT), which integrated the pyrosequencing method, emulsion 
PCR and their PicoTiterPlate (PTP) platform. ePCR beads were deposited into wells of a 
fibre-optic slide (picotiter plate), in which most wells contain a single bead. Only 
picolitre-scale volumes are needed for each well. In one four-hour run, 25 million bases 
were sequenced at 99% or better accuracy.4,5 It would seem that such an approach could 
reach the ultra-massively parallel sequencing goal; however, inherent limitations of 
  
200
pyrosequencing, like ambiguity in homopolymer regions, still present bottlenecks for the 
further development of this technology.  
Church’s group6 also integrated the “sequencing by ligation” method with 
sequencing on beads, through immobilizing ePCR beads in an acrylamide gel to form a 
disordered, monolayered bead array. As they claimed, 1 billion 1 μm beads can 
potentially be fit into the area of a standard microscope slide. This system was applied to 
resequence an evolved strain of Escherichia coli at less than one error per million 
consensus bases. At the time, the major disadvantage of this technique was the short read 
length: only six (seven) continuous accurate bases from the ligation junction in 5’to3’ 
direction, with a total of 13bp per tag and 26bp per amplicon, though this has been 
improved somewhat in the SOLiD system commercialized by Life Technologies. 
DNA sequencing on beads has provided a paradigm shift in sequencing capacity, so 
it is worthwhile to integrate sequencing by synthesis with cleavable fluorescent 
reversible terminators (CF-NRTs) into the bead array system, since SBS with CF-NRTs 
has already shown its great potential for sequencing. In addition, the ability to capture 
and utilize longer templates on beads than directly on surfaces for bridge PCR offers the 
opportunity to better take advantage of mate pair approaches without the need for 
cell-based cloning. This might achieve ultra-massively parallel sequencing with excellent 
accuracy and low cost. With the aim of developing an emulsion-PCR-bead-on-chip 
approach for SBS in mind, we tested different prerequisite conditions, including DNA 
attachment to beads, 4-color SBS on beads, and the formation of emulsions. The 
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resulting accurate sequencing of DNA templates on beads indicates that it has the 
potential to improve the throughput of sequencing by synthesis.   
7.2 Experiment Rationale and Overview 
In this chapter, we explore the applicability of the emulsion-PCR-bead-on-chip 
approach for improving the throughput of sequencing by synthesis with cleavable 
fluorescent nucleotide reversible terminators (CF-NRTs)/nucleotide reversible 
terminators (NRTs). The fundamental rationale of this idea is to transfer arrayed DNA 
sequencing into bead arrayed DNA sequencing, considering the advantages and higher 
throughput of the bead-based approach. In general, as shown in Fig. 7.1, universal 
forward DNA primers are first immobilized onto the microbeads. Emulsion PCR is then 
carried out with a mixture of DNA templates, primer attached microbeads, an external 
reverse primer and deoxynucleotides in a water-in-oil droplet, resulting in beads bearing 
an amplified colony of the same DNA template. The microbeads carrying DNA templates 
were attached to the surface to form high density arrays for sequencing by synthesis 
analysis. Here, each microbead represents one template, while in the conventional 
microarray, a cluster of DNA molecules on the chip represents one template. 
Theoretically, a bead array provides many more templates available for sequencing. 
However, to implement this strategy, the first step is to attach DNA onto the beads 
efficiently and stably to undergo PCR and SBS cycles. The next key step is actually to 
perform SBS with CF-NRTs/NRTs on beads. As our lab has successfully utilized the 
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combination of CF-NRTs (3’-O-N3-dCTP- N3-Bodipy-FL-510, 3’-O-N3-dUTP-N3-R6G, 
3’-O-N3-dATP-N3-ROX, 3’-O-N3- dGTP-N3-Cy5) and NRTs (3’-O-N3-dCTP, 
3’-O-N3-dTTP, 3’-O-N3-dATP, 3’-O-N3-dGTP) (Fig. 7.2) to perform SBS on a chip, 
these two sets of nucleotides were used.7 To thoroughly investigate the requisite 
conditions, a self-priming DNA template was tested both in the DNA conjugation and 
sequencing experiments, with the amount of incorporation on the bead surface as well as 
the amount of specific SBS signal used to test the stability of the DNA molecules on the 
bead surface.  
 



































































































































































Fig. 7.2. Chemical structures of 3’-O-N3-dCTP-N3-Bodipy-FL-510, 3’-O-N3-dCTP, 
3’-O-N3-dUTP-N3-R6G, 3’-O-N3-dTTP, 3’-O-N3-dATP-N3-ROX, 3’-O-N3-dATP, 
3’-O-N3-dGTP-N3-Cy5 and 3’-O-N3-dGTP  
7.3 Results and Discussion 
7.3.1 Covalent attachment of DNA onto the beads 
Magnetic beads were chosen based on their ease of separation and manipulation for 
future applications. To obtain a good sequencing signal, it is very important to maximize 
the amount of DNA template immobilized onto the beads and minimize the background 
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signal caused by nonspecific binding of dye-linked nucleotides. 3’-FAM labeled 
oligonucleotides were therefore used in the coupling test. After subtraction of signal 
produced by a negative control (absence of a chemical required for coupling), a higher 
fluorescent signal was taken to indicate more DNA attached to the beads. PEG 
(polyethylene glycol) grafting has been widely used to reduce non-specific binding and 
hence improve the signal-to-noise ratio.8-11 Introduction of PEG chains onto the beads 
can be achieved in two ways: either the bead can be coated with PEG first and then 
coupled to DNA, or be directly coupled to PEG-DNA conjugates. Different classes of 
beads were tested, via related chemistry methods, as shown briefly in Table 7.1. Results 
indicated that one-step 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) coupling 
on Chemagen PVA beads produced the highest fluorescence signal and hence had the 
largest amount of coupled DNA (part of the fluorescence imaging data was shown in Fig. 
7.3). The mechanism of the EDC coupling chemistry is illustrated in Fig. 7.4. EDC 
activates the carboxyl group on the bead surface to form an active intermediate, 
O-acylisourea, which then reacts with an amino group at the 3’ end of the DNA to form 
coupled products. As the intermediate is very easy to degrade, the addition of fresh EDC 
improved the coupling efficiency.   
7.3.2 Biological affinity attachment of DNA onto the beads 
The interaction between streptavidin and biotin is known to be one of the strongest 
non-covalent bonds, exhibiting a dissociation constant of about 1.3×10-15M. The 
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bio-specificity is similar to antibody-antigen or receptor-ligand recognition, but displays 
much higher affinity constants.12 Streptavidin coated beads were chosen to take 
advantage of this strong affinity and the simple coupling procedure. It was found that 
coupling biotinylated oligonucleotides with just a single 5’-biotin group resulted in 
dissociation from the beads during temperature cycling in PCR, whereas oligonucleotides 
labeled with dual biotin groups at their 5’end were stable to cycling.2 Hence dual-biotin 
labeled DNA was used to enhance the stability. Again, to reduce non-specific binding, 
dual-biotin-PEG-DNA was used.  
 
Fig. 7.3. Fluorescence imaging data on Chemagen PVA beads: a, one-step EDC coupling; c, 
two-step EDC coupling with sulfo-NHS; e, PEG coated first and then coupled to DNA; b, d, f are 



























Desired Product--PEG DNA Coupled beads
1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide    (EDC)
 
Fig. 7.4. Mechanism of EDC coupling 
7.3.3 Nucleotide incorporation studies on bead surfaces  
7.3.3.1 Pyrosequencing  
To ensure that self-priming templates on beads could incorporate nucleotides and 
that enough templates were immobilized on the beads, the coupled PVA beads were first 
tested by pyrosequencing. For test purposes, the set of nucleotides and enzymes was 
added only once, which meant that only the first few bases could be sequenced. As 
shown in Fig. 7.5, the first 7 bases were correctly identified, which demonstrated the 




Fig. 7. 5. Pyrosequencing data 
7.3.3.2 Incorporation of fluorescence labeled ddNTPs and natural dNTPs 
To further confirm the incorporation capability of immobilized DNA templates and 
the quality of the fluorescence signal, a set of commercially available fluorescently 
labeled terminators (Cyanine5-ddGTP, R6G-ddUTP, ROX-ddATP and 
Fluorescein-12-ddCTP) were used in another incorporation test. As shown in the scheme 
(Fig. 7.6A), natural nucleotides were first used to extend the self-priming primer to one 
base upstream of the interrogated base, then single base extension with fluorescently 
labeled terminators was carried out to identify the base. With the exception of the second 
base position, DNA templates on the PVA beads could incorporate modified bases 
accurately, resulting in a high fluorescent signal with low background, as shown in Fig. 
7.6 B. The inaccuracy of the second base was probably caused by mis-incorporation by 
polymerase: since only dUTP was added, without competition by other nucleotides to 
move to the second base position, natural dUTPs could fill the second position as well 




Fig. 7.6. (A) Scheme of incorporation test with ddNTP-dyes and dNTPs; (B) Sequence data 
achieved by using ddNTP-dyes/dNTPs 
           
7.3.3.3 Sequencing by synthesis on beads using CF-NRTs/NRTs 
As discussed above, the key step to implement the ePCR-bead-on-chip approach for 
sequencing by synthesis is to demonstrate the feasibility of performing SBS sequencing 
with CF-NRTs/NRTs on beads, as the amount of DNA templates and the surface 
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conditions would be different from that on a conventional DNA chip. SBS with 
CR-NRTs/NRTs was carried out on bead surfaces. It was demonstrated that this bead 
based sequencing strategy was able to identify continuous sequence with high accuracy, 
both on PVA carboxylic beads (Fig. 7.7) and streptavidin beads (Fig. 7.8). 
 
 
Fig. 7.7. (A) Scheme of SBS using 3’-O-N3-dNTPs and 3’-O- N3-dNTP-N3-fluorophores; (B) 




Fig. 7.8. (A) Scheme of SBS on Streptavidin beads with an alternative strategy; (B) 4-color SBS 
data on Streptavidin beads. 
7.3.4 PCR on beads in solution and beads in emulsion 
As an initial exploration of ePCR, PCR on beads without emulsion generation was 
first tested. Taking PVA carboxylic beads as the example, the forward primer attached 
beads were mixed into PCR solutions consisting of DNA template, reverse primer, 
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nucleotides and enzyme to carry out direct PCR on beads. The PCR result was verified 
by performing direct Sanger sequencing on the beads. If there are templates growing on 
the beads, Sanger sequencing should be able to retrieve this sequence information. As 
shown in Fig. 7.9, the Sanger sequencing was able to obtain information from DNA 
molecules on beads; the negative result on the supernatant after the last wash essentially 
excluded the possibility of non-specific binding of solution generated DNA template 
(data not shown). This demonstrated the possibility of performing ePCR on these 
particular beads.  
 
Fig. 7.9. Sanger sequencing result for PCR products on beads. The associated bar graphs indicate 
the quality of the sequence: good sequence is indicated in blue.  
The conditions for generating water-in-oil droplets (emulsions) were also tested, 
including the ratio of water and oil phase, the concentration of bead suspension, and the 
mixing speed. As shown in Fig. 7.10, for both 5 μm and 8 μm beads, we have 
successfully generated stable single bead resident droplets. 




Fig. 7.10. Emulsion formation containing 5 μm beads (A) and 8 μm beads (B). 
7.4 Materials and Methods 
General information. All the chemicals were obtained from Sigma-Aldrich unless 
specified. PVA Carboxylic beads (M-PVA C22) were purchase from Chemagen 
Biopolymer-Technologie AG (Germany), and Streptavidin Coated COMPELTM Magnetic 
beads (8.03 μm, 5 μm) were from Bangs Laboratories, Inc. (Fishers, IN). Fluorescence 
detection was carried out either under a four-color ScanArray Express Scanner 
(PerkinElmer Life Sciences, Boston, MA) or Canon Fluorescence Microscope.  
7.4.1 DNA attachment to beads 
Before finalizing the chemical coupling protocol, different coupling methods were 
tested, the details of which are shown in Table 7.1. 3’ FAM labeled oligonucleotides were 
used for coupling, and the products were checked under the fluorescence microscope. It 
turned out that one-step EDC coupling on PVA beads gave the best results. Chemagen 
PVA beads consist of a matrix of polyvinyl alcohol, highly carboxyl modified, with a size 
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distribution from 1.0-3.0 μm. The protocol was described as follows. 40 μl of PVA bead 
suspension (50 mg/ml) was washed twice with 0.01N NaOH by mixing using a vortex at 
room temperature. The beads were then washed three times with deionized water and 
2-(N-morpholino)ethane sulfonic acid (MES) buffer (0.1 M, pH 4.5) in the same manner 
and the supernatant was discarded. 20 μl of EDC/MES (~1 M) solution containing 750 
μM 5’NH2-PEG-DNA (Self-priming template ready for sequencing: 5’-NH2-PEG-TTC 
AGGTCGACTTAAGGCGCTTGCGCCTTAAG-3’) was first added to the beads. Then 
the solution was mixed using a rotator for 2.5 hours at room temperature, with addition 
of 10 μl EDC/MES (1M) every 30 min. The beads were washed three times with SPSC 
buffer (sodium phosphate, sodium chloride buffer with 0.2% Tween) three times with 
deionized water, and finally suspended in 200 μl of water and stored at 4oC. Therefore 
the concentration of the coupled bead solution was ~10 mg/ml. In the case of PCR on 
beads, the M13 forward primer (5’-CACTCGCATGGG-TAAAACGACGGCCAG-3’) 
was attached to the beads.  
For Streptavidin bead coupling, 20 μl of streptavidin coated magnetic beads were 
washed with Binding/Wash Buffer (20 mM Tris pH 7.5, 1 M NaCl, 1 mM EDTA, 
0.0005% Triton-X100) three times and suspended in 20 μl Binding/Wash Buffer, after 
which 4 μl of dual-biotin-PEG-DNA (50 μM in H2O) (5’-dual-biotin-PEG-TTC AGG 
TCG ACT TAA GGC GCT TGC GCC TTA AG-3’) was added. The solution was mixed 
using a rotator for 30min at room temperature. After binding, the beads were washed 
twice with Binding/Wash Buffer, three times with SPSC, three times with H2O, and 
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finally suspended in 20 μl 1X ThermoPol II (Mg-free) reaction buffer   (10 mM KCl, 
10 mM (NH4)2SO4, 20 mM Tris-HCl, 0.1% Triton X-100, pH 8.8, Biolabs Inc.) and 
stored at 4oC. 






























































































weak weak no signal no signal 
Note: When NH2-PEG-COOH-t-butyl was used, a deprotection step with TFA was applied to remove 
the t-butyl group and generate the carboxyl group before the next coupling step. EDC: 
1-Ethyl-3-(3-dimethylaminopropyl)-carbodiimide; sulfo-NHS: N-Hydroxy sulfo-succinimide; PyBop: 
benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluoro phosphate; DIPEA: N, N’ 




7.4.2 Nucleotide incorporation test on beads 
To confirm the incorporation capability of immobilized DNA templates, one step 
pyrosequencing was performed. 5 μl of beads were suspended in the pyrosequencing 
plate with reaction buffer, and detected in a 96PSQ Pyrosequencer (Biotage, Uppsala, 
Sweden) under standard operating conditions. For test purposes, the set of reagents was 
added only once, which meant that only the first few bases could be sequenced.  
To further confirm the incorporation capability of immobilized DNA templates and 
the quality of the fluorescence signal, a set of commercially available dye labeled 
terminators, Cyanine5-ddGTP, R6G-ddUTP, Fluorescein-12-ddCTP and ROX-ddATP 
(Perkin Elmer, Boston, MA), were used in another test. As shown in Figure 7.6, this test 
was designed to detect the first four bases. 4 μl of coupled PVA beads were washed three 
times with 1X Thermo Sequenase buffer and divided into four parts, each aliquot of 
which was used for the detection of one base. For the first base, the beads were added to 
10 μl “detection solution” consisting of Cyanine 5-ddGTP     (1 μM), R6G-ddUTP (1 
μM), Fluorescein-12-ddCTP (1 μM), ROX-ddATP (1 μM), 1.5 unit of Thermo 
Sequenase DNATM Polymerase (GE Healthcare, UK) and 1X Thermo Sequenase Buffer, 
and incubated for 15 min at 65oC. For the detection of the second base, the beads were 
added to 10 μl “extension solution” consisting of dUTP (2 μM), 1.5 unit of Thermo 
Sequenase DNA Polymerase and 1X Thermo Sequenase Buffer, and incubated for 5 min 
at 65oC to fill the first base position, and then 10 μl “detection solution” was added, 
reacting for 15 min at 65oC. The third and fourth bases were detected in a similar manner: 
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“extension solution” first to fill in previous bases and then the “detection solution”. The 
scheme of this method is shown in Fig.7.6 A. Before scanning, the beads were washed 
with SPSC and water several times and then suspended in water, 0.2 μl of which was 
spotted on a glass slide. After the spot dried, it was analyzed in a four-color scanner. 
7.4.3 Sequencing by synthesis with cleavable fluorescent nucleotide reversible 
terminators on beads 
After washing PVA beads with 1X ThermoPolII buffer three times, 12.5 μl of a 
solution consisting of 8 pmol 3’-O-N3-dATP-N3-ROX, 1 pmol 3’-O-N3-dGTP- N3-Cy5, 2 
pmol 3’-O-N3-dUTP-N3-R6G, 2 pmol 3’-O-N3-dCTP-N3-bodipy-FL-510,  8 pmol 
3’-O-N3-dATP, 16 pmol 3’-O-N3-dGTP, 16 pmol 3’-O-N3-dCTP, 16 pmol 3’-O-N3-dTTP, 
1 unit TherminatorTM II DNA polymerase (also known as 9oN mutant Polymerase 
enzyme, New England Biolabs, Ipswich, MA), 1X ThermoPolII buffer, and 2 mM of 
MnCl2 was added to 2 μl of coupled PVA beads (10 mg/ml), then incubated at 65oC for 
30 min, mixed using a rotator. After incorporation, the beads were washed three times 
with SPSC buffer and once with water by heating at 65oC for 5 min each time. Then the 
beads were re-suspended in 20 μl water, 0.2 μl of which was spotted on the slide. After 
the spot dried, it was scanned. To extend any remaining priming strand, a capping step 
was performed with 12.5 μl solution containing 3’-O-N3-dNTPs (30 pmol 3’-O-N3-dATP, 
15 pmol 3’-O-N3-dGTP, 40 pmol 3’-O-N3-dCTP and 20 pmol 3’-O-N3-dTTP), 1 unit of 
9oN mutant Polymerase enzyme, 1X ThermoPolII buffer, and 2 mM of MnCl2, 65oC for 
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25 min, twice. After the capping step, the beads were incubated in TCEP cleavage 
solution (100 mM, pH 9) for 15 min at 65oC twice to cleave both the fluorophore and 
3’-O-azido groups. Upon confirmation of cleavage by scanning, the cycles of 
incorporation, detection, capping, cleavage, and detection were repeated to sequence the 
subsequent bases.  
The extension strategy was changed for performing 4-color SBS on streptavidin 
beads. Instead of using a mixture of 3’-O-N3-dNTP-N3-fluorophores and 3’-O-N3-dNTPs, 
only 3’-O-N3-dNTP-N3-fluorophores were used for base identification. Both these 
dye-labeled nucleotides’ concentration and the incorporation time were reduced due to 
the reduced competition. 10 μl of a solution consisting of  3 pmol 
3’-O-N3-dATP-N3-ROX, 0.3 pmol 3’-O-N3-dGTP-N3-Cy5, 1 pmol 
3’-O-N3-dUTP-N3-R6G, 0.5 pmol 3’-O- N3-dCTP-N3-bodipy-FL-510, 1 unit of 9oN 
mutant Polymerase enzyme, 1X ThermoPolII buffer, and 2 mM MnCl2 was added to 5 μl 
of coupled beads (10mg/ml), then incubated at 65oC for 15 min, mixed using a rotator. 
After incorporation, the beads were washed twice with SPSC buffer and once with water 
by incubating in a 65oC water bath for 5 min each time. Then the beads were 
re-suspended in 100 μl water, 0.2 μl of which was spotted on the slide. After the spot 
dried, the slide was checked under the microscope to guarantee the beads were dispersed 
well, and then scanned. To synchronize any unincorporated templates, an extension 
solution consisting of 37.5 pmol of each 3’-O-N3-dNTP, 1 unit of 9oN mutant Polymerase 
enzyme, 1X ThermoPolII buffer, and 2 mM of MnCl2 ,was added to the beads and 
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incubated at 65oC for 25 min, twice. After capping, the beads were incubated in TCEP 
cleavage solution for 15min at 65oC twice to cleave both the fluorophores and 3’-O-azido 
groups. Upon confirmation of cleavage by scanning, the cycles of incorporation, 
detection, capping, cleavage, and detection were repeated to sequence the ensuing bases, 
as shown in Fig.7.8 A. 
7.4.4 PCR on beads and emulsion-beads in droplet 
The bead PCR reaction was carried out in 50 μl of a PCR mixture consisting of 20 
ng pBluescript II SK+, 10 nmol dNTPs, 15 nmol M13 reverse primer 
(5’-CAGGAAACAGCTATGAC-3’), 3 μl forward primer coupled bead suspension,  1 
U JumpStartTM REDTaq® DNA Polymerase and 1X corresponding reaction buffer. 
Amplification was performed under the following conditions: incubation at 94oC for 2 
min, followed by 30 cycles of 94oC for 20 s, 55oC for 30 s, 72oC for 30 s and final 
extension at 72oC for 7 min, with occasionally stops at the annealing step to vortex the 
solution, preventing beads from settling down. After PCR, amplified beads were washed 
extensively to get rid of any non-specific binding of amplified template in solution, and 
the supernatant of the last wash was kept for Sanger sequencing analysis. The Sanger 
sequencing reaction mixture including 0.4 μl of BigDye Terminator 3.1 cycle sequencing 
mix (Applied Biosystems), 1X buffer 3.1, 4 pmol forward primer and the bead 
suspension (or the supernatant from the last wash) was carried out as follows: 25 cycles 
of 94oC for 20 s, 55oC for 45 s, 68oC for 90 s and final extension at 68oC for 3 min.   
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An emulsion was created by mixing 500 μl of oil phase with 240 μl H2O at 25 
rpm/sec for 5 min, followed by gradual addition of 160 μl mix with bead-containing 
aqueous phase at a speed of 18 rps for 5 min. The oil phase was composed of 490 μl of 
mineral oil, 450 μl of 10% Span-80, 40 μl of 10% Tween-80 and 20 μl of 10% 
TritonX-100. The aqueous phase consisted of 58 μl of 1X Taq polymerase buffer,   12 
μl of 25 % glycerol and 5.0 μl of beads.  
7.5 Conclusion 
Aiming at massively parallel sequencing by synthesis using cleavable fluorescent 
nucleotide reversible terminators, we have explored the potential of employing a 
sequencing-on-beads platform to increase the throughput, to overcome current short 
sequencing read-length, and to achieve maximum coverage across the genome. Various 
bio-conjugation chemistries with different types of microbeads have been tested to obtain 
better DNA attachment and less non-specific binding. After incorporation tests on beads 
using conventional pyrosequencing and fluorescently labeled terminators, SBS with 
CF-NRTs (3’-O-N3-dNTP-N3-fluorophores) and NRTs (3’-O-N3-dNTPs) were applied to 
on-bead sequencing and resulted in several contiguous correct base calls. Although the 
approach still needs optimization, it appears very promising for realizing ultra-massively 
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Part III Detection of Nucleic Acids with Molecular Probes 
The improving DNA sequencing and SNP genotyping technologies provide essential 
information on DNA, as well as its encoded RNA and proteins, driving the further 
exploration of biological functions of these molecules. In this chapter, aimed at tracking 
mRNA’s (e.g., sensorin mRNA) and their involvement in long term memory storage, we 
describe our quantum-dot based binary probes for in vitro detection of a DNA target 
similar to a portion of the sensorin mRNA molecule, as a step in their eventual use to 




Chapter 8 Quantum Dot based FRET Binary Probes for 
Detection of Nucleic Acids 
8.1 Introduction 
The study of the flow of biomolecules from their origins in the cell body to their 
targets within highly localized cell compartments can suggest their possible roles in 
physiological and pathological states. Specifically, selective detection and tracking of 
nucleic acids in vivo is of great significance for studying particular biological functions 
and mechanisms. For example, monitoring mRNA transport in living neurons would 
provide important information about the dynamics of gene expression and regional 
changes in post-transcriptional regulation. Over the past years, our group has been 
interested in studying the role of sensorin mRNA in synaptic plasticity for long term 
memory studies in a model organism, the sea slug Aplysia californica, due to its simple 
nervous system, the relatively large size of the neurons, and the easy identification of 
individual neuronal types.1 Long-term memory requires the transcription of specific 
genes in neurons, and the localization of the protein encoded by these transcripts to 
regions in the communicative neuronal connections, the synapses.2 Sensorin is a sensory 
neuron-specific peptide neurotransmitter, whose mRNA (sensorin mRNA) localizes to 
distal neuronal processes and concentrates at synapses in sensory neurons (SNs) paired 
with motor neurons (MNs). The translation of sensorin mRNA is crucial to the synapse 




However, state-of-the-art molecular probes are required to study the specific mRNA 
both in vitro and in vivo with highly selectivity and sensitivity. A variety of molecular 
beacons (MBs) and binary probes (BPs) have been explored as tools to detect 
oligonucleotide sequences or RNA in different environments.4 Nevertheless, non-specific 
opening of MBs often occurs in cells, causing false positive signals. Binary probes with 
multiple dyes displaying Förster resonance energy transfer (FRET) have advantages in 
terms of high specificity and the ease of detection at the injection site, which is very 
important to gain accurate signal reporting.  
Typically, FRET-based BP systems are composed of two single-stranded DNAs 
(ssDNAs) which are complementary to adjacent regions of a common target sequence 
where a donor and acceptor are attached at opposite ends. In the absence of target, the 
fluorescence from the donor is mainly observed. When the pair of BPs selectively 
hybridizes to their target, the two oligonucleotide strands are drawn into close proximity 
and generate a FRET-based signal, the fluorescence of the acceptor. This requires that for 
ideal binary probes, the emission band of the donor should overlap as much as possible 
with the excitation band of the acceptor to maximize FRET efficiency, but the excitation 
band of the donor should be far from that of the acceptor to reduce direct excitation of 
the latter leading to a background signal. This poses challenges to current organic 
fluorophore systems, since no available dye pairs fulfill this criterion perfectly, and hence 
most of the previous BP systems were constructed at the sacrifice of energy transfer 
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efficiency. To significantly enhance its sensitivity and specificity, a binary probe system 
with the choice of a novel fluorescence donor is required.   
Quantum dots (QDs), consisting of CdSe, CdS or CdTe, and ZnS, are a collection of 
semiconducting nanocrystals in the 2-8 nm size range (about twice the size of fluorescent 
proteins) that have large absorption cross sections, size-tunable emission bandwidths, 
high quantum yields, long emission lifetimes and excellent photostability,5 and have 
attracted great interest for medical diagnostics, drug delivery, DNA-based nanosensors 
and solar energy conversion.6-8 Specifically, CdSe/ZnS core shell QDs are advantageous 
over traditional organic fluorophores thanks to their large quantum yields and absorption 
coefficients, photostability, large Stoke’s shifts, relatively long fluorescence lifetimes, 
and narrow and symmetric emissions from the ultraviolet to the infrared allowing 
multicolor multiplex assays. Their broad absorption and narrow emission spectra make 
them excellent FRET donors.9 The QD fluorescence characteristics also allow for the 
selection of a wide range of excitation wavelengths that reduce the direct excitation of 
the acceptor; this also enables the use of a narrow bandpass filter for the effective 
separation of donor and acceptor fluorescence. Therefore, the use of the QD as the donor 
is a promising option for fundamental revision of the current binary probe system.  
In our study, using a sensorin mRNA-like DNA sequence as the target, we describe 
the design and synthesis of a new QD-based BP in which the donor, QD 605, and the 
acceptor, Cy5, are attached to two different oligonucleotide strands with a range of 6, 9, 
and 16 base pair distances (around 2.0 nm, 3.0 nm, and 5.4 nm, respectively) between the 
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fluorophores when they are bound to their target. A simple and convenient method to 
synthesize a compact carboxylic QD-DNA conjugate through carbodiimide coupling is 
described, as an improvement to streptavidin QD-DNA conjugates in terms of FRET 
efficiency. The distance dependence of FRET efficiency was studied to optimize this BP 
system, with the evaluation of FRET using the S/B ratio, in which S/B = (Em667 with 
target/Em667 without target)/(Em605 with target/Em605 without target). 
8.2 Experimental Rationale and Overview 
It is believed that the introduction of quantum dots (QD) will bring a paradigm shift 
to the development of FRET-based binary probe systems due to the many advantages of 
QDs. In our binary probe system, the 605 nm carboxyl QD was chosen as the donor and 
Cy5 as the acceptor, since there is good spectral overlap between the emission of this QD 
at 605 nm and the absorption by Cy5, yet little overlap exists between the excitation 
wavelengths of the QD and Cy5, which avoids direct absorption by Cy5, as shown in Fig. 
8.1. This exactly met the criteria described above for an ideal binary probe.   
 
Fig. 8.1. The emission and excitation spectra of QD 605 and Cy5. 
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The existing methods for the construction of QD-DNA conjugates include 
streptavidin-biotin interaction,10 glycosidic bonding,11 electrostatic interaction,12 
metal-thiol bonding,13 and carbodiimide reaction.14, 15 Due to the molecules/spacers/ 
linkers that coat the QD surface, the size of the QDs is larger than the Förster distance, 
4-7 nm, so the energy transfer efficiency between a core of QD and a single dye is 
sufficiently low.16 The smaller moiety coated QD, carboxylic QD, was chosen to form a 
compact carboxylic QD-DNA conjugate, in which carboxylic groups on the QD surface 
are directly attached to the 3’-end of an oligonucleotide strand through carbodiimide 
coupling.17 This enabled us to reduce the size of the QD probe and allow a separation 
distance between the QD and Cy5 of 4-7 nm. 
Using sensorin mRNA similar DNA sequence as the target, as shown in Fig. 8.2, our 
binary probe system was designed in such a way that QD-based binary probes could 
hybridize to the target DNA with different separation distances between the QD and Cy5, 
by varying the base number between the two hybridization sites of the target DNA: 6, 9 
and 16 bases, respectively. The most favorable separation distance for FRET between the 
QD donor and Cy5 acceptor was studied by measuring the FRET efficiency as a function 





Fig. 8.2. Scheme of QD-based FRET binary oligonucleotide probes for DNA detection. 
8.3 Results and Discussion 
8.3.1 The synthesis of QD-DNA conjugates 
3’-end amino modified oligonucleotides were attached to the carboxylic groups on 
the QD surface to form a carboxyl-QD-DNA conjugate through the carbodiimide 
coupling chemistry. The product of the carboxylic QD-DNA reaction was assessed using 
a gel mobility shift assay with the Agilent Bioanalyzer. As shown in Fig. 8.3, a new band 
appeared between the QD and amino-DNA band, which exhibited decreased mobility 
compared to free DNA, and increased mobility compared to free QD. It was assumed that 




Fig. 8.3. The distribution of carboxyl-QD (1), DNA (2) and carboxyl-QD-DNA conjugates (3) 
after gel electrophoresis.  
 
 
Fig. 8.4. Fluorescence intensity of conjugation products generated with different ratios of 
carboxylic QD to DNA. 
It was noticed that the ratio of acceptor to donor is a very important factor for FRET 
efficiency. The ratio of acceptor to donor was determined by the ratio of amino-modified 
DNA to carboxylic QD. Hence, different ratios of amino-DNA to carboxylic QDs, 1:1, 
5:1, 10:1, 20:1, 30:1, 40:1 and 50:1, respectively, were tested for the coupling reaction. It 
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was found that the fluorescence intensity was highest at the ratio of 40:1, as shown in Fig. 
8.4. Therefore, the ratio of 40:1 was used for coupling synthesis in this work. To compare 
the carboxyl QD-DNA conjugates with streptavidin QD, the ratio of biotin DNA to 
streptavidin QD was also set to 40:1 for their interaction. 
8.3.2 Hybridization kinetics studies 
The feasibility of using this set of QD based binary probes was first assessed by 
measuring their hybridization kinetics. Taking target 3 (T3) as the example, steady-state 
fluorescence analysis of the hybridization kinetic reaction was carried out at an excitation 
wavelength of 460 nm in annealing buffer. Steady-state fluorescence spectra were 
recorded at different reaction intervals. As shown in Fig. 8.5, when the probes are 
randomly distributed in solution, emission primarily from the QD is observed. With the 
introduction of the target DNA, the fluorescence emission intensity of the QD-DNA 
conjugate gradually decreased over time, while the fluorescence intensity of Cy5 
increased. The hybridization took around 5 hours to reach equilibrium. The long 
hybridization time may be because the high density of DNA conjugated on the QD 
surface hindered the hybridization process.18, 19  
This study demonstrated that the binary probes (BPs) can be prepared using 
carboxylic QD as a donor and Cy5 as an acceptor for the detection of DNA. Unlike 
Wang’s method,20 in which spacers were used to coat the QD surface to form QD-DNA 
conjugate nanosensors for DNA detection, our modification for construction of QD-DNA 
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conjugates in which the QD and the Cy5 are on the inner portion of the probes rather than 
the outer portion reduces the distance between the dyes and the QD surface, and hence 
increases the FRET efficiency. This assumption was further verified by the relative 
effectiveness between the two binding methods used for constructing QD-based BPs, as 
discussed in the following section.  
 
Fig. 8.5. The time-dependent spectral evolution of the FRET between carboxylic QD-DNA and 




8.3.3 Comparison of FRET efficiency between carboxyl-QD-DNA conjugate and 
streptavidin-QD-DNA conjugate based binary probes 
In this study, two different methods were used to attach DNA to QDs: (1) covalent 
linkage of amino-labeled DNA to the carboxylic QD surface by carbodiimide coupling 
chemistry and (2) linkage of biotinylated DNA to streptavidin-modified QDs via 
streptavidin-biotin interaction. The two linkage methods have not been quantitatively 
compared in BPs, yet we observed that the linkage method has a measurable effect on the 
properties of BPs. As shown in Fig. 8.6, when the probes are  
 
Fig. 8.6. Comparison of FRET efficiency between Carboxylic QD based BPs and Streptavidin QD 
based BPs: the fluorescence spectra before and after hybridization with target DNA 3. (A) 
Carboxylic QD-Cy5 system; (B) Streptavidin QD-Cy5 system. 
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randomly distributed in solution, emission primarily from the QD is observed. In the 
presence of target (T3), covalent QD-based BP exhibited a more significant increase in 
Cy5 emission at 667 nm and more significant decease in the QD emission at 605 nm than 
that of the streptavidin QD, at equivalent concentrations. The FRET efficiency between 
the QD donor and Cy5 acceptor was evaluated by the S/B ratio. The S/B ratio depends on 
the extent of the increase in the Cy5 signal and the decrease in the QD signal. Based on 
the steady-state fluorescence spectra shown in Fig. 8.6 A , the covalent QD-based BP 
shows a S/B ratio of 7.5 while the streptavidin QD has a S/B ratio of only 2.1 (Fig. 8.6 B). 
The different S/B ratios can be attributed to the different linkage strategies which are 
related to the different distances between the QD core and Cy5. For the streptavidin QD, 
large protein spacers on the surface of the QD greatly increase the distance between the 
QD core and Cy5, a parameter that is critical to FRET based quenching. 
8.3.4 Distance dependent FRET studies with carboxyl-QD binary probes 
In addition to studying the different linkage methods, we also investigated the effect 
of separation distance for FRET between the QD donor and Cy5 acceptor by varying the 
DNA base distance between the donor and acceptor (Fig. 8.2). The steady-state 
fluorescence spectra for all three DNA targets, T1, T2, and T3, all of which hybridize 
with the carboxylic QD-DNA and Cy5-DNA, are similar (Fig. 8.7). The S/B ratio 
increased as the number of bases between the QD donor and Cy5 acceptor increased, 
with T1 having a S/B ratio of 9.0 and the longest distance of 5.4 nm (16 bases). Since 
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there is a high density of DNA on the QD surface, the longest base distance might be 
favorable for QD hybridization with Cy5 due to less of a hindrance effect. 
Time-resolved lifetime fluorescence spectra (Fig. 8.8) of the covalent QD-DNA and 
Cy5-DNA with different targets were consistent with the steady state fluorescence results 
with excitation of QD at 460 nm. The lifetime of free QD in buffer shows biexponential 
decays of 3.15 ± 0.3 ns and 10.28 ± 1.0 ns.  Upon the addition of Cy5-DNA, the lifetime 
of the QD remained nearly the same with a lifetime of 4.40 ± 0.4 ns and 13.03 ±1.0 ns.  
In the presence of the target DNAs, T1, T2, and T3, the lifetime of the QD decreased as 
shown in Table 8.1, was and were fitted to a biexponential decay function. For the three 
sets (see Table 8.1), the lifetimes are 8.39 ± 0.8 ns, 10.17 ± 1.0 ns, and 12.16 ± 1.2 ns. 
The lifetime decreased as the separation distance between the QD and Cy5 decreased. It 
was assumed that with longer distance between QD and Cy5, faster hybridization would 





Fig. 8.7. Steady-state fluorescence spectra of carboxyl-QD and Cy5-DNA hybridization with 
different targets and without targets. Inset is an enlargement of just the target-containing 
hybridization reactions with the abscissa contracted for clarity.  
 
Fig. 8.8. Time-resolved lifetime fluorescence spectra of carboxyl-QD-DNA and Cy5-DNA with 




Table 8.1 Lifetime data for QD-DNA, Cy5-DNA hybridization with different targets 
Entry 
τ exc 460 nm /em  
605 nm, ns 
(abundance,%) 
τ exc 460 nm / em  
667 nm, ns 
(abundance,%) 
τ exc 659 nm / em  































8.4 Materials and Methods 
General information. Qdot® ITKTM Carboxyl Quantum Dots (605 nm) and Qdot® 
605 ITK TM Streptavidin were from Invitrogen by Life Technologies (San Diego, CA).  
1-ethyl-3-(3-dimethyl-aminopropyl) carbodiimide hydrodrochloride (EDC) was obtained 
from Sigma-Aldrich. All the chemicals were purchased from Sigma-Aldrich unless 
specified. The oligonucleotides (Cy5-DNA, amino-DNA and target DNA), whose 
sequences were based on Aplysia sensorin mRNA, were synthesized on a DNA 
Synthesizer (Expedite 8909, Applied Biosystems by Life Technologies) using standard 
solid-phase phosphoramidite chemistry (Glen Research) or obtained from Integrated 
DNA Technologies (Coralville, IA). The sequences of the oligonucleotide probes and 




Table 8.2 Sequences of the probes and targets 
DNA code Sequence ( 5’-3’) 
QD-DNA GUUGAUCACGGCUCAGGCGAAGGGA-QD 
Cy5-DNA Cy5-CAA AAG ACUUGGACCUGUCU 
Target DNA 1(T2) 
(~5.4nm) * 
AGACAGGUCCAAGUCUUUUGAGUCUUCUGGACGGCUUCCCUUCGCCUGAGCCGUGAUCAAC
Target DNA 2 (T4) 
(~3.0 nm) * 
AGACAGGUCCAAGUCUUUUGAGGACGGCUUCCCUUCGCCUGAGCCGUGAUCAAC 
Target DNA 3 (T6) 
(~2.0 nm) * 
AGACAGGUCCAAGUCUUUUGAGGGCUUCCCUUCGCCUGAGCCGUGAUCAAC 
Note: The underscored sequences indicate the positions to which the probes hybridize. * The 
approximate distance between QD and Cy5 after hybridization.  
8.4.1 Synthesis of QD-DNA conjugates  
The carboxylic groups on the QD surface were activated with EDC and allowed to 
react with 3’ amino labeled DNA. 6.4 pmol of QD was mixed with 2.08 nmol of EDC 
and 0.256 nmol of 3’ amino-labeled DNA in 85 µL of H2O, with EDC added every 30 
min to a total amount of 2.08 nmol. The mixture was allowed to react for 3 h at room 
temperature. Excess DNA and EDC were immediately removed from the carboxylic 
QD-DNA conjugates by spin filtration using Amicon Ultra 30,000 MWCO spin filters 
(Millipore, Billerica, MA). To maximize the recovery efficiency, the reaction mixture was 
first diluted with dH2O to a volume of 1400 μl and evenly distributed into 4 spin filters 
for purification. The mixture was spun at 14,000 rpm for 1 min and the retentate was 
suspended in 400 µL water after the flow-through was discarded. The washing was 
repeated at least 3 times before the final products were collected by spinning down the 
filters. The purified QD-DNA conjugates were suspended in water and assessed with an 
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Agilent 2100 Bioanalyzer using the DNA 1000 Kit.  
For the streptavidin QD-DNA conjugate, biotinylated DNA was attached to 
streptavidin QD by the streptavidin-biotin interaction. 6.4 pmol of streptavidin QD was 
mixed with 0.256 nmol of biotinylated DNA and 0.4 mg BSA in 400 µL of phosphate 
buffered saline (PBS, pH 7.4). The mixture was incubated at room temperature for 2h, 
purified and analyzed as described above for the carboxylic QD-DNA conjugate.  
8.4.2 Hybridization of QD-DNA and Cy5-DNA with different targets 
The hybridization of target DNA with the carboxylic QD-DNA conjugates and 
Cy5-DNA was carried out in 1X annealing buffer (10 mM Tris-HCl, 100 mM NaCl, 
1mM EDTA, pH 7.4). For each hybridization event, 2.4 pmol of QD as the starting 
material for QD-DNA conjugate preparation was used and 0.28 nmol of Cy5-DNA was 
added. A fluorescence spectrum was obtained with a Fluorolog-3 spectrometer before 
adding target to generate the background emission spectrum. 40 pmol of target DNA was 
used for hybridization. The total volume of the hybridization reaction solution was kept 
constant at 300 μL. Therefore, 40 pmol of three different targets with different base 
distances were studied under identical conditions. The hybridization reaction was carried 
out at room temperature for ~5 h before the final fluorescence spectra were obtained.  
For kinetic studies, the required carboxylic QD-DNA conjugate and Cy5-DNA 
solution in annealing buffer were prepared and transferred to a fluorescence cuvette, and 
a fluorescence spectrum was obtained. 0.04 nmol target DNA was then added and quickly 
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mixed with a micropipette. Steady-state fluorescence spectra were then recorded at 
different reaction intervals. 
To quantitatively compare the energy transfer efficiency of the various QD-based 
BPs, the fluorescence spectra of the hybridization between the streptavidin QD-DNA 
conjugate, Cy5-DNA and target (T3) were also measured by steady-state fluorescence. 
The concentration of streptavidin QD-DNA conjugate was fixed at 2.4 pmol, Cy5-DNA 
at 0.28 nmol and targets at 0.04 nmol, respectively. 
8.4.3 Steady-state fluorescence and time-resolved fluorescence measurement 
Steady-state fluorescence was recorded at room temperature on a Fluorolog-3 
spectrometer FL3-22 (J. Y. Horiba, Edison, NJ) using quartz cuvettes with a 4 mm path 
length.  Time-resolved fluorescence measurements were performed on an OB920 
single-photon counting spectrometer (Edinburgh Analytical Instruments) with a 
picoquant 460 nm pulsed LED or 659 nm diode laser as excitation source. Exponential 
fittings were obtained by a program included in the instrument (F900). 
8.5 Conclusion 
We have successfully constructed a carboxylic QD-based binary probe for detection 
of a DNA sequence using FRET. We have also demonstrated that QD carboxylic acid 
linkage to DNA reduced the overall particle size compared to the biotin-streptavidin 
linkage. We demonstrated the distance dependence in FRET, with the T1 distance of ~5.4 
nm showing the most efficient FRET between a QD donor and Cy5 acceptor. Further 
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studies are in progress to evaluate the effectiveness of this QD-based probe inside a cell 
extract and in living cells. 
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Chapter 9 Summary and Future Outlook 
The ultimate goal of my thesis research was to contribute to the development and 
improvement of genomic technologies encompassing DNA sequencing and single 
nucleotide polymorphism (SNP) genotyping via different molecular approaches, and to 
the development of novel molecular probes for further understanding of the genetic flow 
and biological functions of nucleic acid molecules as a whole. The following specific 
goals, which were set to test and implement key components of DNA sequencing, SNP 
genotyping as well as the molecular probe development, were achieved: (1) Design, 
synthesis and analysis of a complete set of novel cleavable biotinylated 
dideoxynucleotides for mass spectrometry based DNA sequencing and SNP genotyping 
with high accuracy and sensitivity, and the initial exploration of a microfluidic 
lab-on-chip device with the potential for high throughput, miniaturization and automation; 
(2) Design and integration of a novel primer walking strategy for extending the 
read-length of sequencing by synthesis with cleavable fluorescent nucleotide reversible 
terminators (CF-NRTs), and the exploration of a beads-on-chip approach for increasing 
the throughput as well as the coverage for SBS; (3) Design and construction of quantum 
dot based binary probes for detection of nucleic acids. 
9.1 Mass spectrometric DNA sequencing and SNP genotyping 
with cleavable biotinylated dideoxynucleotides1, 2 
Aiming to improve the current solid phase capturable mass spectrometric DNA 
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sequencing and SNP genotyping method, a complete set (A, C, G, and U) of mass tagged, 
cleavable biotinylated dideoxynucleotides (ddNTP-N3-biotins) was synthesized, and 
successfully used for both DNA sequencing and SNP genotyping with significantly 
improved performance. A sequencing read-length of over 30 bases was achieved for both 
synthetic DNA template (37 bases) and biological samples (32 bases). In SNP genotyping, 
we have been able to detect as low as 2.5% heteroplasmy in mitochondrial DNA samples, 
with interrogation of human mitochondrial genome position 8344 which is associated 
with mitochondrial disease (myoclonic epilepsy with ragged red fibers, MERRF); we 
have been able to quantify the heteroplasmy level by generating a calibration curve; we 
have also determined several mitochondrial MERRF mutations in a multiplex approach. 
We further designed and constructed a SNP genotyping microfluidic lab-on-a-chip device, 
which is also applicable for mass spectrometric sequencing, and confirmed the feasibility 
of this microdevice by performing individual functional steps on-chip. We have 
demonstrated 100% on-chip single base incorporation, sufficient capture and release of 
the biotin terminated single base extension products, and high sample recovery from the 
C18 reversed-phase microchannel with as little as 0.5 pmol DNA molecules.  
9.2 Strategies to improve sequencing by synthesis with 
cleavable fluorescent nucleotide reversible terminators3 
 To overcome the current short sequencing read-length, we have developed a novel 
primer walking strategy to increase read-length for DNA sequencing by synthesis with 
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CF-NRTs. The primer walking method was conducted using three natural nucleotides 
(dNTPs) and one nucleotide reversible terminator (NRT), so that the primer would 
extend with natural nucleotides until the NRT is incorporated, and would resume after the 
cleavage reaction to regenerate the 3’-OH. Repeated cycles of such extension, pause, and 
cleavage enabled initiation of the next round of SBS sequencing anew at a base 
downstream to the first round sequenced region, allowing one to achieve a combined 
read-length from two rounds of SBS. We have successfully demonstrated the integration 
of this primer walking strategy into the sequencing by synthesis platform, and were able 
to obtain a total read-length of 53 bases after performing one round of sequencing, four 
walking cycles and then a second round of SBS.  
The alternative approach we explored is to develop the sequencing bead-on-chip 
method to increase the throughput and hence the overall coverage of SBS with CF-NRTs. 
We have investigated various requisite conditions, including DNA attachment to 
microbeads and the separation of single beads in emulsion droplets, and demonstrated the 
feasibility of performing SBS on microbeads by accurately identifying several bases.  
9.3 Detection of nucleic acids with molecular probes4  
Taking advantage of key characteristics of quantum dots, we designed and tested 
carboxylic QD-based FRET binary probes, with QD as the donor and Cy5 as the acceptor. 
We have demonstrated the feasibility of this BP system in the detection of a sensorin 
mRNA related DNA sequence, and by conducting parallel experiments with slightly 
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different DNA targets, we were able to discover the best probe distance for efficient 
FRET, which will be further evaluated in a cell extract and in living cells. 
9.4 Future outlook 
The molecular tools for genomic analysis are undergoing dramatic evolution with the 
increasing demand for genetic analysis (e.g., whole genome sequencing, SNP genotyping) 
and requirements of further understanding the genetic transmission leading to biological 
functions. It is believed that the advancements in mass spectrometric DNA sequencing 
and SNP genotyping, sequencing by synthesis with CF-NRTs and oligonucleotide binary 
probe systems will continue, and these technologies will continue to play important roles 
in specific applications geared toward personalized medicine. 
9.4.1 Mass spectrometric DNA sequencing and SNP genotyping 
 MALDI-TOF mass spectrometry will continue to offer an attractive option for DNA 
analysis due to its high accuracy, sensitivity and speed. With our introduction of 
mass-tagged, cleavable biotinylated dideoxynucleotides, these mass spectrometry based 
reversible solid-phase-capture sequencing and single base extension SNP genotyping 
technologies would be an ideal choice for sequencing short fragments (e.g., miRNA 
sequencing, transcriptome sequencing), mid-level sample handling and multiplexing, for 
any projects demanding extremely high accuracy and sensitivity at low cost and in a 
time-efficient manner, where either conventional sequencing technologies or 
next-generation sequencing fail to meet these requirements. They will also have 
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applications in genetic linkage and association studies for SNPs in pooled samples and 
regions containing mini-indels. The development of MALDI-TOF mass spectrometry 
technology in terms of higher available mass range, higher sensitivity and higher 
throughput will contribute to these technologies, allowing longer sequencing read-length 
and higher multiplexing level. In particular, the completion of our highly integrated, 
miniaturized, automatic, mass parallel microfluidic platform will push these mass 
spectrometric genotyping technologies to the next level.  
9.4.2 DNA sequencing by synthesis 
 As the core technology in second generation sequencing, sequencing by synthesis 
with CF-NRTs will continue to be the method of choice for genome-wide projects. It is 
believed that the sequencing read-length can be further improved by optimization of 
nucleotide chemistry, advances in detection sensitivity and increasing the number of 
sequenceable targets, as shown in Fig. 9.1. Theoretically, even with the current detection 
system and the number of starting molecules, the SBS approach has the potential to yield 
comparable read-length with Sanger sequencing (~800 bp) if only the cycle efficiency is 
99%. And this will be doubled, tripled or more by our primer walking strategy and 
further improved by the introduction of the bead-on-chip system allowing greater 
amounts of starting DNA molecules. The simple calculation of 300 million DNA 
amplicon carrying microbeads which could be easily immobilized on the microscope 
slide with read-lengths of 150-300 bp with paired-end reads will give more than 24-fold 
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coverage of the human genome in a single instrument run.  
As the development of third generation sequencing, especially single molecule 
sequencing methods, is becoming the trend, the SBS chemistry and our primer walking 
strategy can be still integrated into single molecule detection platforms, with the promise 
of de novo genome sequencing and even wider applications, including RNA expression, 
epigenetic analysis, haplotype analysis, and other important areas of genome biology and 
biomedical sciences.  
 
Fig. 9.1. Theoretical SBS read-length based on sequencing cycle efficiency. 
9.4.3 In vivo visualization of nucleic acids 
 Real-time visualization of the nucleic acids in vivo is essential to decipher the 
fundamental biological functions of genes and transcripts and hence the whole 
mechanisms. The development of next generation molecule probes with long-lived 
fluorescence or luminescence, higher sensitivity and specificity for tracking low 
abundant transcripts and the capability to overcome the cell autofluorescence will be an 
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on-going project. Specifically, for the particular interest in long term memory study using 
Alysia as the model, continuing with the successfully example of using quantum dot as 
the donor in FRET based probe, there are more sets of quantum dot based molecular 
probes that will be developed and tested for in vivo studies, targeting different types of 
mRNA.  
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